ARCHIVED - RPP 2006-2007
Health Canada

This page has been archived.

---

Tony Clement
Minister of Health, and Minister for the Federal
Economic Development Initiative for Northern Ontario

---

Section 1: Overview Section 2: Analysis of Program Activities by Strategic Outcome Section 3: Supplementary Information Section 4: Other Items of Interest

Section 1: Overview

1.1 Minister's Message

I am very pleased to present Health Canada's 2006-2007 Report on Plans and Priorities, which illustrates the initiatives the Department will implement over the next three years to address key government priorities in the area of health. I am honoured to be given the opportunity to work on behalf of Canadians towards ensuring an effective, cost-efficient and high quality health system. Canadians collectively contribute to our public health care system, and all governments have the responsibility to ensure that it is readily available to all Canadians across the country.

Since we were elected to govern in January 2006, our government has adopted six operating principles in its approach to managing the Health Portfolio: putting the patient first in disease prevention and early detection initiatives; making strategic and evidencebased investments; ensuring alignment of policies and programs across the Health Portfolio; building relationships with partners based on trust and inclusiveness; improving performance and ensuring value for money; and strengthening accountability to Parliament and the public. We have already demonstrated our commitment to these principles by agreeing to compensate Canadians who contracted hepatitis C from the blood system before January 1, 1986 and after July 1, 1990.

As Minister of Health, I have a wide array of responsibilities and priorities. As Canadians have made access to health care one of their top priorities, our government has made the Patient Wait Times Guarantee one of its top priorities. The federal government will deliver on this priority in concert with provinces, territories, stakeholders and other partners. I am encouraged by the desire expressed among my provincial and territorial colleagues for innovative and creative ideas to reduce the wait times faced too often by Canadians.

For this reason, Health Canada will work with provinces, territories and other stakeholders to:

1. establish further evidence-based benchmarks for wait times in the areas of cancer, heart, diagnostic imaging procedures, joint replacements and sight restoration;
   
   
2. encourage provincial wait-reduction targets for priority procedures; and
   
   
3. provide regular reports to Canadians on progress on wait times.

A Patient Wait Times Guarantee will complement these efforts and build on current and future accomplishments by assuring Canadians that they will receive needed care within appropriate time frames.

Directly linked to reducing wait times, we will make strides on preventing illness and improving disease management across Canada. To this end, we will work with the Public Health Agency of Canada as well as the provinces and territories to implement the Canadian Strategy for Cancer Control to improve cancer screening, prevention and coordination through work with major cancer organizations and stakeholders in Canada.We will also focus efforts in the areas of cardiovascular disease, mental illness and mental health, to name but a few.We will also take action on active living and nutrition, starting with the release later this year of the updated Canada's Food Guide.Work will continue to help ensure safer living and working environments and access to and regulation of pharmaceutical products.

With the SARS outbreak in 2003, we have seen how the health threats that arise outside our borders can quickly pose serious threats to the health of Canadians. These threats are of particular concern because they are nearly impossible to predict and have potentially catastrophic consequences. In partnership with the provinces and territories, First Nations organizations, technical experts and other federal and international partners, I am working to ensure the Government of Canada has an Avian Influenza Plan and a Human Pandemic Influenza Plan in place to mitigate the effects on Canadians in the event of a pandemic. Areas of focus will include avian and pandemic planning, enhanced surveillance capacity, updated quarantine and biosecurity legislation, and infectious disease prevention and control.

In addition to these important areas, we will work on an array of issues fundamental to the health of Canadians. We will strengthen our understanding of the linkages between health and environment, a key concern to Canadians. Health Canada, in partnership with First Nations and Inuit groups, will continue to support sustainable health care services for First Nations on reserve and Inuit people. We will also work with health partners and other federal departments to find new and innovative ways to reduce the health disparities between Aboriginal people and other Canadians. Health research will support the causes and prevention of disease, screening, diagnosis, treatment, support systems and palliative care for a wide range of conditions. For this research, our priority populations are children and youth, seniors and First Nations and Inuit people. We will also improve partnerships and dialogues with international organizations and other countries to help strengthen the Canadian health system.

As our government is determined to provide clear accountability and demonstrate tangible results to Canadians, I have instructed Health Canada to focus on result-based management. While the 2006-2007 Report on Plans and Priorities includes, for the first time, performance indicators for our programs and services to help measure and report on our progress and value for money, I am looking forward to next year's Report to demonstrate further advances on results-based reporting. We will review investments in priority areas to ensure our efforts yield real results that translate into improvements to health for Canadians.

We have established a bold and ambitious agenda but it is no less than what Canadians expect and deserve from their federal government. Through these comprehensive initiatives I am confident that Canada's health system will provide better access to the care one needs and make Canadians among the healthiest people in the world.

1.2 Management Representation Statement

I submit for tabling in Parliament, the 2006-2007 Report on Plans and Priorities (RPP) for Health Canada.

This document has been prepared based on the reporting principles contained in Guide for the Preparation of Part III of the 2006-2007 Estimates: Reports on Plans and Priorities and Departmental Performance Reports:

• It adheres to the specific reporting requirements outlined in the TBS guidelines;
• It is based on the Department's approved Program Activity Architecture as reflected in its Management, Resources and Results Structures (MRRS);
• It presents consistent, comprehensive, balanced and reliable information;
• It provides a basis of accountability for the results achieved with the resources and authorities entrusted to it; and
• It reports finances based on approved planned spending numbers from the Treasury Board Secretariat in the RPP.

1.3 Summary Information

Raison d'être: Health Canada was established to help the people of Canada maintain and improve their health. We are committed to improving the lives of all Canadians and making this country's population among the healthiest in the world as measured by longevity, lifestyle and effective use of the public health care system.

Financial Resources (in millions of dollars)

2006-2007	2007-2008	2008-2009
3,011.1	2,949.1	2,950.3

 

Human Resources

2006-2007	2007-2008	2008-2009
8,711	8,773	8,671

 

Departmental Priorities by Strategic Outcome

Strategic Outcome #1: Strengthened Knowledge Base to Address Health and Health Care Priorities Program Activity: Health Policy. Planning and Information
Corporate Priority	Planned Spending (in millions of dollars)			Expected Results
	2006-2007	2007-2008	2008-2009
Working with others to strengthen the efficiency and effectiveness of the publiclyfunded health care system (ongoing)	217.3	146.1	144.5	Goals and objectives identified for specific strategies and initiatives Knowledge development and transfer of specific health policy issues
Contributing to the improvement of the health of Canadians (ongoing)	20.7	20.6	20.5
Reducing the risks to the health of the people of Canada (ongoing)	31.7	33.6	32.3
Strengthening accountability to Parliament and the public (ongoing)	18.7	17.9	17.7

Strategic Outcome #2: Access to Safe and Effective Health Products and Food and Information for Healthy Choices Program Activity: Health Products and Food
Corporate Priority	Planned Spending (in millions of dollars)			Expected Results
	2006-2007	2007-2008	2008-2009
Working with others to strengthen the efficiency and effectiveness of the publiclyfunded health care system (ongoing)	102.4	102.4	97.1	Access to Safe and Effective Health Products and Food and Information for Healthy Choices
Contributing to the improvement of the health of Canadians (ongoing)	7.3	7.3	6.9
Reducing the risks to the health of the people of Canada (ongoing)	94.7	94.7	89.8
Strengthening accountability to Parliament and the public (ongoing)	57.7	54.8	54.3

Strategic Outcome #3: Reduced Health and Environmental Risks from Products and Substances, and Safer Living and Working Environments Program Activity: Healthy Environments and Consumer Safety
Corporate Priority	Planned Spending (in millions of dollars)			Expected Results
	2006-2007	2007-2008	2008-2009
Working with others to strengthen the efficiency and effectiveness of the publiclyfunded health care system (ongoing)	33.2	33.0	33.1	Reduced risks to health and safety, and improved protection against harm associated with workplace and environmental hazards and consumer products (including cosmetics) Reduced health and safety risks associated with tobacco consumption and the abuse of drugs, alcohol and other substances
Contributing to the improvement of the health of Canadians (ongoing)	112.1	111.6	117.2
Reducing the risks to the health of the people of Canada (ongoing)	92.2	91.8	86.7
Strengthening accountability to Parliament and the public (ongoing)	52.4	49.8	49.2

Strategic Outcome #3: Reduced Health and Environmental Risks from Products and Substances, and Safer Living and Working Environments Program Activity: Pest Control Product Regulation
Corporate Priority	Planned Spending (in millions of dollars)			Expected Results
	2006-2007	2007-2008	2008-2009
Reducing the risks to the health of the people of Canada (ongoing)	40.2	40.2	36.3	Access to safer pesticides Strengthened compliance with PCPA and Regulations Users informed of reduced risk practices Transparency of pesticide regulation Improved regulatory efficiencies and cost effectiveness Informed public and stakeholders
Strengthening accountability to Parliament and the public (ongoing)	11.4	11.0	10.8

Strategic Outcome #4: Better Health Outcomes and Reduction of Health Inequalities Between First Nations and Inuit and Other Canadians Program Activity: First Nations and Inuit Health
Corporate Priority	Planned Spending (in millions of dollars)			Expected Results
	2006-2007	2007-2008	2008-2009
Working with others to strengthen the efficiency and effectiveness of the publiclyfunded health care system (ongoing)	49.6	50.1	50.5	Strengthened community programs; better health protection; improved primary health care; and access to non-insured health benefits contribute to improved health status of First Nations and Inuit individuals, families and communities.
Contributing to the improvement of the health of Canadians (ongoing)	1,901.4	1,920.4	1,940.0
Reducing the risks to the health of the people of Canada (ongoing)	46.9	47.4	47.9
Strengthening accountability to Parliament and the public (ongoing)	121.2	116.3	115.3
Note: Figures include amounts for other departmental and regional infrastructure costs supporting program delivery.

Part A: Departmental Overview and Priorities

About Health Canada

Health Canada develops, implements and enforces regulations, legislation, policies, programs, services and initiatives and works with other federal partners, the provinces and territories to maintain and improve the overall health of Canadians. As administrator of the Canada Health Act, we ensure that the principles of Canada's universal health care are respected, allowing Canadians to be confident in the services they receive from the public health care system. The Minister of Health is also responsible for the direct administration of another 18 statutes including the Food and Drugs Act, the Pest Control Products Act and the Controlled Drugs and Substance Act. ¹

We provide policy leadership and portfolio coordination among our partners in the Government of Canada's Health Portfolio, each of which produces its own Report on Plans and Priorities, namely:

• the Public Health Agency of Canada; ²
  
  
• the Canadian Institutes of Health Research; ³
  
  
• the Hazardous Materials Information Review Commission; ⁴
  
  
• the Patented Medicine Prices Review Board; ⁵ and
  
  
• the new Assisted Human Reproduction Agency of Canada, which came into being January 12, 2006. ⁶

Health Canada also contributes grants and contributions to several health organizations such as Infoway, Canadian Institute for Health Information and Canadian Health Services Research Foundations.

Health Canada Planning Framework for 2006-2007 Report on Plans and Priorities

Health Canada's Operational Roles

Health Canada employees play key roles in the areas of promoting, protecting and improving the health of Canadians, roles that assist other stakeholders working in the area.

Innovators

As a science-based department, Health Canada employees are innovators, providing leading-edge science, sound policy research, and effective program and service development. Keeping abreast of global developments on diseases enabled Health Canada to play a leading role in Canada's response to the SARS, BSE and West Nile Virus outbreaks.

Knowledge Brokers

Through research, risk assessments and surveillance, Health Canada provides knowledge to Canadians and others working in the health care field to enable them to make sound choices to protect health. The Department also monitors and researches the health threats from environmental factors such as toxic substances, air and water pollution, climate change and other threats. This work fosters sound decisionmaking and policy-development at all levels to help reduce health risks.

Enablers

In all program areas, Health Canada brings stakeholders together, as well as provides information, research and education. The work of Health Canada enables Canadians to be up-to-date and informed about the issues that can impact their health.

Trustees/Stewards

Health Canada, through the administration of the Canada Health Act, aims to ensure that all eligible residents of Canada have reasonable access to medically necessary insured services. The Department's broad regulatory responsibilities to protect Canadians and promote health and safety range from prescription drugs and vaccines to toxic substances, from cardiac pacemakers to natural health products and food, from consumer goods to pesticides.

Proponents of Transparency

All work at Health Canada, from the assessment of products under the Canadian Environmental Protection Act to the regulation and approval of thousands of products, is conducted transparently. Health Canada has committed to be accountable in delivering results to Canadians. The public had an opportunity to be involved in consultations on major regulatory initiatives such as the new Pest Control Products Act and will continue to be consulted in other areas as part of the Department's consultations framework.

Our Mission and Objectives

Health Canada's mission is to help the people of Canada maintain and improve their health. We strive to accomplish this by promoting and protecting the health of Canadians. In order to achieve this, we will:

• Enhance the sustainability, innovation and integration of the health system;
• Sustain health protection and regulations;
• Contribute to safe environments and products; and
• Facilitate healthy lifestyle choices among Canadians.

Health Canada and partners helping Canadians make independent, informed choices

The responsibility for promoting, protecting and improving the health of Canadians does not rest with a specific level of government, the medical profession or Canadians themselves. The responsibility is found in an interwoven community of collaborating stakeholders that each contributes to this goal.

Canadians make choices everyday that affect their health and well-being. Environmental, economic and social factors also affect health. Municipal, provincial and territorial governments, health service providers and not-for-profit organizations help ensure community health services are available and provide the heath care system that Canadians rely on to protect and improve their health. The private sector helps develop pharmaceuticals and other health products for Canadians.

In addition to overseeing the Canada Health Act, the federal government helps assess risks to human health, sustains health protection efforts, regulates and approves products, and funds health services. Health Canada provides national leadership and expertise in the development of health science and policy. The federal government provides assistance to provincial and territorial governments in the provision of health care services through the Canada Health Transfer.

With respect to health programming and services for First Nations and Inuit, Health Canada supports public health and community health programs on-reserve and in Inuit communities, provides non-insured health benefits coverage regardless of residence, and delivers primary care services in remote and isolated communities to supplement and support the services that provincial, territorial and regional health authorities provide.

Health Canada's Corporate Priorities

Given the environment in which we operate, Health Canada has identified four corporate priorities to respond to the key challenges and opportunities facing the health of Canadians.

These priorities reflect the Government of Canada's direction and commitments as well as our objectives and planned strategic outcomes, which are long-term benefits to Canadians that stem from our overall mission of helping Canadians maintain and improve their health. They represent the differences we wish to make for Canadians. For more information on Health Canada's strategic outcomes, please refer to Section II of this report.

1. Working with others to strengthen the efficiency and effectiveness of the publicly-funded health care system

An efficient and effective health care system is consistently identified as a priority for Canadians. Health Canada will work closely with provincial and territorial governments, as well as health organizations and other stakeholder groups to examine new and innovative ways to strengthen the efficiency and effectiveness of a universally accessible and equitable publicly funded health care system.We will work with the provinces and territories to develop the building blocks for a Patient Wait Times Guarantee to ensure that Canadians receive the care they need, when they need it.

2. Reducing the risks to the health of the people of Canada

The Department plays a core role in protecting and promoting the health and safety of Canadians.

A potential pandemic such as the Avian Flu presents a great risk to Canadians and global health in general. That is why pandemic preparedness is a priority for Health Canada and why we will continue to work with the Public Health Agency of Canada, other countries and the World Health Organization to increase international cooperation efforts. We are already active in contributing to pandemic readiness by working in the areas of vaccines, multilateral contributions, workplace health and safety, and in emergency preparedness within First Nations and Inuit communities.

The health of Canadians is linked to the health of the environment. We are actively developing integrated approaches to better assess impacts on health and to develop strategies to mitigate known and emerging risks from pollutants and toxic chemicals in air, water, food and products, for example. Protecting and improving the health of vulnerable populations, such as children, seniors, and Aboriginal peoples, from pollutants and chemicals will benefit all Canadians. We are also active in developing regulations, which contribute to protecting the health of Canadians as well as managing the risks and benefits of health products and devices. We continue to strengthen scientific capacity to inform our regulatory responsibilities and monitor new developments.

3. Contributing to the improvement of the health of Canadians

While the majority of Canadians enjoy a high quality of life, there are areas for improvement. Health Canada will examine and implement new ways to contribute to the improved health of Canadians through collaborative work with other organizations in the Health Portfolio and with other departments towards the Government of Canada's goal of improving the quality of life of Canadians.We are working with the Public Health Agency of Canada to advance efforts on cancer, to support the efforts of stakeholders and to improve screening and prevention.

Health is more than just physical health. Mental health is an integral part of overall well-being and we are working to address mental health and mental illness issues.

A major area of concern continues to be Aboriginal health. While Aboriginal Canadians are living longer, the status of their health continues to lag behind that of other Canadians. Our goal, in collaboration with Aboriginal organizations, Health Portfolio partners, other departments and the provinces and territories, is to deliver efficient and effective health programs, services and initiatives to help improve health outcomes for First Nations and Inuit people.

4. Strengthening accountability to Parliament and the public

Our ability to effectively respond to the health needs of Canadians depends on rigourous management practices to achieve results and ensure value for money. We are reinforcing our commitment to accountability, transparency and sound management of resources by continuing to integrate the principles of modern comptrollership, introducing improved systems and processes for departmental operations and addressing human resource priorities. As part of our continued effort to strengthen our management practices, we will:

• fortify our management of grants and contributions by ensuring that solid governance structures and administrative processes are in place;
• improve governance and control of contracts using a Contract Management Framework established on the basic principles of responsibility, accountability, monitoring, oversight and audit;
• strengthen accountability and stewardship by improving performance measurement and renewing our program evaluation functions;
• continue to initiate reviews of existing systems and processes in line with Government-wide initiatives;
• continue the implementation of "The Way Forward", an information technology (IT) project that will consolidate and realign IT resources and position the Department to align with Government of Canada common services initiatives and generate savings;
• continue the implementation of the new Chief Financial Officer Branch to support the effective management of resources and improve our ability to achieve results across programs through a strengthened Financial Management and Control Framework; and
• establish a work program to continuously review and improve measurable expected results and performance indicators for the 2007-2008 RPP and beyond.

Health Canada is considered to be a leader within the Government of Canada in implementing the Management Accountability Framework (MAF), a framework that establishes the standards for management accountability in the Government of Canada. Health Canada will continue to build upon this solid foundation by integrating MAF requirements into the management culture of the Department including enhancing a risk-based approach to programs and activities.

Key Areas of Focus for Planning Period

Taking into account the current operating context, the emerging risks to the health of Canadians and the trends in Canadian society, Health Canada will focus on the following key strategic areas for the 2006- 2009 planning period:

1. Develop the building blocks for establishing a Patient Wait Times Guarantee - Reach a shared understanding on ensuring that the health care needs of Canadians are met within a universally accessible and equitable health care system. Continue working with provinces, territories and other stakeholders to share best practices and innovative initiatives to develop the building blocks for establishing a Patient Wait Times Guarantee.
2. Advance efforts to prepare for a Global Pandemic Outbreak - Collaborating with other international organizations, departments, provinces, territories and stakeholders to ensure that Canada is well positioned to prepare for and respond to a possible pandemic influenza outbreak.
3. Implement the Canadian Strategy for Cancer Control - Cancer prevention is a priority for the Government of Canada and Health Canada. To this end, we will collaborate with the Public Health Agency of Canada and other organizations to improve cancer screening, prevention and coordination through the Implementation of the Canadian Strategy for Cancer Control. The Strategy's main objectives are to reduce the number of new cases of cancer in Canada, to enhance the quality of life of those living with the disease and to reduce the number of premature deaths attributable to cancer.

Operating principles

We are guided by several operating principles in the delivery of our programs and services that help us maximize efficiency in reaching our objective of improving and maintaining the health of Canadians. These operating principles cover the broad spectrum of Health Canada's activities, which range from indepth policy analysis to scientific research.

• Sound, informed decision-making based on leading edge science
  To bring leadership, coherence and expertise to the overall strategic direction of Health Canada's scientific responsibilities and activities, Health Canada has established the Office of the Chief Scientist (OCS). The OCS will continue to champion science throughout the Department by coordinating involvement in research and regulatory science within Health Canada and within the federal science and technology community, providing scientific expertise on Health Canada priorities, fostering and facilitating partnerships, promoting and communicating Health Canada science and research, and protecting intellectual property.
  
  
• Efficient and sustainable resource utilization within legal, ethical and operational frameworks
  We are committed to sound financial management and delivering value for money for Canadians. Through the newly established Chief Financial Officer Branch, we will continue to review processes to optimize the effectiveness and efficiency of the use of our resources and follow central agency direction to ensure management accountability.
  
  
• Transparency
  We strive to develop and deliver our programs and services in an open and transparent manner by ensuring stakeholders and the public have tangible input to our work through vehicles such as public and stakeholder consultation.
  
  
• Cooperation and engagement with provinces, territories, partners and stakeholders
  We are committed to working with our partners including provincial and territorial governments, First Nations, Inuit and other Aboriginal organizations, communities, professional associations, consumer groups, universities and research institutes, international organizations, not-for-profit organizations, volunteers and other federal departments and agencies.
  
  
• Engagement in international health issues
  Increased global mobility enhances the quick spread of disease throughout the world and necessitates our active involvement in the international health community. We are committed to learning from the experiences of other countries and their best practices to minimize the risks to Canadians from global health threats.

Contributing to Government of Canada Strategic Outcomes

The following chart shows how Health Canada's Program Activities align with the Government of Canada's Strategic Outcomes, which were developed by Treasury Board of Canada Secretariat.

Part B: Internal Areas of Interest for the Planning Period

Health Canada's Operating Environment

Taking stock of domestic and international trends on a variety of aspects and monitoring emerging risks to the health of Canadians help us gain greater insight into Health Canada's operating environment and develop appropriate policies and initiatives. The description of health risks, opportunities and priorities in Canada five years ago does not match today's description and may be very different from what we will face 5 or 10 years from now.

The Changing Face of Canada

Several changes are taking place in Canadian society that affect policy and program development at Health Canada. It is well known that seniors in Canada are growing in number and living longer, posing new challenges for all aspects of health care. The average Canadian child will have an older mother and fewer siblings. A growing proportion of children are living only with single parents and many face low-income. The health system will continue with a growing proportion of them living only with single parents and many still in poverty, especially those living with only their mother. The health system will continue to face the challenges of compromised health and poor living habits among a significant portion of children living in a level of poverty. Over the coming decade, Canadians are more likely to be living in an urban centre. Onefifth will be a visible minority with roots in Asia or the Middle East and speaking languages other than French or English. A more culturally and ethnically diverse society will continue to increase the demand for alternative therapies and service providers.

Technology Pervasive in Daily Life Non-traditional disciplines such as biotechnology, artificial transplants and nanotechnology provide exciting potential to address health issues in new ways and dramatically improve the health of many Canadians in the coming decades. These new technologies will continue to challenge us to have the appropriate regulatory science to input into decision-making.

Ethical and social issues will continue to challenge us in new areas including cloning, DNA manipulation and genomics. As advances in science and technology provide more pervasive solutions in the area of health, it will be imperative to continue to integrate science into decision-making by government, industry and individuals.

The market for pharmaceuticals is expanding at an incredible rate and an efficient and effective health system must respond to this by ensuring that Canadians have timely access to safe and effective health products, drugs, food and information.

Evolving Attitudes and Values towards Health

There has been a significant shift in the Canadian public's perception of health care delivery as they are moving from patients to consumers. Because health information is readily available from a number of different avenues, Canadians are more informed than ever about their health and are more willing to discuss sensitive health issues. Canadians are also seeking new ways to have their health concerns addressed and are influenced by factors, which include religion and culture. They are also more engaged in the review of the public health care system and expect governments to discuss these issues in an open and transparent manner.

Deteriorating Physical Environment

The relationship between human health, the environment and the economy is one of the most complex health areas facing governments in Canada. The health of many Canadians will continue to be threatened by air, water and land pollution, climate change and the thinning ozone layer. The health impacts of many environmental risks are not fully understood. The increasing incidence of respiratory illness from poor air quality could grow with the expansion of urban areas and with the advancement of climate change. The health of Aboriginal communities in the North is especially vulnerable to threats posed by significant changes associated with climate change. Health Canada must be prepared to address the public expectation for protection as well as provide more developed information on the adverse health impacts and enforcement that may be required.

Toward Full Globalization

All departments including Health Canada must acknowledge the increasing unrestricted movement of people, goods and services across the globe and the potential consequences that may arise. Governments and the health community are moving beyond the "what if" to a "when" regarding the possible outbreak of a pandemic. The speed with which a pandemic outbreak can spread internationally is alarming. In order to address this potential disaster, Health Canada is actively participating in and leading many international activities such as the Global Health Security Initiative and the APEC Health Task Force.

Canada's social responsibility to continue to help address the growing health problems faced by the world's poorer nations will only increase as the life-expectancy gap between developed and less developed countries is increased by HIV-AIDS and other new and re-emerging diseases, poverty, child mortality, injuries, and non-communicable diseases.

There are opportunities to help the international community benefit from our experience in many areas including healthy living, tobacco cessation, early childhood health along with disease prevention, vaccinations, and access to safe water, to name a few areas.

Emerging Illnesses, Injuries and Diseases in Canada

While the threat of diseases outside our borders are of particular concern, just as alarming is the growing rate of chronic diseases and injuries in Canada. It is estimated that over 60,000 Canadians will die of cancer this year alone and another 79,000 will die from heart disease. Injuries are the leading cause of death for Canadians aged 1 to 44. What makes these figures particularly alarming is that many of these deaths could be prevented. A more informed population is a healthier one and Health Canada with its partners must work to address these issues and provide Canadians with the information they need to make healthy, independent choices.

Health Canada: Collaboration at Work

At Health Canada, we understand the importance of working collaboratively in order to deliver effective programs and services to Canadians. Working with an integrative and horizontal approach allows us to draw on our strengths and provide effective policy and scientific analysis across our many fields of expertise. For this reason, Health Canada is committed to continuing horizontal collaboration for this planning period. There are many ways in which Health Canada collaborates horizontally with partners to improve and maintain the health of Canadians.

• Departmentally
  At Health Canada, we are organized to respond to the various health needs of Canadians. We collaborate internally to provide the best possible services and programs to Canadians. By doing so, we draw upon not only our strengths but our experiences in any given situation. Examples of departmental horizontal initiatives include tobacco and substance abuse programs, environmental health programs, and research on pesticide residues.
  
  
• Across the Health Portfolio
  Providing health policy leadership and coordination within the Health Portfolio gives Health Canada an important role in the development and implementation of programs and services to Canadians. We collaborate horizontally on a number of health initiatives such as our work with the Public Health Agency of Canada (PHAC) on the Healthy Living and Chronic Diseases Strategy as well as on emergency preparedness and response issues. We obtain much of our health and surveillance data from PHAC. Other examples of cross-cutting initiatives include the alcohol strategy, First Nations and Inuit programs, pandemic preparedness and health benchmarks and indicators.
  
  
• Across the Government of Canada
  Health Canada recognizes the importance of horizontal initiatives across the Government of Canada. Health Canada is one of the largest departments within the federal government and health is a key consideration in the majority of the government's programs and services. Some of the interdepartmental programs we contribute to include the Canadian Environmental Protection Act and Pesticide Regulation, as well as the Service Improvement Initiative and the Sustainable Development Strategy.
  
  
• Provincial, Territorial and Aboriginal
  Health Canada works in collaboration with provincial, territorial and Aboriginal organizations on priority areas such as implementing the First Ministers' commitments of the 10-Year Plan to Strengthen Health Care. Ongoing collaborative efforts will include closing the gap in health outcomes between the general Canadian population and First Nations and Inuit; making timely access to quality care a reality for all Canadians; furthering the development and implementation of the National Pharmaceuticals Strategy; and ongoing efforts in public health and pandemic preparedness. We will also undertake a review of commitments of the 2005 Meeting of First Ministers and Aboriginal Leaders.
  
  
• Internationally
  Health Canada is exploring ways to strengthen the regulatory capacity of developing countries, especially as it relates to imported products, through organizations such as the World Health Organization. We will complete the implementation of the International Regulatory Cooperation Strategic Framework, which will ensure effective prioritization and evaluation of regulatory activities.We will establish a Memorandum of Understanding with the Australian Pesticides and Veterinary Medicines Authority in order to increase international cooperation and information sharing.We will implement regulatory cooperation initiatives under Memoranda of Understanding and Mutual Recognition Agreements on information and technical exchanges with Switzerland, U.S., China and Australia, amongst others. Health Canada is also developing an arrangement with the Therapeutic Goods Administration in the Department of Health and Ageing of Australia that allows for the recognition of quality management systems certificates issued for medical devices.

Responding to Human Resources Risks and Challenges

Health Canada's human resources planning process supports the Department's business objectives.

The Department's Annual Report on Human Resources Indicators identifies human resource management issues, risks and challenges and identifies activities that can be taken to address them. For example, the number of employees who are eligible to retire is rising every year. Therefore, managers have been asked, in their Human Resources planning, to identify succession and knowledge transfer strategies to ensure that the Department can continue to manage staff turnover and deliver results for Canadians.

Given the unique human resources issues at the branch level, each Branch human resources plan identifies the risks and activities to address them. An example of this would be that each Branch has developed a strategy to address the gap in the linguistic capacity of their key feeder groups. As well, given the strong need for renewal in the human resources community the Department is participating in an interdepartmental initiative to recruit and develop qualified human resources professionals. Health Canada is developing a departmental strategic human resources plan that will respond to Branch and Corporate risks, and provide direction for the integrated Human Resources Planning process for 2007-2008.

As a science-based department, Health Canada hires scientists as researchers and regulators, in healthrelated fields and in pure and applied science. The Department has identified several science specialties as 'shortage areas', and has developed a recruitment strategy and an employment inventory to ensure there is a pool of candidates available to fill vacant positions.

In addition, the Department performs a regular workforce analysis to identify gaps in employment equity representation (women, Aboriginal people, persons with disabilities and members of visible minority groups) and to identify measures that can be taken to address those gaps. As a result, since April 2, 2004, the representation of employees from employment equity groups has met or exceeded the proportion of such individuals available from the labour force.

Finally, in 2006-2007, we will continue to support the implementation of the Public Service Modernization Act (PSMA), a major building block in the Government of Canada's overall strategy to modernize human resources management through training and communication activities, the review of staffing policies and guidelines, the piloting of new staffing tools and approaches, and the implementation of a Staffing Monitoring Action Plan. The PSMA and the strengthening of corporate services through the human resources planning process will help ensure that the Department has the human resources it requires to deliver on its mission.

Incorporating Sustainable Development Principles into Practice

Health Canada will continue to work towards fulfilling departmental commitments outlined in its Sustainable Development Strategy 2004-2007, Becoming the Change We Wish to See, in which programs and services identify how they will incorporate sustainable development principles into practice.

Further exploration of the social dimension and its impact on health will be undertaken to better integrate this pillar with environmental and economic pillars within the context of the development of the Sustainable Development Strategy 2007-2010.

In the upcoming year, efforts will be made to work across federal departments and create interdepartmental targets, where appropriate, to facilitate better linkages of activities fostering a sustainable development approach in areas of mutual interest. Health Canada will also do its part to contribute towards government-wide initiatives, including integrating green procurement policy into the Department.

Endnotes:

¹ For more information on Legislative Acts, please visit the Department of Justice Canada's website at: laws.justice.gc.ca/en/index.html
² www.phac-aspc.gc.ca/new-eng.html
³ www.cihr-irsc.gc.ca/
⁴ www.hmirc-ccrmd.gc.ca/
⁵ www.pmprb-cepmb.gc.ca/
⁶ www.hc-sc.gc.ca/hl-vs/reprod/agenc/index-eng.html

Section 2: Analysis of Program Activities by Strategic Outcome

Strengthened Knowledge Base to Address Health and Health Care Priorities

Program Activity: Health Policy, Planning and Information

This program activity contributes to the Government of Canada Strategic Outcome: Healthy Canadians with Access to Quality Health Care.
Planned Spending and Full-Time Equivalents (FTEs)
($ millions)	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Net expenditures	375.1	288.4	218.2	215.0
FTEs	717	627	604	588
Notes: The decrease in expenditures from 2005-2006 to 2006-2007 is mainly due to a decrease in the level of funding of the Primary Health Care Transition Fund, the sunset of the Northern Health Supplement to the 2003 Health Accord, and the Expenditure Review Committee (ERC) reduction. The decrease in expenditures from 2006-2007 to 2007-2008 is mainly due to the sunset of the Primary Health Care Transition Fund. The decrease in expenditures from 2007-2008 to 2008-2009 is mainly due to a decrease in funding for the Implementation of Health Canada's Therapeutic Access Strategy. Figures include an amount for other departmental and regional infrastructure costs supporting program delivery.

Program Activity Description

The objective of this program activity is to provide policy advice and support to the Minister in making decisions to protect and improve the health of Canadians. Health Canada supports the delivery of programs and services to Canadians by developing policies and building and maintaining linkages with other partners to support health care system reform. We also work with international organizations to advance a global health agenda and contribute Canadian expertise. This helps to ensure the health, safety and security of Canadians in a healthier world. We provide a leadership role in strategic planning for the Department. We administer the Canada Health Act, and work with provinces and territories on health care renewal and support. We work with others to provide access to health care services for official language minority communities, and the interface between different sectors of the health care system.

To ensure that all Canadians have access to health services when and where they need them, that the quality of those services is continually improved, and that the system can provide the necessary care today and has the capacity to identify and adapt to the emerging needs and challenges of tomorrow, we are focussing renewal efforts, amongst other things, on the health human resources.

Another type of renewal effort is in the legislative and regulatory arenas. Legislation and Regulatory Renewal is an opportunity to deliver a much anticipated, significant and modernized legislative framework for the Health Portfolio. Much of the health protection legislation that forms Health Canada's regulatory base is out of date and not in line with modern technological advancements or public expectations, leading to gaps in what is covered, inconsistencies in addressing health risks and inadequate enforcement/compliance powers.

We provide policy advice and lead initiatives to advance women's health and to increase understanding of how gender interacts with the other determinants of health to affect health outcomes of women, men, boys and girls over their lifespan.

We undertake research and analysis to improve the availability, quality and use of evidence in health policy decision-making. We reach our goal by identifying future policy research needs, conducting extramural peer-reviewed policy research to meet these needs, communicating the results within Health Canada and externally, and by providing the expertise and tools needed for a sound and rigorous analysis of health policy options.

Our priorities

In addition to tracking emerging issues on an ongoing basis, we continue to actively participate in and collect invaluable information from various scanning activities to help identify future risks to Canadians and challenges to Health Canada. It is important to note that numerous external factors can influence our ability to focus exclusively on our priorities (e.g., the increased attention to global preparedness and response to a possible pandemic influenza outbreak or coordinating relief efforts for natural disasters). We intend to focus on the following priorities in 2006-2007:

Partner in health reform

In the 2004 Health Accord, federal, provincial and territorial governments committed to health system reforms that will improve timely access to quality care. To support the Accord, the federal government is flowing $41 billion to provinces and territories over ten years, including $5.5 billion to augment provincial/territorial existing investments and efforts in wait times reduction. In December 2005, provincial and territorial governments announced a first set of ten common evidence-based benchmarks in the areas such as cancer screening and care, cardiac surgery, hip and knee replacements and cataracts. Health Canada will work with the provinces and territories on the development of a Patient Wait Times Guarantee. Care guarantees have been suggested by many experts as one of the measures to reduce wait times.

We have made progress on all initiatives in the Accord and all governments are moving forward with their health system reforms.Work is also continuing to implement 2004 Health Accord initiatives in the following areas:

• implementing the Internationally Educated Health Care Professionals (IEHP) Initiative, which will provide additional funds to accelerate and expand the assessment and integration of IEHPs for participating governments;
• monitoring the commitment to provide first-dollar coverage by 2006 for certain home care services, based on assessed need, including: two week provision of case management and intravenous medications related to discharge diagnosis, nursing and personal care for short-term acute home care; two-week provision of case management and crisis response services for short-term acute community mental health home care; and case management, nursing, palliative-specific pharmaceuticals and personal services for end-of-life care;
• working to ensure that the populations served by federal departments (specifically First Nations, Inuit and veterans) will have access to the home care services specified in the Accord;
• continuing to support the Best Practices Network for primary health care, which is facilitating information sharing and addressing common barriers to progress; and
• working with the Health Council whose mandate is to monitor and make annual public reports on the implementation of the 2003 First Ministers' Accord on Health Care Renewal and to report on progress of the elements set out in the 2004 Health Accord.

In 2006-2007, we will continue to collaborate with our provincial and territorial counterparts as we implement commitments to health care system reform. ¹

The Primary Health Care Transition Fund (PHCTF) ($800 million over six years) is providing funding to the provinces and territories to support their efforts in reforming their primary health care systems. One of the objectives of the primary health care reform is to strengthen health promotion and prevention activities (both primary and secondary) within the sector so it can help Canadians make healthy lifestyles choices and thereby reduce the incidence of conditions such as diabetes and cancer. With PHCTF-funded initiatives concluding in 2006-2007, dissemination activities are planned to promote the uptake of knowledge and results. In turn, these knowledge transfer activities will support ongoing reform activities.

In concert with other departments involved in the Action Plan on Official Languages, we will work towards implementing administrative practices and policies to ensure that the enhanced accountability provisions of the Official Languages Act, which were introduced in November 2005, will be reflected in the provision of health services to official language minority communities across Canada.

Hepatitis C

The Government of Canada is committed to helping all those infected with hepatitis C. On July 25, 2006, the Prime Minister announced that the government reached an agreement on the elements of a settlement for those Canadians who contracted hepatitis C from the blood system before January 1, 1986 and after July 1, 1990.

Under the terms of the agreement, the Government of Canada will set aside nearly $1 billion in a special settlement fund. The level of compensation will be based on the principle of parity with compensation already provided by the federal government for those who were infected between 1986 and 1990.

Benefits will be paid on a present-value basis, meaning that class members will receive the entire sum of their compensation up front, based on such factors as current disease level and probability of disease progression. This will also serve to minimize administrative costs.

The Government of Canada will be working as quickly as possible to complete the steps needed before compensation is provided to the class. A final detailed agreement needs to be completed, and must be approved by Courts in four jurisdictions. Furthermore, an administrative structure must be set up to evaluate applications and forward payments. The federal government cannot control the timing of every remaining step, however, all efforts will be made to ensure that this proceeds as quickly and as effectively as possible.

Pandemic Influenza

Health security is a critical component of Canada's objectives for health policy, foreign policy and national security. The most pressing challenge for health security at the current time is the threat of an influenza pandemic. As such, it is critical that the Government of Canada is prepared for an influenza pandemic, and that work is undertaken with partners in the public and private sectors domestically and internationally to strengthen preparedness throughout Canada.

The potential severity and impacts have resulted in unprecedented co-operation and collaboration on a global health issue. We will continue to play an active role in preventing and preparing for avian and human pandemic influenza. This involves close collaboration with the Public Health Agency of Canada, which is the public health lead for pandemic influenza preparedness in the Government of Canada. We will strengthen preparedness in the Department's key areas of responsibility, such as First Nations and Inuit health, the regulation of vaccines, and occupational health services for federal employees. We will also complete a business continuity plan in the event of an influenza pandemic to ensure that support is provided for employees and that critical services can continue to be delivered in the event of large-scale worker absenteeism.

We will also focus on international collaboration for avian and human pandemic influenza preparedness and response, which is a critical element of Canada's domestic preparedness. Governments across the world have declared avian influenza to be a "global threat", and have recognized that international collaboration is necessary in order to control the H5N1 avian influenza outbreak, and to prepare for an influenza pandemic. Intensive efforts are underway through multilateral organizations (e.g., World Health Organization, Food and Agricultural Organization, World Organization for Animal Health) and through regional organizations (e.g., Asia Pacific Economic Cooperation, the Security and Prosperity Partnership in North America) and other fora such as G8 to collaborate in preparedness efforts.

Mental Health

Mental health and well-being are fundamental to Canadian's quality of life, as well as our social and economic development. At the same time, mental illnesses such as depression, anxiety disorders, schizophrenia and bi-polar disorders represent a significant public health challenge, impacting as many as 1 in 5 Canadians and resulting in significant costs to the health care system, society and the economy.

In May 2006, the Standing Senate Committee on Social Affairs, Science and Technology released a report on mental health, mental illness and addiction in Canada. Entitled Out of the Shadows at Last, the report underscored the breadth of the challenge associated with mental health, mental illness and addiction, as well as the need for governments to work together in addressing this important issue. Canada is currently the only G7 country without a national strategy or action plan on mental health. The federal government will work with its partners to build the foundation for a national approach to mental health and mental illness in Canada.

Health Canada will also continue to support the development of sound mental health policies and programs within the federal government, and among the provinces and territories. This includes ongoing improvements to the mental health programs, services and support to First Nations and Inuit, as well as broader efforts to improve the mental health and well-being of all Canadians, in areas such as research, information and knowledge exchange, and best practices.

Pharmaceuticals Management Strategy

Drug therapy is an increasingly important component of modern health care. Appropriately prescribed and used, pharmaceuticals can improve health outcomes for individuals and reduce costs in other health care sectors, e.g., hospitals. The development of new drugs has the potential for even greater benefits in the future. Despite their benefits, prescription drugs pose a number of challenges related to equitable and affordable drug access, drug safety and effectiveness, optimal drug therapy, and health care system sustainability. ²

Health Canada has a number of roles with respect to pharmaceuticals at different points in the drug life cycle, including at the research and development, market approval, prescribing, access, utilization and reimbursement stages. In support of improved health outcomes for Canadians and system sustainability, we will work to optimize these roles using available policy, regulatory and program instruments to better integrate pharmaceuticals into a seamless, robust health care system. We will seek to capitalize on opportunities in areas such as post-market drug safety and effectiveness, appropriate drug prescribing and use, and the drug pricing and research role of the Patented Medicine Prices Review Board.

We will also continue to work with the provinces and territories on pharmaceutical activities initiated as part of the 2004 Health Accord under the National Pharmaceuticals Strategy -- an integrated, collaborative, multi-pronged approach to addressing pharmaceutical challenges that builds on governments' shared roles in the pharmaceuticals sector and previous collaborative pharmaceutical initiatives. These activities will be linked, where appropriate, to federal initiatives to modernize the regulatory system for therapeutic products and to integrated pharmaceuticals management among federal jurisdiction drug plans.

Legislative Renewal and Regulatory Reform

Under the Health Protection Legislative Renewal exercise, which responds to shortcomings in Health Canada's legislative basis for health protection, Health Canada, with the Public Health Agency of Canada, continues to review its health protection legislation. The review is intended to modernize and reinforce key existing legislation, namely the Food and Drugs Act (1953), the Hazardous Products Act (1969) and the Radiation Emitting Devices Act (1969) through the development of enhanced health protection legislation. The resulting legislative framework will serve to modernize and strengthen the existing federal laws dealing with health protection and provide clear policy direction. As part of this exercise, the Department is also engaged in reviewing the proposed legislation to determine whether to proceed with a single piece of legislation or to continue with a phased approach as started by the expediting of the new Quarantine Act (2005).

Under the auspices of the Government of Canada's Smart Regulation initiative, Health Canada has been actively contributing to the development of a series of policies, frameworks and tools aimed at modernizing the Canadian regulatory system so that it can better respond to the challenges it currently faces (e.g., rapid scientific developments, globalization, or cross-boundary health risks, etc.) The goal of the initiative is to build a robust and flexible regulatory system that not only maximizes health, safety and environmental protection but also promotes an innovative economy.

This year, we will continue to coordinate the Department's input into a proposed Government Directive on Regulating (GDR), which is intended to build on the existing Federal Regulatory Policy by promoting increased regulatory transparency, the alignment of legislative and regulatory planning, and strategic coordination and collaboration with provincial, territorial and international partners. ³

Establishment of the new Assisted Human Reproduction Agency of Canada and new regulations

We will continue to work toward the implementation of the Assisted Human Reproduction Act, including support to the Assisted Human Reproduction Agency's successful establishment in Vancouver, B.C. in 2006-2007. The Agency will license and inspect activities controlled under the Act. The recruitment process leading to Governor in Council appointments to the Agency's new board of directors will be completed.

We are proceeding concurrently with the development of the components of the regulatory framework, which are required before the Agency can implement the licensing and regulatory regime for activities controlled under the Act. The fact that very little currently exists in terms of established guidelines, standards or regulations necessitates careful and comprehensive consultations, to ensure that regulatory objectives are met while at the same time minimizing the regulatory burden on Canadians. Regulations are expected to be promulgated in 2006-2007 to bring the last outstanding prohibition into effect and work will continue to develop the remaining components of the regulatory framework to implement the Act.

Health Human Resources

The health care sector is labour intensive. Between 60 and 80 cents of every health care dollar in Canada is spent on health human resources (HHR), and this does not include the costs of education. Currently, there are reported shortages for physicians, nurses and other health care providers. HHR is one of the four cornerstones to support real health system change. Therefore, building capacity in the system and providing adequate supply, distribution, and appropriate use of HHR is critical to reducing wait times and improving timely access to health care.

Building on health human resource activities that support the 2003 Accord and the 2004 Ten-Year Plan, we will continue with the implementation of the Health Human Resource Strategy through three broad initiatives (Pan-Canadian Health Human Resource Planning; Interprofessional Education for Collaborative Patient-Centred Practice; and Recruitment and Retention) and the Internationally Educated Health Care Professionals (IEHP) Initiative, which will provide additional funds to increase health care professional supply through the acceleration and expansion of the assessment and integration of IEHPs for participating governments.

Role of science

It is through scientific discoveries and innovations that the greatest potential benefits for the health of Canadians lie. Science also provides a foundation of evidence for policies and programs to improve the health of Canadians. In addition to work in many health sciences policy areas, we will focus on the following areas in 2006-2007:

• The dramatic increase in the development and use of genetic technologies in the health system has clear implications for the sustainability of Canada's health care system in terms of potential new ways to prevent, diagnose, treat and cure thousands of conditions. The development of new genomic-based drugs (pharmacogenomics) and diagnostics will also affect health care delivery. We will undertake policy research and analysis to support federal discussions and action in both domestic and international fora on issues such as pharmacogenomics, patent pooling in medical genetics, intellectual property issues related to stem cell research, and the development and uptake of OECD guidelines on quality assurance in genetic testing. We will also explore approaches to stimulate innovation and undertake analysis of various incentive mechanisms to spur research and development to address health needs, including vaccine development.

We continue to be committed to working with our partners on early issue identification and the monitoring of emerging technologies that impact the health of individuals, vulnerable populations and the overall health system. We will support the development of evidence-based recommendations and strategies through continued collaborative work to support excellence in the ethical conduct of human research in areas such as: research ethics education, quality improvement, the examination of models of accreditation and the development of process standards for research ethics boards; policy development on good research practices related to biobanking of human biological material samples; and the identification of potential societal impacts of nanotechnology. ⁴

Human resources risks and challenges

The human resources challenges are very similar to those faced in other areas of the Department and even across the federal government including staff turnover, retention and the recruitment of skilled and knowledgeable policy analysts. Given the extent of our involvement in policy work and the importance of a viable policy capacity, these issues must be addressed to ensure we maintain an adequate capacity to address future policy issues. Though we are heavily involved in recruitment programs (e.g., Economist and Sociologist Development Program), we continue to face challenges in recruiting and retaining policy analysts, given the competitive labour market in this area.

Horizontal linkages

We continue to manage and collaborate on horizontal files for the Department and build linkages within and outside of Health Canada. For example, we manage and coordinate the Federal Inter-departmental Task Force on Mental Health.We also work across the Health Portfolio to ensure that public health is integrated within our advice and support to the Minister.

Continuing on the horizontal policy research themes (Health Innovation, Research on Regulation, Healthy Communities and First Nations and Inuit Health Sustainability) that resulted from the policy research priority setting exercise completed in 2004-2005, cross Portfolio steering committees pertaining to each of the four priority themes were established under Memoranda of Understanding (MOUs) among our branches and the Public Health Agency of Canada. These MOUs will guide our research efforts over the next two to four years.

Since February 2004, the federal Interdepartmental Working Group on Trafficking in Persons, including organs and tissues (IWG TIP), with 14 federal departments and co-chaired by the Departments of Foreign Affairs and Justice, was mandated to coordinate federal efforts to address TIP and develop a federal strategy.We are the lead for the Health Portfolio and we continue to coordinate the Portfolio's input while promoting a holistic approach to the inclusion of health, gender and diversity considerations.

Health Canada is an active member of the Ontario Federal Council's Ontario Information Technology Network. The objective of the OFC/OITN is to identify and promote areas for collaboration and the sharing of IT resources and strategic planning information among federal government IT managers in the Region. Two significant areas of collaboration are in remote locations IT support and connectivity and integrated IT infrastructure planning.

Performance Measurement Strategy

We continue to enhance our performance measurement to provide information on our activities. To streamline the numerous reporting mechanisms, we adopted a new strategy, linking our activities directly to outcomes over the immediate (one to three years), intermediate (three to five years) and long term for outcomes five years and beyond. This approach will support all of our public reporting requirements including the Program Activity Architecture and the Departmental Performance Report. During this reporting cycle, we will work towards collecting performance information to report on the period over the next three years.

The intermediate outcomes planned for the policy planning and research program activity identified below will be addressed in various areas. As a result, a wide spectrum of activities across the Portfolio will be directed towards the same goal.

Expected Results	Performance Indicators
Goals and objectives identified for specific strategies and initiatives	Reflection of goals and objectives identified in workplans and priorities
Knowledge development and transfer of specific health policy issues	Dissemination of research (e.g, number and type of studies completed, number of requests for input, number of links added to websites) Assessment of knowledge development and transfer among governments and stakeholders

Key Programs and Services

Health Care System Policy

In September 2000, First Ministers agreed to continue to make primary health care reform a priority and indicated that improvements to primary health care are crucial to the renewal of health services. In response to this commitment, the Government of Canada announced the Primary Health Care Transition Fund (PHCTF), an $800 million investment from 2000-2001 to 2006-2007. The Fund is supporting provinces, territories and various health care system stakeholders, via contribution agreements, in their efforts to reform the primary health care system. More specifically, it will support the transitional costs of implementing sustainable, large-scale primary health care renewal initiatives which will improve access, quality of care, accountability, and integration of services. Although the PHCTF itself is time-limited, the main goal of the Fund is to bring about permanent and sustainable changes to the organization, funding and delivery of primary health care services. The fund is supported by a federal, provincial and territorial advisory group and Health Canada plays an active facilitation role to foster dialogue and knowledge sharing between and among recipients (government and non-government). With PHCTF-funded initiatives concluding in 2006-2007, all recipients will be submitting final reports including their evaluation reports, and dissemination activities are planned to promote the uptake of knowledge and results. In 2004-2005 a mid-term evaluation of the PHCTF was conducted to assess program structure and effectiveness. The final, or summative evaluation, will be conducted in 2006-2007 and will focus on the results and impact of the PHCTF; it will be available in early 2007-2008.

Health Canada is also supporting knowledge transfer and the uptake of successful strategies the Best Practices Network (FMM 2004). The Primary Health Care Transition Fund will ensure the results and lessons learned of the program are shared for continued progress in primary health care renewal. Planned activities include:

• a series of synthesis papers highlighting the evidence in areas such as chronic disease management, information management, collaborative care (i.e. teams) and evaluation methodology;
• a series of fact sheets on the results and evidence of each initiative;
• a national conference in February 2007; and
• a database, accessible via Health Canada website, to be an ongoing resource for provinces/territories, stakeholders and the public.

Several provincial and territorial governments have publicly committed to continuing the primary health care reforms begun under the PHCTF.

Recognizing the evidence gap for quantitative data on primary health care in Canada, the PHCTF funded the Canadian Institute of Health Information to develop a set of consensus-based national indicators. A legacy of the PHCTF will be the improved capacity for evaluating primary health care. As well, the Health Council of Canada's monitors and reports publicly on primary health care progress.

Note: With the exception of Quebec, all provinces and territories (and in fact all recipients) are required to submit regular reports to Health Canada including narrative progress reports, financial reports, final reports on results and final evaluation reports. These requirements are consistent with the Treasury Board Transfer Payment Policy and related accountability requirements associated with contribution agreements.

Expected Results	Performance Indicators
Knowledge development and transfer of specific health policy issues	Dissemination of research (e.g, number/type of studies completed, number of requests for input, number of links added to websites) Assessment of knowledge development and transfer among governments and stakeholders

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
66.1	20	0.1	0	0.1	0
*All financial figures in millions of dollars

Intergovernmental

Health Canada is responsible for the administration of the Canada Health Act (CHA), which involves monitoring a broad range of sources to assess provincial and territorial compliance with the criteria and conditions of the Act, working in partnership with provinces and territories to investigate and resolve CHA compliance issues, pursuing activities to encourage provincial and territorial compliance with the CHA, providing policy advice and informing the Minister of possible non-compliance with the Act, and recommending appropriate action.

The Department also provides strategic advice and coordination on a full range of Health Portfolio policy issues involving collaboration with provincial and territorial partners, while ensuring that federal priorities are advanced.

Under the Official Languages Act and the Action Plan for Official Languages, we manage health contribution programs to support the vitality of official language minority communities across Canada and ensure ongoing consultations with these communities.

Expected Results	Performance Indicators
Knowledge development and transfer of specific health policy issues	Dissemination of research (e.g, number and type of studies complete, number of requests for input, number of links added to websites) Assessment of knowledge development and transfer among governments and stakeholders

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
44.0	64	29.8	64	29.8	64
*All financial figures in millions of dollars

International

Public health risks and threats originating beyond Canada's borders increasingly influence the health of Canadians. International collaboration on global health policies and developments is of growing importance to the sustainability and responsiveness of Canada's health system. Health Canada positions itself internationally to: anticipate and respond to international health developments and their impact on Canadians and the health system; influence international health events and fora to improve health globally; provide leadership on selected health issues such as pandemic preparedness, HIV/AIDS and tobacco; and work with the multiplicity of players on the global health scene to advance health and health security.

In order to shape and strengthen the international agenda on health and health care issues, consistent with Canada's priorities and values, we will continue to work in close cooperation with multilateral agencies such as the World Health Organization (WHO) and the Pan American Health Organization (PAHO).

Expected Results	Performance Indicators
Knowledge development and transfer of specific health policy issues	Dissemination of research (e.g, number and type of studies complete, number of requests for input, number of links added to websites) Assessment of knowledge development and transfer among governments and stakeholders

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
21.8	26	21.6	26	22.0	26
*All financial figures in millions of dollars

Assisted Human Reproduction Implementation Office

Description: Set-up of Assisted Human Reproduction Agency of Canada

Expected Results	Performance Indicators
The Assisted Human Reproduction (AHR) Agency begins operations in 2006-2007. Regulatory development - Consultations to continue on all remaining sections of the AHR Act in 2006-2007 to be followed by drafting of regulations in preparation for prepublication in Canada Gazette Part I. Progress towards the development of the Personal Health Information Registry.	Governor-in-Council appointments of candidates to board of directors completed. Timely policy development papers and reports. Consultations in support of regulatory development. Draft regulations in preparation to be prepublished in Canada Gazette Part I. Performance will be measured by state of approval of plans and assessments, and the stage of a test version of the Registry.

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
4.9	29.8	3.3	22	1.6	8
*All financial figures in millions of dollars

Legislation Renewal

Health Canada will continue the development of a proposal to replace the Food and Drugs Act(1953), parts of the Hazardous Products Act (1969/safety of consumer and industrial products) and the Radiation Emitting Devices Act (1970), with a new Health Protection Legislative framework. The objective of the new framework is to update, strengthen, and integrate federal health protection legislation to be more responsive to present and future social and technological realities and provide the tools needed to better protect the health and safety of Canadians.

Expected Results	Performance Indicators
Goals and objectives identified for specific strategies and initiatives	Reflection of goals and objectives identified in work plans and priorities

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
1.3	0	1.3	0	1.3	0
*All financial figures in millions of dollars

Women's Health and Gender Analysis

Health Canada works horizontally to promote equitable health outcomes across the lifespan for women, men, boys and girls. It provides leadership and oversight to: women's health; women's health research and information; gender based analysis; and, with a diversity overlay, in policy development within the Health Portfolio. It funds the Centres of Excellence for Women's Health, Canadian Women's Health Network as well as Research Working Groups, and collaborates with an expansive network of women's health organizations and other stakeholders at the international, provincial and regional levels to engage the public in the policy development process.

Expected Results	Performance Indicators
Knowledge development and transfer for specific health policy issues Enhanced health policy research capacity (ongoing)	Dissemination of research (e.g., number and type of studies completed, number of requests for input, number of links added to websites) Assessment of knowledge development and transfer among governments and stakeholders Number of hits to website Assessment of health policy research capacity among governments and key stakeholders

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
4.9	19	4.9	19	4.9	19
*All financial figures in millions of dollars

Applied Research, Dissemination and Accountability

In the area of applied research and analysis, we support policy decision-making by developing and implementing a strategic policy research agenda for medium and long-term issues, helping co-ordinate internal and external policy research activities, and funding extramural research under the Health Policy Research Program. This fosters a performance-based and outcomeoriented culture by developing the tools and information base for better accountability. It plays a key role in knowledge management by managing a policy research dissemination program, including publication of the Health Policy Research Bulletin, and by making core data sets and the informatics tools to access them available.

Expected Results

Performance Indicators

Target audiences accessing data, analysis and information that is useful for evidence-based policy and program development

Demonstrated impact of analytical and performance information and tools on policy and program development Percentage of target population rating analytical and performance information and tools as useful Percentage of new Statistics Canada and the Canadian Institute for Health Information (CIHI) releases made available on time within Health Canada Number of data files and publication made available on the Department's electronic data and information system

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
4.9	60	36.6	60	36.6	60
*All financial figures in millions of dollars

Endnotes

¹ www.hc-sc.gc.ca/hcs-sss/delivery-prestation/fptcollab/2004-fmm-rpm/index_e.html
² For more information on these challenges, see the National Pharmaceuticals Strategy Progress Report, summer 2006.
³ www.regulation.gc.ca/default.asp?Language=E& Page=thegovernementdirectiveon
⁴ Nanotechnology is defined as the application of science to develop new materials and products, where at least one dimension is smaller than 100 nm, and involves the manipulation of matter at the nanometre scale - a nanometre (nm) is a billionth of a metre (10-9m), or a hundred times smaller than a virus.

Other programs and services that contribute to this program activity total $140.5 million for 2006-2007.

Strategic Outcome: Access to Safe and Effective Health Products and Food and Information for Healthy Choices

Program Activity - Health Products and Food

This program activity contributes to the Government of Canada Strategic Outcome: Healthy Canadians with Access to Quality Health Care.

Planned spending and full-time equivalents (FTEs)

($ millions)	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Gross expenditures	294.6	303.3	300.4	289.3
Less: Expected respendable revenues	37.7	41.2	41.2	41.2
Net expenditures	256.9	262.1	259.2	248.1
FTEs	2,503	2,592	2,667	2,656
Notes: The increase in expenditures from 2005-2006 to 2006-2007 is mainly due to an increase in the level of funding for Strengthening the Safety of Drugs, and is partially offset by a decrease in funding for the Implementation of Health Canada's Therapeutic Access Strategy and the Expenditure Review Committee (ERC) reduction. The decrease in expenditures from 2006-2007 to 2007-2008 is mainly due to the sunset of funding for Health Canada's Response to Bovine Spongiform Encephalopathy in Areas of Risk Management and Targeted Research. The decrease in expenditures from 2007-2008 to 2008-2009 is mainly due to decrease in funding for the Implementation of Health Canada's Therapeutic Access Strategy, and the sunset of a transfer from Agri-Food and Agriculture Canada for the Agriculture Policy Framework. The change in the FTEs is due to the increase of the salary component of the operating budget. Figures include an amount for other departmental and regional infrastructure costs supporting program delivery.

Program Activity Description

As Canada's federal authority responsible for the regulation of health products and food, Health Canada evaluates and monitors the safety, quality and effectiveness of the thousands of drugs, vaccines, medical devices, natural health products and other therapeutic products available to Canadians, as well as the safety and nutritional quality of their food. Under this program activity we also review veterinary drugs sold in Canada for safety and effectiveness for animals, and for the safety of foods derived from animals treated with these drugs. Finally, we promote the health and well being of Canadians through a broad range of activities related to health products and food, including developing nutrition policies and standards such as Canada's Food Guide to Healthy Eating.

A core federal health protection responsibility is the regulation of therapeutic products under the legislative framework of the Food and Drugs Act. The federal government's role in protecting health and safety is well recognized and supported by Canadians. However, the regulatory system for drugs and other therapeutic products is facing a number of challenges, including: rapidly advancing science and technology; public expectations for access, safety and transparency; improving linkages to health system decision-making regarding coverage for, and cost of, pharmaceuticals and related products in current systems; and meeting industry demands for faster approvals and increased intellectual property protection.

There is strong evidence of rising rates of acute and chronic disease directly associated with diet (e.g., diabetes among Canadians). While Canadians are increasingly aware of the threats to their health from factors like poor diet, physical inactivity and excessive weights, work and leisure patterns in our society have changed, making us less active and more reliant on foods high in energy which is contributing to increasing rates of chronic disease. With respect to food safety, emergence of new foodborne pathogens and emerging infectious diseases (e.g., avian influenza), and the threat of bioterrorism (e.g., linked to botulism), have increased consumer expectations in Canada and abroad for the role of governments in ensuring the quality and safety of Canada's food supply.

In moving forward, there is a need to continue to modernize legislative and regulatory frameworks to keep pace with changing science, consumer expectations, international developments and other pressures for change. To ensure an integrated approach, it is suggested that a long-term plan to modernize the regulatory system for therapeutic products be developed, based on a vision to improve access to safe, effective and affordable drugs and other therapeutic products. To strengthen collaboration with provincial and territorial governments in their health system and drug plan management roles, this plan needs to be strongly linked to the National Pharmaceuticals Strategy. From the perspective of food and nutrition, Health Canada will continue to work with Health Portfolio partners, the Canadian Food Inspection Agency and other partners to provide leadership on food policy issues in order to improve health outcomes for Canadians and reduce the burden on the health care system.

Health Canada relies heavily on science and risk management in making our regulatory and policy decisions. As scientific knowledge and technical expertise are critical inputs into the development of our regulations, policies and advice, we will continue to conduct laboratory-based research. We will focus on the human health implications of potentially hazardous chemicals in the food supply, including effects on behaviour and the immune system; conditions leading to the survival, growth and toxin production of infectious and toxigenic bacteria; awareness of hazard-prone foods; establishment of safe levels to prevent human injury; and risks and benefits associated with nutrients in the diet. We will also continue to conduct research in areas related to the safety and effectiveness of biotherapeutics, blood and blood products, and vaccines.

Health Canada faces a pressing challenge in sustaining our human resources. It is estimated that within the next five years a significant number of our employees in the specialized and technical fields, which includes biologists, chemists and medical officers, will be eligible for retirement.We will continue to address this through our human resources planning.

We are working with federal science and technology partners to promote and protect the health and safety of Canadians. Some of our work includes collaborating directly with Agriculture and Agri-Food Canada, Environment Canada, the Canadian Food Inspection Agency (CFIA) and the Public Health Agency of Canada (PHAC) to develop responsive food policies and regulations, such as Canada's Strategy for Safe Food. We are also working with CFIA to promote food safety as a science priority for Canada. Our ongoing work with Statistics Canada and PHAC is enabling us to collaborate on public health data surveys as well as to share information that is important in our ongoing analysis of and preparation for potential health risks associated with emerging diseases.

Internationally, Health Canada is working with the World Health Organization (WHO) and other multilateral organizations on health product and food safety issues. We are also working with other governments to strengthen and promote broader regulatory cooperation and encourage technical information exchange. We will continue to implement the commitments in the Security and Prosperity Partnership of North America, including hosting discussions on pharmaceutical review processes, food safety regulatory coordination, assessment and enhanced surveillance research with related agencies in Canada, the U.S. and Mexico. Bilaterally, we will work with the U.S. Food and Drug Administration through our memorandum of understanding, and on initiatives such as the development of a single set of reference values for nutrition labelling and improving the compatibility between our approaches to food fortification.

Health Canada's regional offices contribute to the delivery of our mandate by developing and delivering key programs and services, including monitoring risks, and the investigation and inspection associated with the importation, sale and manufacture of health products. Working directly with regional stakeholders and provincial and municipal governments, regional offices promote and facilitate consultation and collaboration.¹ These partnerships are allowing our regional offices to participate in the monitoring of adverse reactions and assist in developing policy responses on food safety, nutrition, natural health products, antimicrobial resistance, and the efficacy of health products. Further, regional laboratories are increasing our science capacity to develop and manage food safety research and surveillance projects on natural toxins, genetically modified food, food allergen detection, method development and nutrition as part of the national laboratory network. Two of these laboratories are also supporting our responsibilities to ensure manufacturer compliance with regulatory requirements for health products.

Performance Measurement Strategy

The Performance Measurement Strategy for this strategic outcome will help us measure our expected results over time, and determine if our current program activity is appropriate to ensure Canadians have access to safe and effective health products and food, as well as to provide useful information for healthy choices.

Expected Results	Performance Indicators
Access to Safe and Effective Health Products and Food and Information for Healthy Choices	Level of satisfaction of Canadians and health professionals with the information disseminated for healthy choices and informed decision-making Incidence of foodborne illnesses (where food is the causative agent)

Key Programs and Services

Pre-market evaluation and regulatory process improvement

Description: Making regulatory functions more efficient, effective, and responsive to Canadians by streamlining processes and collaborating more closely with other organizations to ensure Canada continues to have a world class regulatory environment.

Expected Results	Performance Indicators
Improved timeliness, transparency and predictability of the regulatory process	Percentage of overall workload in backlog and percentage of decisions issued within target for submission reviews of: -pharmaceuticals -biologics -food additives, packaging, chemical contaminants, novel foods and nutritional submission processing*

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
125.8	1,164.3	124.4	1,198.0	119.1	1,193.1
* Data is collected and reported quarterly. Our commitment is to meet 90% of performance targets for new pharmaceutical drug submission reviews by March 2006, and for new biologic drug submissions by March 2007. Baseline data for expected performance results is available within current tracking systems and internal records. ** All financial figures in millions of dollars

Health Canada will contribute to regulatory renewal through improving regulatory performance and modernizing the regulatory system. ² For example, given the increasing number and complexity of drug submissions, the initiatives under the Therapeutics Access Strategy will continue to reduce and eliminate submission backlogs, enabling us to meet our performance targets for pharmaceuticals in March 2006 and biologics and genetic therapies by March 2007. ³ In addition, we are reducing submission times for veterinary drugs and have set service standards dependent on submission type. These milestones will be met by enhancing human resources capacity and increasing international collaboration and cooperation as well as adopting and applying project management techniques. The Community of Federal Regulators, a partnership of all federal departments and agencies that have a regulatory role, is working to meet the requirements of the proposed new Government Directive on Regulating and Smart Regulations. ⁴

We will continue to develop and apply innovative approaches to the regulation of health products and food to improve and sustain the timeliness and efficiency of the regulatory process to address the concerns of Canadians regarding safety, effectiveness and access. We will develop new regulatory approaches for radio-pharmaceuticals used for diagnosis and radiation therapy; for product-specific health claims for foods; for drug product licensing to support early access to promising drug therapies; and for a national approach to clinical trials. As well, a new external charging regime will be developed as part of a long term funding strategy to ensure adequate resources to sustain regulatory performance for human and veterinary drugs and other therapeutic products. We will begin to review regulations that require the pre-market safety assessment and authorization of foods and food products before they can be offered for sale.

As part of Health Canada's initiative to strengthen the safety system for therapeutic products, we will strengthen the oversight of clinical trials and investigational testing of medical devices conducted in Canada, access points for patients to new and innovative therapies. The trials and investigational testing provide the evidence of safety and efficacy required by the Regulations before a product may receive a general market authorization from Health Canada. The Department will increase capacity in 2006-2007 to allow the continued assessment of an increased number of applications within targeted time-frames; strengthen capacity to assess clinical trial and investigational testing of adverse reaction reports in order to detect, communicate and act on safety signals; and engage sponsors earlier in the clinical trials process. Moreover, through the safety initiative, Health Canada will update the national standards for blood and for cells, tissues and organs, while continuing to develop and implement an appropriate regulatory framework for these components. A program for compliance inspections of establishments will also be implemented.

Health Canada will work with the federal, provincial and territorial health and agriculture agencies involved in administering the national food safety system to better respond to current and emerging food safety issues. A major initiative will be Canada's Strategy for Safe Food. It engages federal, provincial and territorial governments, industry, academia and consumer groups to improve the overall management of the food safety system in Canada by developing a common vision and national priorities, and national public health outcomes, targets and indicators.

We will continue to lead development of a federal Biotechnology Stewardship Framework to encourage an integrated approach to managing the risks and benefits of biotechnology products and services in the public interest.

Information, education and outreach on health products, food and nutrition

Description: Responding to the growth of Canadian public interest in health issues by disseminating more information, written in language that is easy to understand, on how Canadians can maintain and improve their health.

Expected Results	Performance Indicators
Improved adoption in making safe and healthy choices for health products, food and nutrition	Percentage of target populations using information in their decision-making*

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
13.1	93.6	13.0	96.3	12.4	95.9
* Data is analysed and reported every two years. Health Canada will conduct a survey to assess the rate at which people use information to make health related choices. The target and actual rate will be determined in 2006-2007. The date to achieve the target is April 2008. *All financial figures in millions of dollars

Health Canada will continue to provide useful information about the risks and benefits related to health products and food in order to help Canadians make informed decisions about their health. For example, we will develop food labelling policies as part of an integrated health and food safety policy tool kit that will be capable of responding more quickly and effectively to current and emerging health and food safety challenges. MedEffect, part of the initiative to strengthen the therapeutic products safety system, will enable us to maintain a website for posting safety alerts, public health advisories, press releases and notices for health professionals, consumers and other interested parties. ⁵ A similar website has been developed for veterinary drugs. ⁶ Also, as part of the overall effort to better inform Canadians, Health Canada will continue to provide balanced information on newer technologies and their applications, including biotechnology and nano-technology.

Promoting and supporting healthy eating and informing Canadians about risks related to the food supply are key in helping them to maintain and improve their health. For instance, Canada's Food Guide to Healthy Eating plays an important role in communicating healthy eating to Canadians. In 2006, a revised Food Guide will be completed and disseminated along with supporting materials, including a resource for intermediaries and a web-based interactive component. The Food Guide is being revised to ensure the guidance it offers continues to promote a pattern of eating that meets nutrient needs, promotes health, and minimizes the risk of nutrition-related chronic diseases. At the same time, the revision will strive to improve Canadians' understanding and application of the Food Guide.

Health Canada is working with the Public Health Agency of Canada to advance the healthy eating component of the Integrated Strategy on Healthy Living and Chronic Disease with a focus on multisectoral leadership and collaboration nationally and internationally. In addition, through this initiative Health Canada will develop nationally agreed upon nutrition indicators and targets, enhance efforts in knowledge development, synthesis and exchange, as well as develop and enhance nutrition surveillance capacity.

In 2006, an interactive Nutrition Label tool on the Health Canada website will be launched to help Canadians make informed choices about the foods they eat. ⁷ The tool will explain how the information on the new food label, which became mandatory on most prepackaged foods in December 2005, can be used to make healthy food choices. Enhancing awareness of nutrition labelling will also be accomplished through related initiatives such as the launch of the revised Canada's Food Guide.

Monitoring safety and therapeutic effectiveness and risk management

Description: Increasing the responsiveness to specific public health issues through the development of monitoring and surveillance systems and stronger compliance and enforcement activities.

Expected Results	Performance Indicators
Strengthened vigilance over safety and therapeutic effectiveness for health products and food on the market	Overall rating of Health Canada's post-market safety and therapeutic effectiveness activities*

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
104.8	1,171.3	103.7	1,205	99.2	1,200.3
* Health Canada's performance will be assessed through surveys, compliance rates and statistical analysis of adverse reaction data. Results from surveys such as those conducted by the Canadian Hemophilia Society will be reviewed as they are available. 8 Target of 95% compliance from inspections based on internal records has been set for health products. Implementation of new technologies will be used to meet internally harmonized standards for adverse reaction reports by 2007. *All financial figures in millions of dollars

Recognizing the cross cutting nature of nutritionrelated surveillance activities, we will continue to transfer knowledge and build capacity needed for creating and improving evidence-based policies, programs and community interventions in collaboration with the following partners: Statistics Canada, the Public Health Agency of Canada, the Canadian Institutes of Health Research, and stakeholder organizations such as the Federal/Provincial/Territorial Group on Nutrition, the Network on Healthy Eating and the Canadian Community Health Survey (CCHS) User's Group. Specific activities in 2006-2007 will include the approval of national nutrition indicators, the dissemination of a user's guide to assist nutrition stakeholders with the interpretation of the CCHS nutrition data, and the dissemination of a themed report on Food Security using CCHS data. ⁹

The 2006-2007 Canadian Health Measures Survey conducted by Statistics Canada will help increase Health Canada's capacity to monitor determinants of healthy eating. For example, the results of the survey will help decision-making related to the fortification of foods and the assessment of the prevalence of nutrition-related risk factors for cardiovascular disease and diabetes.

Health Canada will implement new safety measures to strengthen post-market surveillance activities designed to improve real world safety and effectiveness that are linked to the National Pharmaceutical Strategy. We have developed and used the Canadian Adverse Drug Reaction Information System to monitor suspected adverse reactions to health products. With significant advancements in technology and the establishment of international standards for data transmission, we will obtain and begin the implementation of a new and advanced adverse reaction monitoring system. The system will enable the collection and assessment of adverse reaction reports which span the entire life-cycle of health products, from pre-market testing to postmarket use, and will improve the overall efficiency of processing, managing and assessing adverse reaction reports. The system will comply with international standards recommended by the International Conference on Harmonization. For veterinary drugs, we have developed an adverse drug reaction reporting system and plan to develop a closer link between pre-market and post-market activities. In addition, Health Canada will consult with stakeholders and Environment Canada to develop environmental assessment regulations to help minimize the effects of therapeutic products on the environment.

Clinical trials require compliance inspections to protect people enrolled in them as well as the integrity and accuracy of the data that supports the application for new drugs bound for market. Through the initiative to strengthen the safety system, the number of clinical trial inspections in 2006-2007 will be increased to 60, equivalent to 1.5% of all clinical trials, with a view to achieving the international level of 2% in future years. This objective was recommended by the Standing Committee on Health in 2004. ¹⁰

The 2004 Office of the Auditor General's Report noted the need to take action concerning unapproved medical devices on the Canadian market.¹¹ Health Canada had already implemented an inspection program for medical devices establishments in 2004 with limited funds. For 2006-2007, the Therapeutic Product Safety Initiative is increasing the program's funding to $1.8 million to conduct an estimated 170 inspections and associated follow up activities on medical devices establishments. This will increase our presence in the field and will encourage greater compliance with the Medical Devices Regulations.¹²

Health Canada will continue to work with PHAC to implement the Canadian Pandemic Influenza Plan and to support the WHO's Global Agenda for Influenza Surveillance and Control. The Department will spend $6.2 million over 5 years, as well as $1.2 million ongoing, for planning and preparedness activities, providing regulatory guidance during the development of a prototype vaccine, developing a regulator's emergency implementation plan and designing an accelerated approval process.

Transparency, public accountability and stakeholder relationships

Description: Bringing more transparency to our decision-making processes by providing more accessible information about the science underpinning our decisions. Health Canada is also strengthening its capacity to involve the public in decisionmaking that in the past have been limited to scientific experts.

Expected Results	Performance Indicators
Improved public confidence and trust in the safety of health products, food and the regulatory system Level of public confidence of safety of health products, food, and nutrition	Level of public confidence of safety of health products, food, and nutrition Percentage of stakeholders who hold a positive view on HPFB's transparency and openness regarding regulation of health products and food

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
18.3	163.0	18.1	167.7	17.4	167.0
The progress of public confidence will be monitored with the aim of maintaining or increasing this level. The goal is to attain 85% of stakeholders holding a positive view on transparency and openness initiatives related to health products and food. Feedback from stakeholders will be sought as part of consultation activities to learn and improve over time. *All financial figures in millions of dollars

Incorporating the views of citizens and stakeholders is critical for effective regulation in the public interest. Maintaining and strengthening public confidence is especially important in a world where the accelerating rate of scientific and technological advances carries both benefits and risks. Public confidence in the regulatory system, particularly as it applies to healthrelated products and services, is a prerequisite for ensuring that new and sustainable health innovations are available to and used by Canadians. As such, Health Canada is developing new tools to improve the transparency and openness of our regulatory system including convening national consultations and public forums on therapeutic health product and food safety issues important to Canadians, as well as developing and updating food safety guidelines, and assuring that new substances used in health products meet Canada's environmental assessment requirements.

Health Canada's Office of Paediatric Initiatives will serve as a focal point for an integrated approach to child health and safety issues across a number of regulatory areas, including food and nutrition and the safety and effectiveness of health products. The Office will bring together internal and external stakeholders to focus on these issues. The intended result for Canadians is improved, accessible information on the safety and effectiveness of health products used in children and on safe and nutritious food for them to consume.

In its April 2004 report, the Standing Committee on Health recommended that Canada introduce measures to ensure public confidence in the clinical trial process, starting with the disclosure of information about clinical trials through a public database. An External Working Group was formed to develop options for the registration and disclosure of clinical trial information. Further consultations will be held over the next year and will be informed by international efforts to create a harmonized approach to clinical trial registration and disclosure. ¹³ This process will allow for improved public access to meaningful clinical trial information while respecting the need for patient privacy and commercial confidentiality.

Endnotes

¹ The Ayurvedic Medicine Information Session, Dietary Guidance Regional Consultations, MedEffect Information Session, and Regional Stakeholder Food Forum.
² www.pco-bcp.gc.ca/smartreg-regint/en/08/rpt_fnl.pdf
³ Numbers of Health Canada clinical trial applications and medical device investigational testing applications

	2001	2002	2003	2004	2005(Q1-2)
Clinical Trial Applications (30-day)	642	614	691	707	628
Clinical Trial Applications (7-day)	129	677	796	1,026	1,066
Clinical Trial Application - Total	771	1,291	1,487	1,733	1,694
Investigational Testing	89	94	100	123	131

⁴ www.cfr-crf.gc.ca
⁵ www.hc-sc.gc.ca/dhp-mps/medeff/index_e.html;
www.hc-sc.gc.ca/ahc-asc/branch-dirgen/hpfb-dgpsa/mhpd-dpsc/pediat_e.html
⁶ www.hc-sc.gc.ca/dhp-mps/vet/index_e.html
⁷ www.hc-sc.gc.ca/fn-an/surveill/index_e.html
www.hc-sc.gc.ca/fn-an/label-etiquet/nutrition/index_e.html
⁸ www.hemophilia.ca/en/10.1.4.php
⁹ www.hc-sc.gc.ca/fn-an/surveill/index_e.html
www.hc-sc.gc.ca/fn-an/surveill/nutrition/commun/index_e.html
¹⁰ www.hc-sc.gc.ca/dhp-mps/compli-conform/clini-pract-prat/report-rapport/2003-2004_tc-tm_e.html
¹¹ www.oag-bvg.gc.ca/domino/reports.nsf/html/20040302ce.html
¹² www.hc-sc.gc.ca/dhp-mps/compli-conform/info-prod/md-im/insp_strat_md-strat_insp_im_tc-tm_e.html
¹³ www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/proj/enreg-clini-info/index_e.html

Strategic Outcome: Reduced Health and Environmental Risks from Products and Substances, and Safer Living and Working Environments

Program Activity - Healthy Environments & Consumer Safety

This program activity contributes to the Government of Canada Strategic Outcome: Healthy Canadians with Access to Quality Health Care.

Planned spending and full-time equivalents (FTEs)

($ millions)	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Gross expenditures	289.9	305.4	301.9	302.3
Less: Expected respendable revenues	12.0	15.4	15.7	16.0
Net expenditures	277.9	289.9	286.2	286.3
FTEs	1,927	1,956	1,963	1,966
Notes: The increase in expenditures from 2005-2006 to 2006-2007 is mainly due to an increase in the level of funding for the Canadian Environmental Protection Act, which is partially offset by the Expenditure Review Committee (ERC) reduction. The decrease in expenditures from 2006-2007 to 2007-2008 is mainly due to a sunset of funding for Implementing the Border Air Quality Strategy and Related Air Quality Measures initiative. This decrease is partially offset by an increase in the level of funding for the Canadian Environmental Protection Act. Figures include an amount for other departmental and regional infrastructure costs supporting program delivery.

Program Activity Description

This program activity touches many elements of day-to-day living that have an impact on the health of Canadians. These include drinking water safety, air quality, radiation exposure, substance use and abuse (including alcohol), consumer product safety, tobacco and secondhand smoke, workplace health, and chemicals in the workplace and in the environment. We are also engaged in other health and safety related activities including the Government's public safety and anti-terrorism initiatives; chemical and nuclear emergency preparedness; inspection of food and potable water for the travelling public; and health contingency planning for visiting dignitaries. Much of this work is governed through legislation including the Food and Drugs Act, the Controlled Drugs and Substances Act, the Hazardous Products Act, the Radiation Emitting Devices Act, the Canadian Environmental Protection Act, the Tobacco Act, the Quarantine Act and others.

The Canadian public and governments are increasingly recognizing the critical link between human health, the physical environment and the economy. There is growing evidence that environmental factors, hazardous products, tobacco, alcohol and controlled substances contribute to a number of health problems including cancer, asthma and other illnesses and injuries which ultimately will have an impact on our health care system and society as a whole.

Building on our work to help protect the health of Canadians and in accordance with the principles of sustainable development, we will generate new research, partnerships and increased federal leadership to improve health outcomes, particularly for vulnerable populations such as children and young adults by:

• Reducing health and safety risks associated with tobacco consumption and the abuse of drugs, alcohol and other controlled substances; and
• Reducing risks to health and safety, and improving protection against harm associated with workplace and environmental hazards, consumer products (including cosmetics), radiation-emitting devices, new chemical substances and products of biotechnology.

From a health protection perspective, the Department will continue to focus on regulatory priorities such as Legislation Renewal and its impacts on the Hazardous Products Act, and we will also address regulations in the area of tobacco and other controlled substances. We will continue to improve national compliance and enforcement programs so they are effective, riskbased, and harmonized with provincial, territorial and international partners and stakeholders.

To protect the health of Canadians, we will continue to advance science and use evidence-based research to formulate our health promotion and harm prevention programs and policies. Health Canada will conduct research and use the science conducted by a network of external science organizations to respond to emerging health and safety challenges to Canadians. We will create a science plan which will outline the strategic scientific directions for our five key program areas for the coming years and we will continue to work closely with a number of other federal departments and agencies on common science-based issues, such as water.

We rely on professionals with expertise in applied sciences (e.g., toxicology, epidemiology, biology) and in both occupational and public health (e.g., nurses, medicine, psychologists, industrial hygienists) to achieve our key results for Canadians. The Healthy Environments and Consumer Safety Branch must compete with other organizations to attract highly qualified scientists and health professionals. To address this risk, we will develop and implement a Human Resources Strategy focussed on succession planning, learning, recruitment and retention in order to ensure we have the human resources to support our activities under this strategic outcome.

The broad mandate under this strategic outcome requires sustained partnerships that have a significant impact on the health of Canadians. For example, Health Canada is the lead on horizontal files that require significant interdepartmental collaboration, such as Canada's Drug Strategy. We contribute significantly to the Government of Canada's efforts on health and environment issues. For example, we share responsibility for the Canadian Environmental Protection Act with Environment Canada. We also work closely with Environment Canada on files such as climate change.

Internationally, we will continue to advance some of our key work with the U.S. on a range of issues such as children's health and the environment, sound risk-management of chemicals and the Canada-U.S. Memorandum of Understanding on Consumer Product Safety.

Within the Health Portfolio, the Healthy Environments and Consumer Safety Branch works in partnership with the Public Health Agency of Canada, First Nations and Inuit Health Branch, and Health Products and Food Branch to achieve integrated approaches to health. We also collaborate with the provinces and territories through various committees to develop guidelines on issues such as safe drinking water and to coordinate nuclear emergency preparedness actvities.

Performance Measurement Strategy

Expected Results Branch PAA	Performance Indicators
Reduced risks to health and safety, and improved protection against harm associated with workplace and environmental hazards and consumer products (including cosmetics)	Percentage of federal public employees remaining at work through and following an injury, illness or traumatic incident Treasury Board of Canada Secretariat Statistics on leave, accommodation and injury in the workplace Level of client satisfaction with occupational health and contingency planning services Client satisfaction surveys Percentage of Canadians who are aware that their health can be affected by environmental factors Level of reported incidences of product related deaths and injuries associated with: Consumer Products; Cosmetics; Workplace Chemicals; New Chemical Substances; Products of Biotechnology; Radiation- Emitting Devices; Environmental Noise; Solar UV Radiation.
Reduced health and safety risks associated with tobacco consumption and the abuse of drugs, alcohol and other substances	Prevalence of drug and substance abuse in Canada Canadian Alcohol and Drug Use Monitoring Survey Smoking prevalence in Canada Reduce smoking prevalence from 25% to 20%, Canadian Tobacco Use Monitoring Survey

Key Programs and Services

Tobacco Control

Description: As lead department for the Federal Tobacco Control Strategy, Health Canada supports the four pillars of prevention, cessation, protection and harm reduction. Health Canada works with partners to pilot and evaluate a range of stop smoking approaches. For instance, the Department develops and implements national and regional education campaigns that inform Canadians about the health impacts of smoking and that provide information and referrals to help more Canadians quit smoking, and reduce exposure to second hand smoke in public and private spaces. On the international front, Health Canada, through its International Affairs Directorate, supports tobacco control initiatives around the globe.

Expected Results	Performance Indicators
Reduce smoking prevalence among the Canadian population to 20%   Reduce number of cigarettes sold in Canada by 30%	Smoking prevalence rate Measured by Canadian Tobacco Use Monitoring Survey (CTUMS) Consumption rates - number of cigarettes sold in Canada Measured by industry reports

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
53.8	282	53.6	282	53.7	282
*All financial figures in millions of dollars

In Manitoba and Saskatchewan, the Tobacco Control Programme will continue to ensure that the nationally-recognized Retailer Toolkit developed in Saskatchewan (preventing sales to minors, etc.) will be adapted for use with First Nations retailers on reserves. Tobacco Enforcement Officers work hand-in-glove with Prevention, Cessation and Education Program managers and community based organizations. Innovation and partnerships account for consistently high Tobacco Act compliance rates among retailers in the Region.

Key Initiatives

As part of our commitment to monitor and report on the progress and success of the tobacco control initiative, Health Canada will conduct an evaluation of the first five years of the Federal Tobacco Control Strategy. In order to determine the direction for tobacco control over the next five years, the Department will analyse the outcomes from strategic planning sessions and consultations held with partners during the previous fiscal year. The knowledge derived from this evaluation will help us to most effectively focus Tobacco Control resources and activities for the future.

While considerable inroads have been made in reaching our targets and reducing smoking prevalence to 20% of the population, certain segments of the Canadian population continue to experience persistently high tobacco use, and further improvements to the smoking prevalence rate will depend upon addressing tobacco use among this population. Historically, young adults aged 20 to 24 have had the highest rates of smoking as compared with rates for all other age groups in the Canadian population, and this trend continues. For the first half of 2005, the smoking prevalence for those aged 20 to 24 was 27% as compared to 20% for the entire population 15 years of age and older (CTUMS). Therefore, the Department will focus its attention on youth and young adults who are most at risk of smoking, and will work with the provinces and territories to identify appropriate interventions and future directions for this important demographic. We will also provide support for targeted prevention and cessation activities of the no-smoking message through youth engagement initiatives, such as Health Canada's "Youth Action Committee on Tobacco", which will engage youth from across the country to help young people in their schools and communities live smoke-free.

Drug Strategy and Controlled Substances

Description: Health Canada administers the Controlled Drugs and Substances Act (CDSA) and its regulations, develops harm reduction and promotion strategies to combat alcohol and drug abuse (including health promotion activities targeted at youth), and provides expert scientific advice and drug analysis services to law enforcement agencies. Health Canada leads Canada's Drug Strategy, which was renewed in 2003. The Strategy is designed to coordinate and enhance substance abuse programs across the country, and strengthen knowledge and partnerships in the areas of prevention, treatment, harm reduction and enforcement to create healthier Canadians and communities.

Health Canada uses a variety of partnerships and funding vehicles to fulfill its mandate in this area. The Drug Strategy Community Initiatives Fund (DSCIF) was recently established to fund initiatives at the national, regional, provincial/territorial and local levels in two broad areas: health promotion and prevention, and harm reduction. DSCIF is delivered through Health Canada's national and regional offices and Northern Secretariat, with an overall aim to address problematic substance use and to promote public awareness of alcohol and other drug issues. The Alcohol and Drug Treatment and Rehabilitation Program (ADTR) aims to improve treatment for women and youth who are dealing with substance abuse problems. Health Canada also provides funding for the treatment component of Drug Treatment Courts.

Expected Results	Performance Indicators
Reduced health and safety risks associated with the abuse of drugs, alcohol and other controlled substances by managing the Controlled Drugs and Substances Act and its Regulations, and providing national leadership for Canada's Drug Strategy.	Reduced prevalence rate of substance use/abuse in Canada and among target populations such as youth Level of misuse/abuse of controlled substances Change in the type and level of health-related, at-risk behaviours Change in the nature and level of the social, health and economic costs associated with substance use and abuse in Canada

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
65.1	347	64.8	347	65.0	347
*All financial figures in millions of dollars

Key Initiatives

Advancing the National Framework for Action to Reduce the Harms Associated with Alcohol and Other Drugs and Substances in Canada continues. Key planned components include the initiation of the Canadian Alcohol and Drug Use Monitoring Survey; the development of a National Alcohol Strategy; the implementation of the National Strategy to Combat the Production and Distribution of Marihuana and Synthetic Drugs and the Diversion of Precursor Chemicals; the development of a national and integrated approach to psychotropic pharmaceuticals; and the establishment of single website access to information about Canada's Drug Strategy. There will be an increase in research done in Canada on drug and alcohol abuse, and a detailed analysis of the Canadian Addiction Survey (CAS) of unique components (e.g., alcohol, youth, etc.) in order to support sound, evidence-based decision-making.

We will develop a strategy to enhance our inspection capacity for compliance with the Controlled Drugs and Substances Act (CDSA) and its regulations, in particular the Precursor Control Regulations. From a regional perspective, we will work on the provincial Alberta Methamphetamine Partnership Strategy Committee on Illicit Drug Use.

Marihuana is categorized as a controlled substance. The Marihuana Medical Access Regulations allow people who are suffering from grave and debilitating illnesses access to marihuana. It is important to note that the Regulations deal exclusively with the medical use of marihuana. Through authority of the Marihuana Medical Access Regulations, we will proceed with the development of a pilot project to assess the feasibility of distributing marihuana for medical purposes through the conventional pharmacy-based drug distribution system.

Health Canada will continue to operate four regional Drug Analysis Service (DAS) laboratories located in British Columbia, Manitoba, Ontario and Quebec. The DAS programme has three principal business lines: Drug Analysis, which includes regular identification of seized police exhibits; support in clandestine laboratory investigations (illicit drug manufacturing); and training to our clients (police, crown attorneys). We assess approximately 100,000 samples per year in the four facilities for law enforcement. Such work helps to support the Enforcement element of Canada's Drug Strategy, along with Prevention, Harm Reduction and Treatment. The Ontario laboratory also provides drug standards for the four DAS laboratories across Canada, and, in 2005, was the first to make an application for accreditation to the International Organization for Standardization (ISO) 17025 standard.

Safe Environments

Description: The environment continues to be a key determinant of health for all Canadians. Recent studies demonstrate that environmental factors contribute to a number of health problems. Air pollution, for example, is a factor in 5,900 deaths per year in Ontario and is responsible for 30% of asthma and 5% of cancers in children. Improving the health of Canadians by addressing environmental factors will strengthen their quality of life. The Safe Environments Programme promotes and protects the health of Canadians by identifying, assessing and managing health risks posed by environmental factors in living, working and recreational environments. The scope of activities encompassed within this area includes research on drinking water, air quality, contaminated sites, climate change, and vulnerable populations assessment of risks from environmental impacts, as well as preparedness for environmental emergencies. Health Canada is also the lead for coordinating Canada's preparedness for nuclear emergencies under the Federal Nuclear Emergency Plan.

Expected Results

Performance Indicators

Availability and Canada-wide adoption of measures to control the risks to human health posed by environmental contaminants Increased knowledge, understanding and involvement by Canadians in environmental health issues Science-based decision-making within Canada regarding health risks of environmental contaminants** Improved scientific knowledge and capacity within the Canadian scientific community and international collaboration on environmental health issues to ensure that Canadians have increased confidence in environmental health information and protection mechanisms*

Percentage of completion of legislated obligations and other commitments Percentage of Canadians who are aware that their health can be affected by environmental factors ** Please Note: Work is in progress to develop a better set of indicators for these expected results by Fall 2006

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
68.4	576	68.1	582	68.3	584
*All financial figures in millions of dollars

Key Initiatives

Health Canada's Sustainable Development Strategy (2004-2007) reflects our commitment to protect the health of Canadians from environmental threats. Under this strategy, the department will advance the development of the Guidelines for Canadian Drinking Water Quality, and an integrated source-to-tap approach to drinking water quality in Canada. In collaboration with other federal departments, Health Canada will develop a "Federal Waterborne Contamination and Illness Response Protocol" to ensure a coordinated and systematic federal approach to dealing with outbreaks of waterborne illness and contamination of drinking water. Health Canada is also partnering with all three levels of government on the Technical Advisory Committee on Safe Drinking Water (TACSDW) to effectively address public health issues pertaining to drinking water in Alberta.

To assist in monitoring health risks attributable to changes in air quality, the Department will continue to build on its recently completed collaborative international research to develop an Air Health Indicator and will release the Air Quality Benefits Assessment Tool to help quantify the health impacts of changes in air pollution. In particular, the Safe Environments Programme in Ontario and Region is working to support the Canada-United States Border Air Quality Strategy, and will examine the impacts of air pollution on the health of children and other vulnerable populations, such as pregnant women and diabetics, in the Great Lakes Basin region. Health Canada will also complete and disseminate the Canadian Climate Change and Health Vulnerability Assessment in 2007, which will assess climate change impacts on human health and well-being.

To protect the health of Canadians from environmental contaminants, Health Canada will make additional progress under the Canadian Environmental Protection Act, 1999 (CEPA) by completing the identification and prioritization ("categorization") of the 23,000 Existing Substances on the Domestic Substances List. The Domestic Substances List (DSL) is a compilation of about 23,000 substances used, imported or manufactured in Canada for commercial use.

In partnership with the Public Health Agency of Canada and working through the joint Emergency Preparedness Sub-Committee on Chemical Emergencies, we will develop a joint Health Portfolio response plan for chemical emergencies in 2006 - 2007. Health Canada is also working with its provincial counterparts to strengthen guidelines to protect the health of Canadians in the event of a nuclear emergency, and will be participating in international nuclear emergency exercises to assess the implications of implementing radiation contamination counter-measures.

In the Alberta Region, Health Canada, with the support of the Health Innovation Fund, is addressing the impact and influence of the state of the environment on children's health in the region. A one-day symposium presently under development with participation from federal, provincial, territorial and other partners, will provide a forum to exchange knowledge related to research, policy and best practices in the area of children's health and the environment.

Product Safety

Description: As part of our legislative mandate, Health Canada identifies, assesses, manages and communicates to Canadians the health and safety hazards and health risks associated with: consumer products; hazardous workplace materials; cosmetics; new chemical substances; products of biotechnology; radiation produced by radiation emitting devices; environmental noise; and solar UV radiation.

To carry out this mandate, we advance critical research, carry out needed risk assessments and develop risk management strategies to minimize the exposure of Canadians to toxic substances in consumer, commercial, personal care and pharmaceutical products. The Department annually carries out health risk assessments of approximately 800 new chemicals and products of biotechnology notified under the New Substances Notification Regulations of the Canadian Environmental Protection Act, 1999. When a significant risk is identified, control measures are imposed.We identify which of the Food and Drugs Act substances in Canadian commerce between 1987 and September 2001 require priority assessment, and work with stakeholders on the process for notification of these substances. The Department also carries out screening level health risk assessments on existing micro-organisms, and both environmental and health risk assessments on new Food and Drugs Act substances, including risk management when necessary.

Health Canada's National Office of Workplace Hazardous Materials Information System (WHMIS) provides leadership to its federal, provincial and territorial MOU partners regarding effective hazard communication of workplace chemicals, including the delivery of training for WHMIS inspectors across the country. In addition, the Department will continue its involvement and participation in standardization work to ensure continued improvement of radiation emitting equipment safety.

Expected Results**	Performance Indicators
Reduced risk of death and injury from exposure to hazardous products and substances associated with: Consumer products; cosmetics; workplace chemicals; new chemical substances; products of biotechnology; radiation-emitting devices; environmental noise; solar UV radiation.	Level of reported incidences of product related deaths and injuries; Level of exposure to hazardous products and substances associated with: consumer products; cosmetics; workplace chemicals; new chemical substances; products of biotechnology; radiation-emitting devices; environmental noise; and solar UV radiation.

2006-2007		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
25.6	334	25.5	334	25.5	334
*All financial figures in millions of dollars

Key Initiatives

In support of the government's commitment to the health of children, we will proceed with the implementation of the Lead Risk Reduction Strategy (LRRS) for Consumer Products. These measures will protect the health of Canadians by reducing health risks related to lead exposure. Lead is hazardous to health and is particularly dangerous for infants and young children because they are more susceptible to its harmful effects. The LRRS proposes maximum lead content limits for four categories of consumer products with which children are likely to interact. Regulations for each category will be developed separately, moving first on product groups where the risk to children is greatest. We will also check for compliance rates for products already regulated for lead content. Performance will be based on the removal of such hazardous products from the Canadian marketplace and the level of public awareness of risks.

Other regulatory and educational activities will also support the commitment to the protection of children's health. For example, to protect the health of children and reduce strangulation hazards that are associated with flexible loops employed in the manufacture and use of window covering products (mini-blinds and curtains), regulations will be developed to require mandatory adherence by importers, advertisers and retailers to safety standards for these corded window covering products.

To effectively manage the continuing incidence of skin cancer, we need to ensure that children develop healthy behaviours with regards to their outdoor activities. The best time to influence or change behaviours is at the time the behaviour is being established. This is the fundamental driver for the Sun Awareness Project, a school-based outreach program to teach primary school children and teenagers of both the benefits of sun exposure and the risks associated with excessive sun exposure. The Sun Awareness Project involves learning elements and exercises integrated into the regular teaching schedule at both primary and secondary schools.

At the World Summit on Sustainable Development in 2002, Canada made a commitment to fully implement the Globally Harmonized System (GHS) of Classification and Labelling of Chemicals by 2008. The GHS is viewed globally as the basis for the sound management of chemicals, and enhances the protection of human health and the environment by harmonizing chemical hazard classification and communication internationally. Building on stakeholder consultations on the GHS, Health Canada will make further progress toward carrying out the legislative and regulatory changes needed for full implementation by 2008.

In carrying out our responsibilities under the Canadian Environmental Protection Act, 1999, a priority will be placed on working with Environment Canada to develop regulatory amendments to the New Substances Notification Regulations (Organisms) that reflect changes in the regulatory, policy and science environment, such as the production of transgenic, chimeric and cloned animals (e.g., livestock). In addition, we will work to develop appropriate environmental regulations for substances in products that are regulated under the Food and Drugs Act.

Workplace Health & Public Safety

Description: The Workplace Health and Public Safety Programme (WHPSP) provides services to protect the health and safety of the federal public sector, the travelling public, dignitaries visiting Canada, and others. It also establishes and promotes national workplace health and safety policies.

Health Canada will continue to provide occupational health services to nearly 200,000 federal employees working in Canada and overseas for approximately 100 departments and agencies. Health Canada delivers Employee Assistance Program services on a cost recovery basis to approximately 143 Canadian public and para-public sector organizations. Through the International Health Bureau, Health Canada provides emergency health services to Internationally Protected Persons and their families while they are on official visits to Canada.

The health of those who travel within Canada is protected through voluntary inspection programs for passenger conveyances to address public health risks relating to food, water and sanitation. Potable water regulations provide some authorities for inspection and enforcement of water quality on conveyances. As well, under the Quarantine Act and in fulfilment of WHO International Health Regulations, WHPSP Environmental Health Officers are responsible for inspecting and assessing conveyances, goods and cargo, and ordering the detention, remediation, removal and destruction when necessary to protect against the transmission of communicable quarantinable diseases.

Expected Results**

Performance Indicators

Healthy Public Service Improved Public Health for the Travelling Public

Percentage of federal public employees remaining at work through/and following an injury, illness and/or traumatic incident (Treasury Board of Canada Secretariat Statistics on leave, accommodation and injury in the workplace) Client satisfaction with occupational health and contingency planning services (client satisfaction surveys) Percentage occurrence of incidents of gastrointestinal diseases on cruise-ships with a target of less than 2% of passengers and crew

2006-2007*		2007-2008		2008-2009
$	FTEs	$	FTEs	$	FTEs
24.5	417	24.4	418	24.5	419
*All financial figures in millions of dollars

Key Initiatives

In light of newly emerging health threats, Health Canada works with the Public Health Agency of Canada (PHAC), Public Security and Emergency Preparedness Canada, and other organizations to plan, prepare and implement physical and psychosocial emergency responses to national health emergencies such as pandemic influenza and terrorist or suspected terrorist attacks. Health Canada supports departments and agencies in their emergency preparedness and response activities through the provision of advice, guidance, training, health evaluations, prophylaxis and immunizations and will continue to support PHAC with environmental quarantine services. We will also continue to offer psycho-social services in support of federalized emergency responders and federal public employees who provide essential services during and immediately following critical incidents.

We will develop approaches to better identify and manage mental health and addictions in the workplace. Areas of activity will focus on: preventing and mitigating mental disorders and addictions among federal employees through mental health promotion, early identification and referral; a disability case management program; and the development and implementation of a comprehensive federal workplace health strategy.

Web Links

Tobacco

Tobacco

Canada's Drug Strategy

Canada's Drug Strategy

Marihuana Medical Access Regulations

Medical Use of Marihuana

Scheduling of a number of controlled substances and development of other proposed amendments to the Precursor Control Regulations

Controlled Substances and Precursor Chemicals

Reducing the supply of and demand for drugs through prevention, harm reduction, treatment and enforcement programming.

Canada's Drug Strategy

National Framework for Action on Substance Use and Abuse.

A National Framework for Action to Reduce the Harms Associated with Alcohol and Other Drugs and Substances in Canada

National Research Agenda

National Research Agenda

Drug Strategy Community Initiatives Fund

The Drug Strategy Community Initiatives Fund -- At a Glance

Canada's Drug Strategy Campaign publications

Canada's Drug Strategy Publications

Climate Change

Climate Change and Health

Air

Air Quality

Water

Water Quality

Canadian Environmental Protection Act

Human Health and the Canadian Environmental Protection Act (CEPA): An Overview

Healthy Living Initiative

Protect Yourself Don't Delay Learn the Facts about UV Rays

Globally Harmonized System

The Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

Lead Risk Reduction Strategy

Lead Risk Reduction Strategy

Workplace Health

Workplace Health and Public Safety Programme

* Other programs and services that contribute to this program activity total $52.5 million for 2006-2007

Program Activity - Pest Control Product Regulation

This program activity contributes to the Government of Canada Strategic Outcome: Healthy Canadians with Access to Quality Health Care.

Planned spending and full-time equivalents (FTEs)

($ millions)	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Gross expenditures	60.5	58.6	58.2	54.1
Less: Expected respendable revenues	5.9	7.0	7.0	7.0
Net expenditures	54.6	51.6	51.2	47.1
FTEs	675	652	656	604
Notes: The decrease in expenditures from 2005-2006 to 2006-2007 is mainly due to the Expenditure Review Committee (ERC) reduction. The decrease in expenditures from 2006-2007 to 2008-2009 is mainly due to a decrease in the level of funding for Building Public and Stakeholder Confidence in Pesticide Regulation initiative. Figures include an amount for other departmental and regional infrastructure costs supporting program delivery.

Program Activity Description

Health Canada's program activity, Pest Control Product Regulation, protects human health and the environment by minimizing risks associated with pesticides imported, sold, or used in Canada. The activity is strengthened through the use of sound, progressive science, modern risk assessment, risk management approaches and innovative approaches to sustainable pest management.

Science is the foundation for Health Canada's activities related to Pest Control Product Regulations. We conduct assessments of risk to human health and the environment arising from exposure to chemical and biological pesticides as well as assessments of the value of these products. In support of this work, we develop assessment methodologies, pesticide testing protocols, risk reduction strategies and risk management tools. Scientific expertise is in place in the following areas: toxicology, environmental toxicology, analytical chemistry, environmental fate and chemistry, biochemistry, endocrinology, ecology, crop science, plant pathology, entomology, occupational and bystander assessment, and aggregate and cumulative assessment.

To meet the primary objective of this program activity "to protect the health of Canadians and the environment from unacceptable risks associated with pest control products", we collaborate with experts in a variety of disciplines throughout the Health Portfolio and with the five natural resource departments. We also work with: the Canadian Food Inspection Agency and provincial governments on compliance activities; with Agriculture and Agri-food Canada to develop risk reduction strategies and improve access to specialized pest control; and with a federal interdepartmental working group on pesticide research and monitoring. This working group provides the opportunity for us to discuss our research and monitoring needs, as well as obtain information on the levels of pesticides in the environment, effects on human health and the environment, testing protocols, risk reduction practices, pest control alternatives, and pesticides for minor use. It also gives our partners the opportunity to effectively link their research results to regulatory decisions, and, at the same time, it will improve our regulatory decision making process for pesticides.

Advisory groups play an important role in decisionmaking at Health Canada. The Minister's Pest Management Advisory Council allows for dialogue between stakeholders and Health Canada. The Economic Management Advisory Committee provides strategic advice on improving efficiency and cost effectiveness, and the Federal, Provincial, Territorial Committee on Pest Management and Pesticides helps strengthen federal, provincial and territorial relationships in the area of pest management and pesticides. The Committee also provides advice and direction to federal, provincial, and territorial governments on programs, policies and issues.

The major human resource challenge for this program activity is to keep up with the pace of growing scientific knowledge and industry innovation. We will need to continue to recruit additional resources that have the appropriate knowledge base, and develop and train staff in a number of scientific disciplines.

This program activity has three main objectives: protected health and environment; increased use of reduced risk pest management practices and products; and increased public and stakeholder confidence in pesticide regulation. To achieve these objectives we focus on five main activities that respond to a number of challenges facing Health Canada such as consumer demands, globalization, and rapid scientific and technological change. They are:

1. Regulatory Improvement

The new Pest Control Products Act, which came into force June 28, 2006, will strengthen health and environmental protection by enshrining in legislation modern risk assessment and risk management approaches that are currently applied as a policy matter. These include specific protection for infants and children, accounting for pesticide exposure from all sources (including food and water), and considering cumulative effects of pesticides that act in the same way. It will also continue to support pesticide risk reduction by ensuring that only pesticides that make a useful contribution to pest management are registered and by expediting the registration of lower-risk products. The registration system will be made more transparent by establishing a public registry to allow access to test data detailed evaluation reports on registered pesticides. Health Canada will continue to share scientific results on pesticides with provincial, territorial and international regulators to enhance the process for international joint reviews of pesticides.We will share sustainable pest management practices with provinces and territories to enhance agricultural stewardship. As a result, Canadian growers will have improved access to newer and safer pesticides so they can be more competitive in the marketplace.

In addition, the new PCPA will strengthen postregistration controls for all products. These requirements include: reporting by pesticide companies of adverse effects related to their pesticide products; re-evaluation of older chemicals on a cyclical basis; public transparency regarding the basis of regulatory decisions; and ensuring in legislation the special review program to address potential identified specific concerns for registered products.

To support the need to provide Canadians with a transparent and participatory regulatory process, we will transform our work from traditional business interfaces and information delivery practices to interactive, web-based practices. This transformation will allow information to be delivered, stored, accessed, retrieved, exchanged and used more effectively and efficiently, and will lead to more efficient and cost-effective management of the regulatory process.

2. New Pest Control Product Registration

New pesticides undergo an extensive pre-market assessment by Health Canada to ensure their use poses no unacceptable risks. This includes an assessment of human health risk (including worker and bystander exposure), food residues, environmental risk (including environmental fate and potential effects on wildlife), and an assessment of value. Assessments are carried out using the most modern scientific methods available and meet international best practices.

To provide for continual updating of our assessments, we are participating in a joint review program with the United States through NAFTA that is being expanded globally through the Organisation for Economic Co-operation and Development (OECD). This furthers the goals of timely registrations, harmonization and work sharing efforts to ensure pesticide risk assessments are efficient and benefit from the best science available internationally. Public consultation will continue to be used routinely for the development of major science policies and for registration decisions.

3. Registered Pest Control Product Evaluation

We re-evaluate older pesticides currently on the market to determine if their continued use is acceptable in consideration of modern data and current scientific approaches. Significant public consultation is undertaken on risk assessments and risk management proposals to engage stakeholders, including registrants, other government departments, growers and their associations, other non-governmental organizations, as well as the general public.

Risk mitigation measures will continue to be implemented where required to address concerns regarding risks that could emerge during the re-evaluation of a chemical. As required, under the PCPA, we will continue to work with the Environmental Protection Agency in the United States on a proposed approach to re-evaluation and develop a plan to work cooperatively on future re-evaluations.

4. National Pesticide Compliance Program

We have the ongoing responsibility to help protect the health of Canadians and their environment by facilitating, encouraging and maximizing compliance with the PCPA and its regulations. Where non-compliance is detected, we apply the appropriate enforcement (e.g., education, monetary penalties or prosecution). Health Canada promotes and monitors compliance with the Act and Regulations principally through its National Pesticide Compliance Program (NPCP).

The NPCP includes programs that address regional, multi-regional or national compliance and enforcement problems and issues. Much of this work is accomplished through a regional network of designated officials who inspect and investigate those who manufacture, distribute and use pesticides. An example of compliance activities is the monitoring of pesticide use in grape and blueberry production that will be done this coming year. Other pesticides will be monitored as issues arise.

In addition, we will continue to work in partnership with provincial and other federal regulators and will explore further opportunities for coordination and collaboration with international organizations. Specifically, in 2006-2007 Health Canada plans, through an OECD workshop, to continue to develop performance indicators for the compliance area.

5. Pesticide Risk Reduction in Agriculture

The Pesticide Risk Reduction Program supports the objectives of the new Pest Control Products Act to facilitate access to reduced risk products and enhance sustainability in agriculture. It is a growerled, commodity-based program that is jointly facilitated by the Sustainable Pest Management Section of the Pest Management Regulatory Agency and the Pest Management Centre of Agriculture and Agri-Food Canada (AAFC). The goal of the program is to improve the sustainability of Canadian agricultural commodities through the development and implementation of commodity-based risk reduction strategies. Benefits resulting from this program will include the development and adoption of alternative pest management practices through applied research into reduced risk alternative tools and biopesticides.

AAFC and Health Canada will continue working with stakeholders to develop commodity-specific pesticide strategies for twenty priority crops including apples, potatoes, dry beans and greenhouse vegetables. Active stakeholder participation in building and implementing strategies is critical to the success of the program.

Performance Measurement Strategy

Expected Results

Performance Indicators

Access to safer pesticides             Strengthened compliance with PCPA and Regulations Users informed of reduced risk practices Transparency of pesticide regulation Improved regulatory efficiencies and cost effectiveness     Informed public and stakeholders

Number of new reduced risk active ingredients available for use in Canada Percentage of reduced risk chemicals and percentage of biopesticide active ingredients registered/pending registration in the U.S. that are registered/pending registration in Canada Number of new active ingredients registered through the PMRA/U.S. EPA Joint Review or work share program Number of active ingredients addressed through re-evaluation Feedback from public and stakeholders Number of proposed and final regulatory decisions posted on the website Implementation of reading rooms and adverse effects reporting Efficiency gains achieved through electronic processes and harmonization permit the integration of new science policies and methodologies Feedback from public/stakeholders Number of web hits Number of responses provided to the public through the Pest Management Information Service

Web Links

Pest Management Regulatory Agency (PMRA)

home page: Health Canada's Pest Management Regulatory Agency (PMRA)

PMRA Strategic Plan 2003-2008

The Strategic Plan - Pest Management Regulatory Agency (PMRA)

Strategic Outcome: Better Health Outcomes and Reduction of Health Inequalities Between First Nations and Inuit and Other Canadians

Planned spending and full-time equivalents (FTEs)

($ millions)	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Gross expenditures	1,930.8	2,124.6	2,139.7	2,159.2
Less: Expected respendable revenues	3.4	5.5	5.5	5.5
Net expenditures	1,927.5	2,119.1	2,134.2	2,153.7
FTEs	2,722	2,884	2,883	2,857
Notes: The increase in expenditures from 2005-2006 to 2006-2007 is mainly due to the yearly growth of the Indian Envelope and an increase in the funding level for the Follow-Up to the Special Meeting of First Ministers and Aboriginal Leaders (September 12, 2004). This increase is partially offset by the Expenditure Review Committee (ERC) reduction. The increase in the expenditures from 2006-2007 to 2007-2008 is mainly due to the yearly growth of the Indian Envelope and an increase in the funding level for the Follow-Up to the Special Meeting of First Ministers and Aboriginal Leaders (September 12, 2004). This increase is partially offset by the Expenditure Review Committee (ERC) reduction. The increase in expenditures from 2007-2008 to 2008-2009 is mainly due to the yearly growth of the Indian Envelope. This increase is partially offset by a decrease in funding for the sunset of the Implementation of the First Nation Water Management Systems initiative. The change in the FTEs is due to the increase of the salary component of the operating budget. Figures include an amount for other departmental and regional infrastructure costs supporting program delivery.

Program Activity Description

The objectives of Health Canada's First Nations and Inuit health program activity are improving health outcomes, ensuring the availability of and access to quality health services, and supporting greater control of the health system by First Nations and Inuit.

To achieve these goals, the Department must face many of the same challenges as other Canadian health care providers such as increasing costs, health human resource shortages and an aging population. The First Nations and Inuit health system has additional challenges due to rapidly growing populations with a higher than national average rate of injuries and disease burden, and a population living largely in remote and rural areas.

Within this context, Health Canada will focus on four key priority areas in 2006-2007: continuing to provide health-related programs and services; improving quality and access to health-related programs and services; promoting healthy living and disease prevention; and improving accountability and performance measurement. These priorities recognize the importance that determinants of health such as education and family income play in improving health outcomes, as well as the need for innovation in the field of health. They will also be informed by a government review of the health commitments of the 2005 Meeting of First Ministers and Aboriginal Leaders.

Continued health-related programs and services

Health Canada provides a range of First Nations and Inuit health programs and services that will continue into 2006-2007. In partnership with First Nations and Inuit, we will continue to provide primary health care services in approximately 200 remote communities by approximately 600 nurses through nursing stations and community health centres in remote and/or isolated communities. Through our regional offices, we also deliver programs focussed on children and youth, mental health and addictions, chronic diseases, environmental health, and communicable and noncommunicable disease prevention. These services supplement and support the services that provincial, territorial and regional health authorities provide.

The Non-Insured Health Benefits (NIHB) coverage of drugs, dental care, vision care, medical supplies and equipment, short-term crisis intervention mental health services, and medical transportation will continue to be available to all 765,000 registered Indians and recognized Inuit in Canada, regardless of residency.

Health Canada works closely with our health partners and other federal departments. We support the Public Health Agency of Canada in its delivery of Children and Youth programming through the Aboriginal Head Start in Urban and Northern Communities program as well as a number of pan-Aboriginal programs. We also work closely with Indian and Northern Affairs Canada through the First Nations Water Management Strategy to ensure that all First Nations communities across Canada have access to a safe and reliable water supply.

Improving quality of and access to health-related programs and services

The key elements of this priority include: working towards seamless integration of services; increasing the number of Aboriginal health professionals; support for accreditation; improved community dental capacity; and capital improvements and investments.

We will work to make progress towards better integration of federal, provincial and territorial health programming and services to First Nations and Inuit and to ensure that services meet the needs of Aboriginal peoples. This will include implementation of the Aboriginal Health Transition Fund, which was designed to enable federal, provincial and territorial governments, First Nations governments who deliver health care services, and Aboriginal communities to devise new ways to integrate and adapt existing health services. Attention will also be given to implementation of best practices and lessons learned from a series of Health Integration Initiative pilot projects.

Health Canada in the Atlantic Region is assisting the Innu communities of Labrador to develop their capacity to manage and control health programs. In an effort to strengthen communitybased health services and to reduce health status inequities, Labrador-based Health Canada staff are working with the Mushuau Innu First Nation in the planning of a healing lodge and wellnes centre, and with the Sheshatshiu Innu First Nation in the development of a community health survey and a training plan for addictions treatment staff.

Health Canada will continue to fund the Aboriginal Health Human Resources Initiative to increase the long-term supply of First Nations, Inuit and Métis health professionals. In order to focus on Aboriginal youth, scholarship and bursary funds will be made available to eligible youth who pursue post-secondary studies in health support. To meet the continuing challenge of recruitment and retention of nurses to support health services in communities, we will provide ongoing professional development and continuing education opportunities. In partnership with the Canadian Nurses Association, we will launch a National Nursing Portal to provide critical support to nurses in rural and remote areas.

Health Canada will also continue to support the development and implementation of First Nations and Inuit accreditation and quality improvement activities. This will increase the number of accredited health care services in First Nations communities and ensure that the health care provided is responsive to the needs of the communities. We will also continue to implement, in selected communities, the Children's Oral Health Initiative to improve the oral health of First Nations children. This will focus on increasing the awareness of preventive oral health care and positive self-care practices for parents and caregivers, and will serve to increase the capacity of communities to deliver and maintain dental public health initiatives.

Finally, Health Canada supports the construction, operation, maintenance and environmental management of on-reserve health facilities and staff residences. In 2006-2007, fifteen health facilities will be constructed or expanded, and recapitalization initiatives (repairs, replacements, upgrades) will improve the working environment of clients and staff, and enhance the quality of health care services offered at the community level. In 2006-2007, Health Canada will also invest $1.2 million in environmental remediation and assessment to ensure operations of health facilities in First Nations communities meet environmental codes and requirements and are consistent with the Department's commitments to sustainable development.

Promoting healthy living and disease prevention

This priority focuses on maternal and child health, mental wellness, suicide prevention, prevention of chronic disease, communicable disease readiness, and safe drinking water. Initiatives have been put in place, such as a Maternal and Child Health (MCH) program to further expand and enhance the continuum of services provided and to improve health and social outcomes for pregnant women and families with infants and young children within a targeted number of First Nations and Inuit communities. In 2006-2007, Health Canada will continue to expand the number of sites and spaces available for Aboriginal Head Start On Reserve (AHSOR) children and will provide training to AHSOR workers.

Health Canada will oversee the development of a strategic action plan in 2006-2007 to improve mental wellness outcomes for First Nations and Inuit. Among other issues, the strategic action plan will guide Health Canada's efforts to more effectively position its current programming so that they are better able to serve the diverse needs of Aboriginal communities.

We will also continue to implement the National Aboriginal Youth Suicide Prevention Strategy (NAYSPS). This new strategy will establish projects in a targeted number of Aboriginal communities, where it will focus on building a solid foundation for effective approaches for preventing youth suicide. The activities supported by NAYSPS will include: skills training; tool and resource development; and primary prevention and awareness initiatives that promote mental wellness and youth resiliency. The strategy will also develop protocols to respond to communities in crisis and support various research projects. In addition to these new activities, Health Canada will continue to offer a continuum of mental health and emotional support services to former students of residential schools and their families as Canada renews its efforts to resolve Indian Residential School legal claims more expeditiously in 2006-2007.

Health Canada will continue its efforts to address high rates of chronic disease within the Aboriginal community. In particular, the Department will enhance the Aboriginal Diabetes Initiative by increasing the level of community-based funding that communities can access to expand promotion, prevention and care activities. Beyond our efforts to address diabetes, we will develop a First Nations and Inuit Chronic Disease Prevention Strategic Plan that will be developed in partnership with key stakeholders and experts and will inform the development of future chronic disease prevention approaches.

In light of federal responsibilities to protect First Nations communities against health risks associated with communicable diseases, Health Canada will begin to implement Communicable Disease Emergencies Plans. Efforts will be focussed on increasing emergency planning and response capacity at the regional and community levels, strengthening collaborative relationships with provinces, territories and stakeholders and ensuring that emergency supplies are purchased and readily available to First Nations and Inuit communities. Health Canada will develop and pilot test Pandemic Influenza Plans in First Nations and Inuit communities by the end of 2006-2007.

Health Canada's Northern Secretariat, working in partnership with the Government of Nunavut and Nunavut Tunngavik Incorporated (NTI), will build on Nunavut's 2005-2006 Health Integration project to increase integration between federal and territorial health promotion programs at the community and territorial level and develop initiatives to strengthen community involvement in planning and delivery of wellness programming. This partnership also fulfils the intent of Article 32 of the Nunavut Land Claim Agreement to provide for Inuit participation in the development, design and delivery of programs.

Finally, through the Water Management Strategy, Health Canada will work in partnership with First Nations communities (except the Yukon and the Territories), to implement drinking water monitoring as per the Guidelines for Canadian Drinking Water Quality. This will involve the development of options and an action plan for the implementation of a regulatory regime for drinking water in First Nations communities. Health Canada will investigate potential drinking water problems and provide advice and recommendations to First Nations communities and federal partners such as Indian and Northern Affairs Canada. Health Canada is also actively involved in the development of community-based education and awareness activities on drinking water quality issues.

Improving accountability and performance measurement

Health Canada has developed a strategy to monitor, measure progress and report on program performance results. This includes establishing performance measurement strategies in consultation with the organizations delivering the services at the community level.

In the B.C. Region, Health Canada will expand and accelerate the "Drinking Water Safety Program". The Program will focus on capacity building and certified training for community members responsible for water quality, and enhancing the surveillance, water quality analysis, and data management components of the program. Results of the program will include an increase in the number of trained and certified water quality operators; community water analysis programs that meet national guidelines; and a consistent, accurate and timely reporting system on water quality.

We will undertake efforts to improve health surveillance and information analysis, including data development, data analysis, research evidence to support priority-setting and decision-making on health-related investments. For example, as a further enhancement to the Aboriginal Diabetes Initiative, Health Canada will begin to support the development of an Aboriginal-specific diabetes research agenda and will increase the Department's surveillance activities in an effort to identify research priorities that will inform future diabetes programming.

Health Canada also draws information from evaluation and review studies on areas for improvement. In 2006-2007, we will conduct a joint evaluation with Indian and Northern Affairs Canada on the First Nations Water Management Strategy. The Department will also develop processes and tools and collect information for evaluating primary health care, immunization and mental health programs. It will finalize the evaluation of the Home and Community Care program.

Performance Measurement Strategy

The First Nations and Inuit Health program has established expected results and performance indicators to assess progress towards the achievement of the strategic outcome. Use of the information below will contribute to providing a snapshot of the health status of First Nations and Inuit.

Expected Results	Performance Indicators
Strengthened community programs; better health protection; improved primary health care; and access to non-insured health benefits contribute to improved health status of First Nations and Inuit individuals, families and communities.	Life expectancy (at birth, on and off reserve) Infant Mortality Rates Birth weight NIHB Client utilization rates

Key Programs and Services

The following describes six key program areas that Health Canada will continue to be engaged in throughout 2006-2007: children and youth; mental health and addictions; chronic disease and injury prevention; environmental health and research; communicable disease control; and primary health care.

Children and Youth Programs

Description: These programs are designed to collectively improve the cultural, emotional, intellectual and physical growth and development of First Nations and Inuit infants, children and youth. Programs targeting maternal, infant and child health, increasing children's knowledge of language and culture, and increasing children's readiness for school are the main priorities of the Department's children and youth programming. These programs include: Aboriginal Head Start on Reserve; the Canada Prenatal Nutrition Program; the Fetal Alcohol Spectrum Disorder program; and the Maternal Child Health program.

Expected Results	Performance Indicators
Improved continuum of programs and supports in First Nations and Inuit communities Increased participation of First Nations and Inuit individuals, families, and communities in programs and supports	Number and percentage of communities with programs Number and type of participants in programs by program type

2006-2007*		2007-2008*		2008-2009*
$	Salary $	$	Salary $	$	Salary $
102.2	6.1	109.8	6.1	115.7	6.1
* Based on the PAA with adjustments for approved Treasury Board submissions. It was assumed that no growth would be applied to new funding and non-envelope funding. It was also assumed that 3% growth would be applicable to envelope funding. Only salary dollars was provided because the information on the number of FTEs is not available at this level. ** All financial figures in millions of dollars

Mental Health and Addictions Programs

Description: These programs provide culturally appropriate counseling services, addiction prevention and promotion services and mental wellness services that are largely delivered by Aboriginal people. These programs include: Building Healthy Communities; the Brighter Futures program; the National Native Alcohol and Drug Abuse Program (NNADAP) - Residential Treatment; the National Native Alcohol and Drug Abuse Program - Community based; the Youth Solvent Abuse Program; the First Nations and Inuit Tobacco Control Strategy; the National Aboriginal Youth Suicide Prevention Strategy; the Labrador Innu Comprehensive Healing Strategy; and the Indian Residential Schools-Mental Health Support Program.

Expected Results	Performance Indicators
Improved continuum of programs and services in First Nations and Inuit communities Increased participation of First Nations and Inuit individuals, families and communities in programs and services	Number of communities with programs (percentage of communities with programs) Number and type of participants in programs by program type Number of community health facilities by type

2006-2007*		2007-2008*		2008-2009*
$	Salary $	$	Salary $	$	Salary $
139.1	5.8	130.7	4.3	133.3	4.4
* Based on the PAA with adjustments for approved Treasury Board submissions. It was assumed that no growth would be applied to new funding and non-envelope funding. It was also assumed that 3% growth would be applicable to envelope funding. Only salary dollars was provided because the information on the number of FTEs is not available at this level. ** All financial figures in millions of dollars

Chronic Disease and Injury Prevention Programs

Description: These programs support the development and implementation of community-based activities that promote healthy lifestyle choices and support healthy and active living. Over the long term, these programs will contribute to the prevention of chronic disease and injuries within First Nations and Inuit communities across Canada. These programs include: the Aboriginal Diabetes Initiative; Nutrition and Physical Activity Promotion; and Injury Prevention.

Expected Results	Performance Indicators
Improved continuum of programs and supports in First Nations and Inuit communities	Number and percentage of communities with programs

2006-2007*		2007-2008*		2008-2009*
$	Salary $	$	Salary $	$	Salary $
34.9	2.8	45.1	2.8	50.1	2.8
* Based on the PAA with adjustments for approved Treasury Board submissions. It was assumed that no growth would be applied to new funding and non-envelope funding. It was also assumed that 3% growth would be applicable to envelope funding. Only salary dollars was provided because the information on the number of FTEs is not available at this level. ** All financial figures in millions of dollars

Environmental Health and Research Programs

Description: These programs are designed to reduce the risk of exposure to environmental health hazards by improving the capacity of communities to implement measures to manage, contain and control them. They also create and maintain healthy and safe community environments through: the investigation of potential environmental health-related outbreaks; raising awareness of environmental health hazards such as waterborne, foodborne and vector borne illnesses including health problems associated with poor indoor air quality, such as mould in housing. They provide for pest control and build community human resource capacity to adapt to environmental conditions, to maintain safe environments and to deal safely with environmental hazards. These programs include: First Nations Water Management Strategy; West Nile Virus; Contaminated Sites; Transportation of Dangerous Goods; Food Safety, Facilities Health Inspections; housing; and research.

Expected Results	Performance Indicators
Improved environmental health risk management	Number of communities with environmental health officers/trained community-based water quality monitors Number of communities equipped with water testing/sampling kits

2006-2007*		2007-2008*		2008-2009*
$	Salary $	$	Salary $	$	Salary $
46.1	11.9	46.7	11.9	22.2	9.1
* Based on the PAA with adjustments for approved Treasury Board submissions. It was assumed that no growth would be applied to new funding and non-envelope funding. It was also assumed that 3% growth would be applicable to envelope funding. Only salary dollars was provided because the information on the number of FTEs is not available at this level. ** All financial figures in millions of dollars

Communicable Disease Control Programs

Description: These programs support public health needs and priorities in the design, implementation, management and delivery of programs to protect First Nations and Inuit communities from communicable diseases, and to implement measures to manage, contain and control risks of outbreak. These programs include: Tuberculosis; Immunization; HIV/AID; and Communicable Disease Emergencies.

Expected Results	Performance Indicators
Improved access to communicable disease prevention and control programs for First Nations and Inuit individuals, families, and communities	Number and percentage of communities with programs

2006-2007*		2007-2008*		2008-2009*
$	Salary $	$	Salary $	$	Salary $
26.0	6.1	26.8	6.4	28.0	6.4
* Based on the PAA with adjustments for approved Treasury Board submissions. It was assumed that no growth would be applied to new funding and non-envelope funding. It was also assumed that 3% growth would be applicable to envelope funding. Only salary dollars was provided because the information on the number of FTEs is not available at this level. ** All financial figures in millions of dollars

Primary Health Care Programs

Description: Comprehensive health care services are provided to remote and/or isolated First Nations and Inuit settlements to supplement and support primary care services provided by provincial, territorial and/or regional health authorities. These include emergency and acute care health services. Health Canada ensures links to appropriate care by other health care providers and/or institutions as required by the client condition. The continuum of community health care and primary care services includes illness and injury prevention and health promotion activities. This includes the Home and Community Care Program and the Oral Health Strategy, for example.

Expected Results	Performance Indicators
Improved access to primary health care programs and services for First Nations and Inuit individuals, families and communities	Number and percentage of communities with programs Number of treatment centres by type, in the communities Eligible client utilization rates of NIHB - Dental Benefits

2006-2007*		2007-2008*		2008-2009*
$	Salary $	$	Salary $	$	Salary $
232.9	66.7	233.7	66.4	237.8	65.7
* Based on the PAA with adjustments for approved Treasury Board submissions. It was assumed that no growth would be applied to new funding and non-envelope funding. It was also assumed that 3% growth would be applicable to envelope funding. Only salary dollars was provided because the information on the number of FTEs is not available at this level. ** All financial figures in millions of dollars

Web Links

Other programs and services that contribute to this program activity total $1,539.9 million; for further information on those programs and services please see the following web links.

Aboriginal Head Start On Reserve

Aboriginal Head Start On Reserve

Fetal Alcohol Syndrome and Fetal Alcohol Effects

Fetal Alcohol Syndrome/Fetal Alcohol Effects

Aboriginal Diabetes Initiative

Diabetes

Injury Prevention

www.hc-sc.gc.ca/fnih-spni/promotion/injury-bless/index_e.html

Indian Residential Schools

Indian Residential Schools

National Native Alcohol and Drug Addictions Program

National Native Alcohol and Drug Abuse Program

Tobacco Control Strategy

Tobacco

NIHB

Non-Insured Health Benefits Directorate

Communicable Disease Control

Communicable Disease Control Division

Children's Oral Health Initiative

Children's Oral Health Initiative

Environmental Health

Environmental Health Division

Drinking Water Quality

Drinking Water Quality

Home and Community Care

Home and Community Care

E-Health

eHealth

Aboriginal Health Human Resource Initiative

Aboriginal Health Human Resources Initiative

Section 3: Supplementary Information

Table 1: Departmental Planned Spending and Full Time Equivalents

($ millions)	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Health Policy. Planning and Information	448.4	288.6	218.2	214.9
Health Products and Food	262.4	303.2	298.4	283.1
Healthy Environments and Consumer Safety	287.8	306.1	301.7	301.3
Pest Control Product Regulation	58.3	58.7	58.2	54.1
First Nations and Inuit Health	1.867.7	2.087.9	2.126.9	2.138.8
Budgetary Main Estimates (gross)	2.924.6	3.044.5	3.003.4	2.992.2
Less: Respendable Revenues	68.9	69.1	69.4	69.7
Total Main Estimates	2.855.7	2.975.4	2.934.0	2.922.5
Adjustments: 1 Governor General Special Warrants:
Operating Budget Carry Forward (horizontal item)	14.1
Additional funding in support of Aboriginal health further to the Special Meeting of First Ministers and Aboriginal Leaders on September 13. 2004	25.5
Additional funding to territories for medical travel costs and health systems reform (TB vote 5)	30.0
Additional funding for initiatives related to the 10-Year Plan to Strengthen Health Care. such as wait times reduction. internationally educated health care professionals. and improved reporting to Canadians on the progress made in strengthening health care ($15.0 million from TB Vote 5)	25.7
Funding to ensure the safety of therapeutic products. including enhanced clinical trials oversight. monitoring of drugs and medical devices in the marketplace. and the implementation of new regulations for blood transfusion and organ transplantation (horizontal item)	2.6
Funding to enhance early learning and childcare programs for First Nations on reserve (horizontal item)	6.1
Additional funding for health risk assessments and protection measures related to the Canadian Environmental Protection Act	1.7
Activities to mitigate the impact of the Bovine Spongiform Encephalopathy (BSE) crisis (horizontal item)	1.1
Funding to deliver federal programs and services. including health in two Labrador Innu communities (Labrador Innu Comprehensive Healing Strategy) (horizontal item)	3.9
Funding to continue the Government's plan to establish core genomics research and development capacity (horizontal item)	0.2
Additional funding for the Access to Medicines Program which provides affordable access to Canadian patented pharmaceuticals for the treatment of HIV/AIDS. malaria. tuberculosis and other epidemics. in the least developed and developing countries	0.7
Funding related to the assessment. management and remediation of federal contaminated sites (horizontal item)	0.6
Funding to strengthen initiatives in support of the Canadian Strategy on HIV/AIDS in Canada (horizontal item) ($0.8 million from TB Vote 5)	1.2
Funding to improve the capacity to detect and the readiness to respond to a potential pandemic influenza outbreak including emergency preparedness. antiviral stockpiling and rapid vaccine development technology (horizontal item)	0.4
Funding for the environmental clean-up of the Sydney Tar Ponds and Coke Oven Sites in the Muggah Creek Watershed (horizontal item)	0.1
Funding to launch an integrated public health strategy to reduce the impact of chronic disease by promoting healthy living including specific initiatives to combat diabetes. cancer and cardiovascular disease (horizontal item)	0.2
Funding to undertake projects related to the development and application of biotechnology (Canadian Biotechnology Strategy) (horizontal item)	0.2
Funding for the development of and reporting on environmental indicators related to clean air. clean water and greenhouse gas emissions (horizontal item)	0.2
Funding for the delivery of federal programs and services. including health. to the O-Pipon-Na-Piwin Cree Nation (horizontal item)	0.1	1.5	1.6	0.4
Less: Spending authorities available	-61.0
Other adjustments:
Collective Agreements	41.4
Joint Career Transition Committee (TB Vote 10)	0.1
Adjustment - Statutory Items	0.4
EBP Adjustment	7.9
Funding for the Genomics Research and Development Initiative. under the auspices of the Canadian Biotechnology Strategy				4.0
Funding to Recognize a Landless Band and for the Registration of Newfoundland Indians		7.3	7.5	7.8
Funding for the Winter Olympics				0.6
One year extension of funding authority for First Nations and Inuit Non-Insured Health Benefits Program Review		30.0
Funding for the Settlement Agreement for Indian Residential Schools			2.0	11.0
Funding for Avian and Pandemic Influenza Preparedness. with a Focus on Animal and Human Health		1.5	4.0	4.0
Government Wide Efficiencies - Procurement Savings		-4.6
Year End Lapse 2	-66.9
Total Adjustments	36.3	35.7	15.1	27.8
Total Planned Spending 3	2,892.0	3,011.1	2,949.1	2,950.3
Less: Non-respendable Revenue	8.9	8.9	8.9	8.9
Plus: Cost of services received without charge 4	85.6	84.7	84.6	84.6
Total Departmental Spending	2,968.7	3,086.9	3,024.8	3,026.0
Full-Time Equivalents 5	8,544.0	8,711.0	8,773.0	8,671.0
1 Adjustments reflect Governor General Special Warrants and TB Vote 5 Access for 2005-2006. 2 Year-end Lapse as per the 2005-2006 Public Accounts. 3 Refer to Section 2 for an explanation by program activity of year-over-year fluctuations. 4 Includes the following services received without charge: accommodation charges (Public Works and Government Services Canada); contributions covering employers' share of employees' insurance premiums and expenditures (Treasury Board Secretariat); Workers' Compensation (Human Resources and Skills Development Canada); and Legal Services (Department of Justice Canada). 5 Full-time equivalents reflect the human resources that the Department uses to deliver its programs and services. This number is based on a calculation that considers full-time. term. casual employment. and other factors such as job sharing.

 

Table 2: Program Activities for 2006-2007 (in millions of dollars)

Program Activity	Operating	Capital	Grants	Contributions	Gross	Respendable Revenue	Total Main Estimates	Adjustments (planned spending not in Main Estimates)	Total Planned Spending
Health Policy. Planning and Information	95.6		57.1	135.9	288.6		288.6	-0.2	288.4
Health Products and Food	291.9	1.4	5.9	4.0	303.2	-41.2	262.0	0.1	262.1
Healthy Environments and Consumer Safety	260.4	1.0	5.1	39.6	306.1	-15.4	290.7	-0.8	289.9
Pest Control Product Regulation	58.7				58.7	-7.0	51.7	-0.1	51.6
First Nations and Inuit Health	1,144.7	1.5	30.0	911.7	2,087.9	-5.5	2,082.4	36.7	2,119.1
Total	1,851.3	3.9	98.1	1,091.2	3,044.5	-69.1	2,975.4	35.7	3,011.1

 

Table 3: Voted and Statutory Items listed in Main Estimates (in millions of dollars)

2006-2007
Vote or Statutory Item	Truncated Vote or Statutory Wording	Current Main Estimates	Previous Main Estimates
1	Operating expenditures	1,674.4	1,552.6
5	Grants and contributions	1,189.3	1,201.8
(S)	Minister of Health- Salary and motor car allowance	0,1	0,1
(S)	Contributions to employee benefit plans	111.5	101.2
	Total Department	2,975.4	2,855.7
The difference between the current and previous year is due to various increases and decreases to the reference levels, of which some of the major increases are related to: the Special Meeting of the First Ministers and Aboriginal Leaders, the Strengthening the Safety of Drug Strategy, the Canadian Environmental Protection Act, and the yearly growth of the Indian Envelope. The major increases are partially offset by the major decrease in the level of funding for the Primary Health Care Transition Fund.

 

Table 4: Services Received Without Charge

($ millions)	2006-2007
Accommodation provided by Public Works and Government Services Canada (PWGSC)	36.6
Contributions covering employers' share of employees' insurance premiums and expenditures paid by Treasury Board of Canada Secretariat Employers' contribution to employees' insured benefits plans and expenditures paid by TBS	44.1
Worker's compensation coverage provided by Human Resources and Skills Development Canada	0.8
Salary and associated expenditures of legal services provided by the Department of Justice Canada	3.2
2006-2007 Services received without charge	84.7

 

Table 5: Sources of Respendable and Non-Respendable Revenues

Respendable Revenues (millions of dollars)
Program Activity	Forecast Revenue 2005-2006	Planned Revenue 2006-2007	Planned Revenue 2007-2008	Planned Revenue 2008-2009
Health Products and Food	37.7	41.2	41.2	41.2
Healthy Environments and Consumer Safety	12.0	15.4	15.7	16.0
Pest Control Product Regulation	5.9	7.0	7.0	7.0
First Nations and Inuit Health	3.4	5.5	5.5	5.5
Total Respendable Revenues	59.0	69.1	69.4	69.7
Non-respendable Revenues (millions Of Dollars)
Program Activity	Forecast Revenue 2005-2006	Planned Revenue 2006-2007	Planned Revenue 2007-2008	Planned Revenue 2008-2009
Health Products and Food	3.9	3.9	3.9	3.9
Healthy Environments and Consumer Safety	1.7	1.7	1.7	1.7
Pest Control Product Regulation	1.0	1.0	1.0	1.0
First Nations and Inuit Health	2.3	2.3	2.3	2.3
Total Non-Respendable Revenues	8.9	8.9	8.9	8.9
Total Respendable and Non-Respendable Revenues	67.9	78.0	78.3	78.6

 

Table 6: Resource Requirements by Branch and by Program Activity (in millions of dollars)

($ millions)	Health Policy. Planning and Information	Health Products and Food	Healthy Environments and Consumer Safety	Pest Control Product Regulation	First Nations and Inuit Health	Total Planned Spending
Health Policy Branch	269.6					269.6
Health Products and Food Branch		204.4				204.4
Healthy Environments and Consumer Safety Branch			237.5			237.5
Pest Management Regulatory Agency				40.1		40.1
First Nations and Inuit Health Branch					1,997.9	1,997.9
Chief Financial Officer Branch	3.2	9.2	8.6	2.0	16.7	39.7
Corporate Services Branch	7.9	24.3	21.9	4.8	41.3	100.2
Departmental Executive Branch*	7.7	24.2	21.9	4.7	63.2	121.7
Total	288.4	262.1	289.9	51.6	2,119.1	3,011.1
Note: *Includes such areas as Communications, Legal Services, Office of the Chief Scientist, Audit and Accountability Bureau, Executive Offices and Offices of Regional Directors General.

 

Table 7: Major Regulatory Initiatives

Part A - New Initiatives
Program Activity: Health Policy, Planning And Information
Regulations	Expected Results
Regulations under the Assisted Human Reproduction Act	New regulations will protect the health and safety of Canadians who use assisted human reproduction (AHR) procedures and ensure that AHR-related research, which may help find treatments for infertility and diseases, takes place in a controlled environment. Regulated activities include embryo research, clinical and laboratory practices and pre-implantation genetic diagnosis. The regulatory framework will also include a licensing framework for AHR activities, and provisions governing the reimbursement of expenditures, counselling, and the reporting of health information.
Program Activity: Health Products And Food
Regulations	Expected Results
Food and Drug Regulations (Amendments to Division 3 respecting Positron Emitting Radiopharmaceuticals)	Amendment to Part C, Division 3 of the Food and Drug Regulations to provide for an exemption for the requirement to file Clinical Trial applications for certain radiopharmaceutical studies. The amended regulations will eliminate regulatory burden for certain limited basic research studies, while helping to ensure that patient safety is not compromised.
Food and Drug Regulations (Introduction of Emergency Use New Drug Regulations in Division 8)	Division 8 of the Food and Drug Regulations requires manufacturers of new drugs intended for sale in Canada to provide substantial evidence of clinical effectiveness in humans. This initiative will provide Health Canada with a formal mechanism to approve products which only contain substantial evidence of clinical effectiveness in animal or in-vitro studies for use in emergency situations and meet emergency preparedness measures, such as the approval and distribution of a vaccine for the treatment and prevention of a pandemic influenza virus.
Food and Drug Regulations (Prohibition of Importation for Personal Use)	Increase the scope of the prohibition on importation of veterinary drugs to include the personal importation of drugs intended to be used in food-producing animals to avoid potentially harmful residues in food products from animals treated with these drugs.
Food and Drug Regulations (Carbadox)	Prohibition of sale of products containing carbadox for sale in Canada to avoid potentially harmful residues in food products from animals treated with this drug.
Medical Device Regulations (Introduce additional requirements for investigational testing for medical devices)	Further address risks to health associated with investigational testing by requiring conformity to Good Clinical Practices, reporting to Health Canada for reviewing/ monitoring, and introducing an inspection program.
Medical Device Regulations (Amendment to regulate the reprocessing of single-use devices)	The amended regulations will mitigate the risks associated with the reprocessing of single-use devices by requiring reprocessors of single-use devices to operate under a standards-based licencing program administered by Health Canada.
Food and Drug Regulations (Regulations amending Divisions 1 and 8, Progressive Licensing Project)	A new regulatory framework that is based on sound science and risk management is being developed, including revised requirements for initial licensing of new products, provisions allowing for conditions of licensing (e.g., post-market commitments), regulations for the content and revisions of product monographs, provisions for continual evaluation and re-evaluation of licenses, new enforcement and compliance tools, regulations for the issuance of risk communication tools, and provisions for public involvement in the regulatory process.
Program Activity: Pest Control Product Regulation
Regulations	Expected Results
Pest Control Products Act (Sales Information Reporting Regulations)	New regulations will specify how pest control product sales information will be collected by specifying the requirements for recording, retaining and reporting sales of pest control products.
Part B - Ongoing Initiatives
Program Activity: Health Products And Food
Regulations	Expected Results
Food and Drugs Act (New regulatory framework for cells, tissues and organs intended for use in transplantation)	The new regulations will aim to balance the need for safe cells, tissues, and organs of high quality with the need to ensure the availability of cells, tissues and organs for transplantation. Phase I regulations will focus on the basic safety requirements for human cells, tissues and organs. Phase II regulations will include adverse event reporting requirements and a compliance and enforcement strategy.
Food and Drugs Act (New Regulations Respecting Blood and Blood Components)	The new regulations will aim to balance the need for safe blood and blood components with the need to ensure their availability for transfusion. They will include basic safety requirements, adverse event reporting requirements and a compliance and enforcement strategy.
Food and Drug Regulations (Amendment to provisions respecting plasmapheresis in Division 4 of Part C)	The amended regulations will reflect current methods and practices used to collect human plasma as well as the list of transmissible diseases for which tests must be performed in order to maximize the safety of plasma and plasma donors.
Food and Drugs Act (Amendment to the Processing and Distribution of Semen for Assisted Conception Regulations)	The amended regulations will reflect current safety standards for semen used in assisted conception.
Food and Drug Regulations (Addition of Vitamins and Minerals to Foods)	Facilitation of greater consumer choice and industry innovation by revision of regulations on the addition of vitamins and mineral nutrients to foods taking into account the role of nutrient addition to foods, consumer needs and expectations, and industry requests.
Food and Drug Regulations (Enhanced Labelling)	Enhanced protection of allergic consumers through mandatory labelling of specific food allergens, gluten sources and sulphites when present at 10 parts per million or more on the labels of prepackaged food products, whether they have been added directly or indirectly.
Food and Drug Regulations (Mandatory Labelling of Raw Ground Meat and Ground Poultry)	Reduction of foodborne illness as a result of providing safe handling information on the labels of these products which, due to their raw state, can introduce diseasecausing bacteria to the food preparation environment.
Food and Drug Regulations (Health Claims)	Addition of two diet-related health claims to the list of claims manufacturers can use to promote healthy foods (e.g., fruits, vegetables and whole grains and reduced risk of heart disease, folic acid and reduced risk of neural tube defects).
Food and Drug Regulations (Saccharin)	Availability of an additional intense sweetener to allow a wider range of low sugar or sugar free food products for the benefit of consumers who wish to consume these products.
Food and Drug Regulations (Caffeine)	Additional label information on levels of caffeine in prepackaged beverages, including caffeine containing energy drinks, to allow consumers to make an informed choice about their caffeine intake.
Food and Drug Regulations (Labelling of Unpasteurized Juice)	Reduction of foodborne illness related to the consumption of prepackaged unpasteurized juice products by providing additional information on the labels of these products.
Food and Drug Regulations (Revisions to Division 12 - Prepackaged Water and Ice)	Modernization and expansion of the safety and labelling requirements for prepackaged water and ice products.
Food and Drug Regulations (Regulations amending the Special Access Program)	The current Special Access Program allows for the use of unauthorized drugs prescribed to patients on an individual basis. The amendment will allow for the block release of unauthorized drugs to a population and/or for stockpiling to address public health emergencies.
Food and Drug Regulations (Regulations amending the data protection provisions)	The data protection provisions are being amended to provide effective data protection for a period of eight years for innovator drugs that contain medicinal ingredients not previously approved for sale in Canada. Submissions including pediatric studies that were designed and conducted with the purpose of increasing knowledge about the drug in pediatric age groups will be protected for an additional six months.
Program Activity: Healthy Environments And Consumer Safety
Regulations	Expected Results
Controlled Drugs and Substances Act (Regulations to expand the authority for regulated health professionals to prescribe controlled substances where appropriate)	Federal legislation will not unnecessarily restrict the professional practice of any health profession regulated by provincial or territorial (P/T) authorities, including practitioners of medicine, dentistry, veterinary medicine, podiatric medicine, midwifery, and nurse practitioners, with respect to the use of controlled substances in the treatment of their patients. This result will be achieved over the next 2 to 3 years as federal and P/T regulations are amended to allow health professionals to prescribe controlled substances in accordance with the standards of professional practice defined by their regulatory authorities. Achievement will be measured by improved alignment of federal and P/T regulatory frameworks governing the appropriate use of controlled substances for medical purposes.
Tobacco Advertising Regulations	Increased awareness of tobacco-related health hazards through mandating of new health warnings in advertising. Awareness will be measured through surveys.
Tobacco Act (Amendment to the Tobacco Labelling Regulations)	Increased awareness of tobacco-related hazards through the introduction of new health warnings on packaging. Awareness will be measured though surveys.
Tobacco Regulations (Amendments regarding "Light" and "Mild" Descriptors)	Reduced confusion among smokers regarding these descriptors. Greater awareness that no class of cigarettes is a "safer" alternative. Achievements will be measured through surveys.
Tobacco Retail Promotion Regulations	Reduced visibility of tobacco promotion at retail. Achievements will be measured through surveys at retail
Program Activity: Pest Control Product Regulation
Regulations	Expected Results
Pest Control Products Regulations	Revised regulations will include changes to clarify and modernize the Pest Control Product Regulations (PCPR) to make the PCPR coherent with the new Pest Control Products Act, and to formalize current procedures and practices for better compliance.
Pest Control Products Act (Amendments to the Agriculture and Agri-Food Administrative Monetary Penalties Regulations)	Revised regulations will address violations under the new Pest Control Products Act and regulations.
Pest Control Products Act (New regulations on review panels)	The new Pest Control Product Act includes a process for the reconsideration of major registration decisions by a review panel. New regulations will specify the parameters for establishing review panels and for the selection and remuneration of panel members. This will contribute to better public participation in the regulatory process, increased transparency and increased public and stakeholder confidence in pesticide regulation.
Pest Control Products Act (New regulations on the reporting of adverse effects from the use of pest control products)	New regulations will specify the prescribed information and time frames for reporting adverse effects of pest control products. This will contribute to strengthened health and environmental protection.

 

Table 8: Details on Transfer Payments Programs

Over the next three years, Health Canada will manage the following transfer payment programs in excess of $5 million:
2006-2007
Organization for the Advancement of Aboriginal People's Health (OAAPH) Payments to Indian bands, associations or groups for the control and provision of health services First Nations and Inuit Health Governance and Infrastructure Support (HG/IS) First Nations and Inuit Community Programs First Nations and Inuit Health Facilities and Capital Program First Nations and Inuit Health Benefits First Nations and Inuit Health Protection First Nations and Inuit Primary Health Care Bigstone Non-Insured Health Benefits Pilot Project Grant for Nunavut Medical Travel Fund Named Grant to the Health Council of Canada Grant to the Canadian Patient Safety Institute (CPSI) Grant to the Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Contributions for the Primary Health Care Transition Fund (PHCTF) Health Care Strategies and Policy Contribution Program Contributions Program to Improve Access to Health Services for Official Language Minority Communities Grant to the Canadian Blood Services Contributions in support of the Federal Tobacco Control Strategy (FTCS) Alcohol and Drug Treatment and Rehabilitation Contribution Program Drug Strategy Community Initiatives Fund
2007-2008
Organization for the Advancement of Aboriginal People's Health (OAAPH) Payments to Indian bands, associations or groups for the control and provision of health services First Nations and Inuit Health Governance and Infrastructure Support (HG/IS) First Nations and Inuit Community Programs First Nations and Inuit Health Facilities and Capital Program First Nations and Inuit Health Benefits First Nations and Inuit Health Protection First Nations and Inuit Primary Health Care Bigstone Non-Insured Health Benefits Pilot Project Grant for Nunavut Medical Travel Fund Named Grant to the Health Council of Canada Grant to the Canadian Patient Safety Institute (CPSI) Grant to the Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Health Care Strategies and Policy Contribution Program Contributions Program to Improve Access to Health Services for Official Language Minority Communities Grant to the Canadian Blood Services Contributions in support of the Federal Tobacco Control Strategy (FTCS) Alcohol and Drug Treatment and Rehabilitation Contribution Program Drug Strategy Community Initiatives Fund
2008-2009
Organization for the Advancement of Aboriginal People's Health (OAAPH) Payments to Indian bands, associations or groups for the control and provision of health services First Nations and Inuit Health Governance and Infrastructure Support (HG/IS) First Nations and Inuit Community Programs First Nations and Inuit Health Facilities and Capital Program First Nations and Inuit Health Benefits First Nations and Inuit Health Protection First Nations and Inuit Primary Health Care Bigstone Non-Insured Health Benefits Pilot Project Grant for Nunavut Medical Travel Fund Named Grant to the Health Council of Canada Grant to the Canadian Patient Safety Institute (CPSI) Grant to the Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Health Care Strategies and Policy Contribution Program Contributions Program to Improve Access to Health Services for Official Language Minority Communities Grant to the Canadian Blood Services Contributions in support of the Federal Tobacco Control Strategy (FTCS) Alcohol and Drug Treatment and Rehabilitation Contribution Program Drug Strategy Community Initiatives Fund
For further information on the above-mentioned transfer payments programs see www.tbs-sct.gc.ca/est-pre/estime.asp

 

Table 9: Conditional Grants (Foundations)

Over the next three years, Health Canada will contribute to the following foundations using conditional grants:
2006-07
Canada Health Infoway Inc. (Infoway) Canadian Institute for Health Information Canadian Health Services Research Foundation
2007-08
Canada Health Infoway Inc. (Infoway) Canadian Institute for Health Information Canadian Health Services Research Foundation
2008-09
Canada Health Infoway Inc. (Infoway) Canadian Institute for Health Information Canadian Health Services Research Foundation
For further information on the above-mentioned foundations see http://www.tbs-sct.gc.ca/est-pre/estime.asp

 

Table 10: Horizontal Initiatives

Over the next three years, Health Canada will be involved in the following horizontal initiatives as either the lead or as a partner:
2006-07
Canada's Drug Strategy (lead) Building Public Confidence in Pesticide Regulation and Improving Access to Management Products (lead) Federal Early Childhood Development (ECD) Strategy for First Nations and Other Aboriginal Children (lead)
Further information on the above-mentioned horizontal initiatives see http://www.tbs-sct.gc.ca/est-pre/estime.asp

 

Table 11: Sustainable Development Strategy

Health Canada's current Sustainable Development Strategy entitled Becoming the Change We Wish to See is a three year strategic plan that tells Canadians and Parliament what general and specific commitments Health Canada has made to sustainable development (SD). To build on the success of the previous strategy, the Department's third strategy continues with the themes identified in the previous one. These key themes are: Helping to create healthy social and physical environments. Integrating sustainable development into departmental decision-making and management processes. Minimizing the environmental and health effects of the Department's physical operations and activities. Whereas the Department's first strategy contained over 100 commitments, this Strategy focuses on 20 commitments, highlights how employees are an integral part of the overall plan, and identifies a number of practical tools to help incorporate sustainable development at work and at home.
Sustainable Development Strategy Commitments
1.1.1: In partnership with federal, provincial and territorial departments of health and environment, Health Canada will develop an integrated, source-to-tap approach to drinking water quality in Canada.
1.1.2: Health Canada will work with other federal departments to develop a compliance framework for drinking water quality in areas of federal jurisdiction.
1.1.3: Health Canada, in conjunction with other federal departments, will reduce cross-border air pollution by undertaking pilot projects that enable greater opportunities for coordinated air quality management between Canada and the United States.
1.1.4 Health Canada will collaborate with partners and other federal departments to assess climate change impacts on human health and well-being, and research and develop approaches to adaptation planning and implementation as part of the Climate Change Plan for Canada.
1.1.5: Health Canada will work in consultation with stakeholders to develop and/or update science-based guidelines and standards to improve the safety of the food supply and reduce foodborne illness.
1.1.6: Health Canada will help prevent the exploitation of flora and fauna used for medicinal purpose
1.1.7: Health Canada will improve its process for making regulatory decisions for pest control products, including providing access to safer products, and will provide information on pest control products and on sustainable pest management practices.
1.2.1: Health Canada will work in collaboration with First Nations and Inuit and provinces and territories to better integrate health services for a sustainable, seamless system of health services for First Nations and Inuit.
2.1.1: Health Canada will improve the integration of SD considerations within the Department by developing a framework to identify key planning, reporting activities and modern management practices that could incorporate SD considerations, and will integrate sustainable development into these areas where appropriate by March 31, 2007.
2.1.2: Health Canada will improve the integration of SD considerations within the Department by effectively integrating SD into key departmental policies, legislation and contracts where appropriate, and establishing a formal process to evaluate this integration by March 31, 2007.
2.1.3: Health Canada will increase employee awareness about sustainable development by developing and implementing a social marketing campaign for March 31, 2007.
2.1.4: Health Canada will increase employee awareness about sustainable development by developing and implementing a departmental training curriculum on sustainable development to be provided to at least 1,000 Health Canada employees by March 31, 2007.
2.1.5: Health Canada will contribute to increase federal employee awareness of sustainable development through partnering with other government departments, federal committees and networks to design and deliver an interdepartmental course about sustainable development by March 31, 2007.
3.1.2: By March 2007, Health Canada commits to providing facility managers and other managers with authorities over facilities with training on the sustainable operation and management of Health Canada facilities. The training will be based on the departmental guidebook.
3.2.3: By January 2007, Health Canada will begin implementing and reporting the recommendations outlined in the departmental pollution prevention guidebook and action plan.
Since the first strategy, Health Canada has worked to create a culture that recognizes the importance of sustainable development in its operations. Approval of a Sustainable Development Policy in December 2000 enabled the integration of five key principles (shared responsibility, integrated approaches, equity, accountability, and continuous improvement) into the Department's third Sustainable Development Strategy. They will act as guiding principles for the development of the next strategy covering 2007 to 2010, to be tabled in Parliament in December 2006. The Department will continue to report annually on progress made on SD Strategy commitments. Strategic Environmental Assessment (SEA) is a systematic and comprehensive process for evaluating the environmental effects of a policy, plan or program and its alternatives, at the earliest stage in planning. Health Canada has a requirement to complete SEAs in conformance with the 2004 Cabinet Directive on the Environmental Assessment of Policy, Plan and Program Proposals. Health Canada has developed a policy and guidelines for strategic environmental assessment to support departmental efforts to ensure proposals with important positive or negative environmental effects are identified and enhancement or mitigation measures are identified. The Department is committed to providing training on this initiative to policy staff as required and will continue to consider the environmental impacts of our activities. Additionally, use of an environmental management system, or EMS, is another way to promote sustainable development. Two of the priorities of the EMS Division are the review of the EMS to reflect the multiple changes within the federal government and the revamping of the EMS database (the primary resource for environmental information). Some preliminary work on the EMS database has already started and will continue in 2006-2007. Other databases in the Health Portfolio used to capture environmental information include a fleet database for tracking vehicle operations and a hazardous waste database for some hazardous streams. Building on previous experiences and incorporating best practices in our work will help to achieve sustainable development in the long term.

 

Table 12: Internal Audits and Evaluations

Project Title	Estimated Completion Date1
Recently Completed Internal Audits
Review of the Administration of the Health Canada Contract with First Canadian Health Management Corporation Inc.	Approved by the DA&EC on April 7, 2005
Follow-up of the Directed Audit of Société Santé en Français Inc.	Approved by the DA&EC on November 1, 2005
Upcoming Internal Audits
Audit of the Handling of Controlled Drug Substances (CDS) in FNIHB Health Facilities within Two Selected Regions	Approved by the DA&EC April 2006
Audit of Primary Health Care Transition Fund (PHCTF) Contributions to the Ministry of Health and Long Term Care of the Province of Ontario	Fall 2006
Audit of Selected Administrative Areas	Summer 2006
Audit of Health Canada Initiatives for GOL	Approved by the DA&EC June 2006
Audit of IT Security in Health Canada	Fall 2006
Audit of the Implementation of Corrective Measures Ordered by the Public Service Commission	Fall 2006
Selected Results-Based Management Accountability Frameworks	January 2007
Audit of Mental Health and Addictions Programs	January 2007
Audit of the Drug Strategy and Controlled Substances Programme	January 2007
Recently Completed Evaluations
Evaluation of the Memorandum of Understanding between the Assistant Deputy Ministers and Regional Directors General	Approved by the DA&EC November 2005
Evaluation of the Health Canada Innovation Fund	Approved by the DA&EC November 2005
Evaluation of the Canada Health Infostructure Partnership Program	Approved by the DA&EC November 2005
Impact Evaluation of the Health Transition Fund	Approved by the DA&EC November 2005
Formative Review of the Research Management and Dissemination Division	Approved by the DA&EC November 2005
Health Transfer Policy - FNIHB	Approved by the DA&EC April 2006
Brighter Futures and Building Healthy Communities Program - FNIHB	Approved by the DA&EC April 2006
Non-Insured Health Benefits Pilot Projects - FNIHB	Approved by the DA&EC April 2006
Primary Health Care Transition Fund - interim evaluation - Health Policy Branch (HPB)	Approved by the DA&EC April 2006
Cost Recovery in the Pest Management Regulatory Agency	Approved by the DA&EC April 2006
Health Care Strategies and Policy Grant and Contribution programs - Performance Measurement System Review - HPB	Approved by the DA&EC June 2006
Upcoming Evaluations
Review of Evaluation and Performance Measurement at Health Canada - CFOB	Fall 2006
First Nations and Inuit Home and Community Care Program - FNIHB	Fall 2006
Canada Prenatal Nutrition Program - FNIHB	Fall 2006
Aboriginal Diabetes Initiative - FNIHB	Winter 2006-2007
Augmenting Health Canada's Response to Bovine Spongiform Encephalopathy (BSE) - BSE I phase II of Health Canada's and the PHAC's response to BSE in the areas of Risk Assessment and Targeted Research - BSE II	Fall 2006
Federal Drinking Water Compliance Program (HECS)	Winter 2006-2007
Federal Tobacco Control Strategy	March 2007
Contribution Program for Improving Access to Health Services for Official Languages Minority Communities - HPB	Winter 2006-2007
Canadian Regulatory System for Biotechnology - HPFB	Fall 2006
Therapeutics Access Strategy - HPFB	Fall 2006
Natural Health Products Research Program - HPFB	Fall 2006
Drug Strategy and Controlled Substances Program, Canada's Drug Strategy Renewed Year 2 - HECSB	Fall 2006
Canadian Environmental Protection Act - HECSB	Fall 2006
Building Public Confidence in Pesticide Regulation and Improving Access to Pest Management Products - PMRA	Fall 2006
Expenditure Review Reductions and the Impact on Health Canada - DAEC/DPMED	Winter 2006-2007
Contracting for Professional and Special Services in Health Canada - DAEC/DPMED	Winter 2006-2007
1 The 'Estimated Completion Date' is the date the internal audit or evaluation report is expected to be tabled for approval by Health Canada's Departmental Audit and Evaluation Committee (DA&EC).

Section 4: Other Items of Interest

Health Canada's Regional Operations - An Overview

On January 6, 2006, the Deputy Minister of Health and the Associate Deputy Minster of Health announced the establishment of the Public Affairs, Consultation and Regions Branch. This new Branch incorporates the Communications, Marketing and Consultation Directorate; the external and internal ombudsman services; and the regions. The Branch affords Health Canada an opportunity to better integrate national and regional perspectives in all policies and strategies, communications and consultation functions, and is key to a commitment of transparency on the part of the Department.

Over the course of the last year, an initiative has been underway that aims to improve service to Canadians by strengthening the Department's programs and regional role, and enhancing communication and collaboration. As such, the role of the Regional Directors General has been enhanced in order to fully realize their integral role as Health Canada's senior representatives in the regions, responsible for the management of all of Health Canada's regional operations and personnel. The creation of the new Branch complements this ongoing work and will enable the Department to continue to evolve in the context of a changing environment. It also fulfills Health Canada's continuing commitment to ensure both greater coherence and a consistent presence for the Department nationally and in each region across the country.

In recognition of the unique program and service delivery challenges and opportunities among a diverse and often remote northern population, responsibility for all Health Canada activities in the Northwest Territories, Yukon and Nunavut is now overseen by the Northern Secretariat component of Regional Operations. This consolidation of responsibility for the North, under the Northern Secretariat, will provide a consistent Territorial lens for Health Canada's policy and program development, and greater coherence to Health Canada programs and services in northern communities. Further, in consideration of the needs and priorities identified within the community and among stakeholders, the Manitoba and Saskatchewan Region has been re-organized so that Manitoba and Saskatchewan each now assume status as an individual region. This will serve to enhance communications and consultations within the Department and with Health Canada's numerous stakeholders, partners and the public.

Health Canada's presence across the country will continue to be reflected through program and service delivery tailored to meet the varied needs of each of the geographic regions it serves. This includes the British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec and Atlantic regions, as well as the Northern Secretariat. Over one third of Health Canada's employees work in communities outside of the National Capital Region. This regional proximity to clients provides the Department with specialized knowledge and capacity to assist in furthering departmental goals and priorities. Health Canada's Regions offer local intelligence and a community connection which serves to bring regional perspective and coherence into the design and delivery of health protection and promotion programs as well as national policy development. Such citizen-centred engagement helps to ensure that program delivery in the regions is representative of and responsive to local issues and priorities, while respecting national program integrity and accountability.

The close ties between regional offices and their counterparts in other federal departments provide frequent opportunities for collaboration and partnership. Representation by Health Canada's Regions on regional Federal Councils serves to support the broader federal government agenda. In addition, it allows Health Canada to play a key role in reflecting regional views in the development of national cross-departmental policy and in the design of program delivery.

Health Canada's Regions foster and strengthen effective, long standing relationships and associations with provincial, territorial and municipal governments and key stakeholders. These relationships serve to advance horizontal collaboration and facilitate multipartnered and inter-governmental initiatives. They also improve the Department's understanding of challenges and opportunities which cross program boundaries as provincial and territorial approaches to managing the health care agenda evolve.

Strategic and targeted use of the Health Canada Innovation Fund continues to provide Health Canada's Regions with the ability to create and leverage partnership opportunities in response to local issues and concerns. Whether in partnership with academic institutions, non-governmental community based organizations or health research foundations, Health Canada Innovation Fund initiatives seek to identify and answer the specific needs and priorities within local groups and communities.

Providing Support to Departmental Strategic Outcomes and Corporate Objectives

Strengthened knowledge base to address health priorities:

• Manage intergovernmental affairs; and
• Foster communication, consultation and stakeholder engagement within the Regions.

Safe and effective health products and food and information for healthy choices:

• Conduct surveillance, enforcement and compliance activities for health-related products;
• Assist in ensuring safe and effective health products and food and information for healthy choices through regional contributions to national policies, programs, and regulations; and
• Engage in consultation to build stakeholder relations and provide information for making healthy choices.

Reduced health and environmental risks from products and substances, and safer living and working environments:

• Conduct inspection and surveillance activities as well as health promotion activities related to consumer products, tobacco, controlled drugs and substances, and the environment;
• Establish marketplace and user inspection programs as well as compliance and promotional activities for pesticides;
• Conduct risk assessments and evaluations and provide health advice to federal employees, provinces and municipalities related to chemical contaminates and exposure levels, drinking water standards, and work environments.

Better health outcomes and reduction of health inequalities between Aboriginals and other Canadians:

• Direct provision of Non-Insured Health Benefits to First Nations and Inuit clients;
• Delivery of community-based health promotion and disease prevention programs for First Nations and Inuit populations;
• Delivery of Home and Community Care Program and addictions treatment services for First Nations and Inuit populations;
• Development and delivery of health protection programs and services for First Nations and Inuit populations;
• Capacity building in the areas of health information management and analysis for First Nations and Inuit populations;
• Provision of management capacity support and capital investments in First Nations and Inuit communities; and
• Collaborate in emergency preparedness and response and pandemic planning.

Corporate Management - Leadership and infrastructure to support the Department's Regional Operations:

• Ensure sound stewardship of both the human and financial resources of the Department through effective and accountable management and administration of assets, human resources, information technology, policy, planning, security and business continuity services.

Supporting Health Canada's Programs and Services

Health Canada requires efficient and effective corporate services to ensure that it has the capacity and capability to undertake its main activities of promoting, protecting and improving the health of Canadians. The following examples demonstrate the Department's ongoing efforts and commitment to strengthen its corporate services and management practices

Our human resources planning process responds to the human resources risks and challenges we encounter in support of our business objectives. As well as consolidating and realigning IT resources and positioning the Department to align with the Government of Canada common services initiatives and generate savings, The Way Forward information technology project will ensure that service levels are maintained for all clients and that our IT infrastructure is sustainable in support of Health Canada's programs.

Health Canada was an early adopter of the Government's Management Accountability Framework (MAF) and will continue its efforts to not only promote the MAF throughout the Department but to implement management improvement initiatives to strengthen stewardship and accountability including the Financial Management Control Framework, the Contract Management Framework, the Contract Requisitions and Reporting System, the Asset Management Framework and the Departmental Real Property Management Framework. We will use the results of our MAF Assessment and other management or government priorities to determine areas requiring further attention or action. In addition, the Department will continue to share information and, as required, coordinate efforts with other Portfolio members.

We have also recently begun a department-wide operational planning process and we will continue our efforts to enhance and improve this process. Not only does operational planning link expected results to the allocation of resources, it will assist in identifying key priority pressures within the Department as well as reviewing opportunities for reallocation of resources from lower to higher priorities.

We will continue to implement an Integrated Risk Management (IRM) Framework and to update the Department's Corporate Risk Profile and Internal Scan on a regular basis. As well, we will continue to systematically manage risk in key functional areas and decision-making processes through such tools as the risk-based audit plan, the risk communications framework, risk-based disposition of records, an information technology enterprise approach predicated on risk management and a risk-based approached to human resources classification and staffing. We will also complete the development of an internal Departmental Business Continuity Plan in the Event of a Pandemic Influenza Outbreak that will allow us to maintain operations to the extent possible while protecting the health and safety of employees.

Initiatives are also underway to review, improve and update privacy policies and practices to ensure that personal information is protected within Health Canada. For example, a Departmental Information Management Awareness campaign is reinforced by more in-depth courses on both access to information and privacy offered to employees throughout Health Canada. We also conduct Privacy Impact Assessments on an on-going basis to identify and address privacy risks related to Departmental programs or services that handle personal information.

We foster an ethical culture that best embodies the core values of Health Canada and the Public Service through our Centre for Workplace Ethics. The Centre collaborates as appropriate with the services of Internal Ombudsman and Informal Conflict Management System (ICMS) to assist staff or teams with specific and pressing ethical challenges or conflict related issues. Regular reporting on trends by these three services provides the Deputy Minister with a department-wide perspective on progress as well as an early identification mechanism for areas of concern.

Details on Transfer Payments Programs

Name of Transfer Payment Program: Contributions to the Organization for the Advancement of Aboriginal People's Health (OAAPH)
Start Date: April 2005			End Date: March 2010
Description: to support the Organization for the Advancement of Aboriginal People's Health
Strategic outcomes: Improved knowledge-based activities (including research) related to the health of Aboriginal people and communities
Expected Results : Continued empowerment of Aboriginal peoples through advancements in knowledge and sharing of knowledge on aboriginal health
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) First Nations and Inuit Health
Total Grants
Total Contributions	0	5.0	5.0	5.0
Total Other Types of Transfer Payments
Program Activity (PA) First Nations and Inuit Health	0	5.0	5.0	5.0
Planned Audits and Evaluations: N/A

 

Details on Transfer Payments Programs

Name of Transfer Payment Program: Payments to Indian bands, associations or groups for the control and provision of health services
Start Date: 1989			End Date: 2006
Description: T o increase responsibility and control by Indian communities of their own health care and to effect improvement in the health conditions of Indian people.
Strategic outcomes: Strengthened and enhanced accountability of community leaders to community members in transferred communities regarding the management and the delivery of health programs and services
Expected Results: Increased control or accountability by First Nations communities of health care services.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) First Nations and Inuit Health
Total Grants
Total Contributions	209.6	217.9	227.9	233.9
Total Other Types of Transfer Payments
Total PA First Nations and Inuit Health	209.6	217.9	227.9	233.9
Planned *Audits and Evaluations: N/A

*Recipients are required to provide year end financial audited statements. Contribution compliance audits are conducted every year for a sample of recipients.

Details on Transfer Payments Programs

Name of Transfer Payment Program: Contributions for First Nations and Inuit Health Governance and Infrastructure Support (HG/IS)
Start Date: April, 2005			End Date: March 2010
Description: Governance and Infrastructure Support to the First Nations and Inuit Health System
Strategic outcomes: Contributes to the improved health status of First Nations and Inuit individuals, families and communities through strengthened governance and infrastructure support.
Expected Results: Improved health status of FNI through strengthened governance and infrastructure
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) First Nations and Inuit Health
Total Grants
Total Contributions	0	167.6	188.3	179.1
Total Other Types of Transfer Payments
Program Activity (PA) First Nations and Inuit Health	0	167.6	188.3	179.1
Planned *Audits and Evaluations: Evaluation Initiatives for the adaptation and integration of health services for Aboriginal peoples

* Contribution compliance audits are completed every year for a sample of recipients.

Details on Transfer Payments Programs

Name of Transfer Payment Program: Contributions for First Nations and Inuit Community Programs
Start Date: April 1, 2005			End Date: March 2010
Description: community programs support child and maternal-child health; mental health promotion; addictions prevention and treatment; chronic disease prevention and health promotion services.
Strategic outcomes: Contributes to the improved health status of First Nations and Inuit individuals, families and communities through strengthened community programs and supports.
Expected Results: Increased participation of First Nations and Inuit individuals, families, and communities in programs and supports Improved continuum of programs and services in First Nations and Inuit communities
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) First Nations and Inuit Health
Total Grants
Total Contributions	0	211.3	228.6	243.5
Total Other Types of Transfer Payments
Program Activity (PA) First Nations and Inuit Health	0	211.3	228.6	243.5
Planned *Audits and Evaluations: NNADAP - residential Tobacco Control Strategy (FN/I)

* Recipients are required to provide year end financial audited statements. Contribution compliance audits are conducted every year for a sample of recipients.

Details on Transfer Payments Programs

Name of Transfer Payment Program: Contributions for First Nations and Inuit Health Facilities and Capital Program
Start Date: April, 2005			End Date: March 2010
Description: Provides funding to eligible recipients for the construction acquisition, leasing, operation and maintenance of nursing stations, health centres, health stations, health offices, treatment centres, staff residences, and operational support buildings.
Strategic outcomes: Modern and well maintained health care facilities and residences that support effective health program delivery.
Expected Results: Increase availability of health facilities, equipment and other moveable assets in First Nations and Inuit communities that support the provision of health services
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) First Nations and Inuit Health
Total Grants
Total Contributions	0	53.1	51.2	48.6
Total Other Types of Transfer Payments
Program Activity (PA) First Nations and Inuit Health	0	53.1	51.2	48.6
Planned *Audits and Evaluations: N/A

** Contribution compliance audits are conducted every year for a sample of recipients.

Details on Transfer Payments Programs

Name of Transfer Payment Program: Contributions for First Nations and Inuit Health Benefits
Start Date: April, 2005			End Date: March 2010
Description: A limited range of medically necessary health-related goods and services which supplement those provided through other private or provincial/territorial health insurance plans is provided to registered Indians and recognized Inuit. Benefits include drugs, dental care, vision care, medical supplies and equipment, short-term crisis intervention mental health services, and transportation to access medical services not available on reserve or in the community of residence.
Strategic outcomes: Access to non-insured health benefits contributes to improved health status of First Nations and Inuit eligible clients
Expected Results: Access by eligible clients to Non-Insured Health benefits
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) First Nations and Inuit Health
Total Grants
Total Contributions	0	123.3	120.7	124.2
Total Other Types of Transfer Payments
Program Activity (PA) First Nations and Inuit Health	0	123.3	120.7	124.2
Planned *Audits and Evaluations: N/A

*Recipients are required to provide year end financial audited statements. Contribution compliance audits are conducted every year for a sample of recipients.

Details on Transfer Payments Programs

Name of Transfer Payment Program: Contributions for First Nations and Inuit Health Protection
Start Date: April, 2005			End Date: March 2010
Description: Communicable Disease and Environmental Health and Research programs facilitate preparedness to implement measures in the control, management and containment of outbreaks of preventable diseases and improve management and control of environmental hazards.
Strategic outcomes: Health protection interventions contribute to improved health status of First Nations and Inuit individuals, families and communities.
Expected Results: Environmental health risk management contributes to improved health status of First Nations individuals, families and communities Improved access to quality well- coordinated communicable disease prevention and control programs for First Nations and Inuit individuals, families, and communities
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) First Nations and Inuit Health
Total Grants
Total Contributions	0	9.7	10.3	9.2
Total Other Types of Transfer Payments
Program Activity (PA) First Nations and Inuit Health	0	9.7	10.3	9.2
Planned *Audits and Evaluations: Water Management Strategy

* Recipients are required to provide year end financial audited statements. Contribution compliance audits are conducted every year for a sample of recipients.

Details on Transfer Payments Programs

Name of Transfer Payment Program: Contributions for First Nations and Inuit Primary Health Care
Start Date: April, 2005			End Date: March 2010
Description: Primary Health Care services include emergency and acute care health services, Community primary health care services which include illness and injury prevention and health promotion activities. These programs also include: the First Nations and Inuit Home and Community Care; and the Oral Health Strategy.
Strategic outcomes: Primary health care contributes to improved health status of First Nations and Inuit individuals, families and communities
Expected Results: Improved access to quality well-coordinated culturally appropriate primary health care programs and services for First Nations and Inuit individuals, families and communities
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) First Nations and Inuit Health
Total Grants
Total Contributions	0	119.7	121.2	123.0
Total Other Types of Transfer Payments
Program Activity (PA) First Nations and Inuit Health	0	119.7	121.2	123.0
Planned *Audits and Evaluations: Home and Community Care Primary Health Care Program

* Recipients are required to provide year end financial audited statements. Contribution compliance audits are conducted every year for a sample of recipients.

Details on Transfer Payments Programs

Name of Transfer Payment Program: Contributions for Bigstone Non-Insured Health Benefits Pilot Project
Start Date: April, 2005			End Date: March 2010
Description: Administration and delivery of benefits with Bigstone Health Commission to registered Indians and recognized Inuit.
Strategic outcomes: Access to non-insured health benefits contributes to improved health status of First Nations and Inuit eligible clients
Expected Results: Provide registered Indians and recognized Inuit with a limited range of medically necessary health related goods and services not provided through private or federal/provincial/territorial health insurance plans.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) First Nations and Inuit Health
Total Grants
Total Contributions	0	8.2	8.5	8.8
Total Other Types of Transfer Payments
Program Activity (PA) First Nations and Inuit Health	0	8.2	8.5	8.8
Planned Audits and Evaluations: 1 including a contribution audit

 

Details on Transfer Payments Programs

Name of Transfer Payment Program: Grant for Nunavut Medical Travel Fund
Start Date: April 2005			End Date: March 2010
Description: To support the Nunavut medical travel fund
Strategic outcomes: To Improve Health System Sustainability in the Territories
Expected Results: address the significant and immediate pressures facing the Yukon, Northwest Territories and Nunavut (the territories) in the area of medical travel expenditures offset a portion of the territories' medical travel costs; and enable the territories to redirect resources to alternative sustainable health reform initiatives.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) First Nations and Inuit Health
Total Grants	0	10.2	10.2	10.2
Total Contributions
Total Other Types of Transfer Payments
Program Activity (PA) First Nations and Inuit Health	0	10.2	10.2	10.2
Planned Audits and Evaluations: N/A

 

Details on Transfer Payments Programs

Name of Transfer Payment Program: Named Grant to the Health Council of Canada
Start Date: September 1, 2004			Renewal Date: March 31, 2008
Description: The mandate of the Health Council of Canada is to monitor and make annual public reports on the implementation of the 2003 First Ministers' Accord on Health Care Renewal and the 2004 Health Accord.
PAA Strategic Outcome #1: Strengthen knowledge base to address health and health care priorities.
Expected Results: Through monitoring and the annual public reporting on the progress achieved in implementing the 2003 First Ministers' Accord and the 2004 Health Accord, the Health Council of Canada will contribute to enhancing accountability and transparency in health system care reform.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) Health Policy, Planning and Information
Total Grants	10.0	10.0	10.0	10.0
Total Contributions
Total Other Types of Transfer Payments
Total PA	10.0	10.0	10.0	10.0
Planned Audits and Evaluations: The Health Council of Canada publishes annual audited financial statements

 

Details on Transfer Payments Programs

Name of Transfer Payment Program: Grant to the Canadian Patient Safety Institute (CPSI)
Start Date: December 10, 2003			End Date: March 31, 2008
Description: Establishment of a class grant program to support the federal government's interest in a federal/provincial/territorial partnership context, in achieving an accessible, high quality, sustainable and accountable health system adaptable to the needs of Canadians.
Strategic Outcome(s): Strengthen knowledge base to address health and health care priorities. To improve the quality of health care services by strengthening system coordination related to patient safety, including promoting national collaboration among key players
Expected Results: Provide advice to governments, stakeholders and the public on effective strategies to improve patient safety; Perform a coordinating role across sectors and systems; Promote best practices related to patient safety; and Raise awareness of patient safety issues with patients and the general public through public education and reporting.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) Health Policy, Planning and Information
Total Grants	8.0	8.0	8.0	8.0
Total Contributions
Total Other Types of Transfer Payments
Total PA	8.0	8.0	8.0	8.0
Planned Audits and Evaluations:The CPSI will undertake an initial program evaluation 3 years after the start date of the grant and once every 5 years thereafter. A full independent audit and auditor's report are required on an annual basis.

 

Details on Transfer Payments Programs

Name of Transfer Payment Program: Grant to the Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
Start Date: April 1, 2005			End Date: March 31, 2008
Description: CCOHTA is an independent not-for-profit corporation established under the Canada Corporations Act , Part II, whose purpose is to co-ordinate, perform and facilitate the collection, analysis, creation and dissemination of information concerning the effectiveness and cost of technologies and drugs and their impact on health and the appropriateness of their use. The purpose of the Named Grant is to provide financial assistance to support CCOHTA's core business activities namely, Common Drug Review ("CDR"), Health Technology Assessment ("HTA") and Canadian Optimal Medication Prescribing and Utilization Service ("COMPUS").
Strategic Outcome(s): Strengthen knowledge base to address health and health care priorities. The evidenced-based adoption, diffusion, management and utilization of health technologies within the Canadian health care system.
Expected Results: Increased capacity building in jurisdictions for the assessment and analysis of information on health technologies as well as the receptor capacity relating to policy analysis in accordance with the priorities of the Federal/Provincial/Territorial health systems/Ministries of Health. Increased relevance of Canadian health technology assessment products and services, produced by CCOHTA and its partners. Implementation of the Canada's Health Technology Strategy including the establishment of structures and a transparent process to allow jurisdictions to share information and, where appropriate, work together for the better management of health technology. Promoting and facilitating the adoption of best practices in drug prescribing services. Implementation of the Federal Provincial Territorial Common Drug Review Program, which provides participating federal, provincial and territorial publicly funded drug plans with a systematic review of the available clinical evidence, a review of pharmacoeconomic data and formulary listing recommendations for new drugs.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) Health Policy, Planning and Information
Total Grants	16.9	17.4	17.4	16.9
Total Contributions
Total Other Types of Transfer Payments
Total PA	16.9	17.4	17.4	16.9
Planned Audits and Evaluations: CCOHTA is to carry out and submit to the Minister, no later than June 30, 2007, an independent evaluation of CCOHTA's core business activities for the period of March 31 st , 2003 to March 31, 2007.

 

Details on Transfer Payments Programs

Name of Transfer Payment Program: Contributions for the Primary Health Care Transition Fund (PHCTF)
Start Date: June 13, 2001			End Date : September 30, 2006
Description: $800 million PHCTF established in response to FMM 2000 commitment that improvements to primary health care are crucial to the renewal of the health care system overall.
Strategic Outcome(s): Strengthened knowledge base to address health and health care priorities Program Strategic outcomes: Effect quality improvement and cost-effectiveness of primary health care service delivery across Canada; knowledge development and translation initiatives to facilitate continuous improvement of primary health care service delivery; fund initiatives supporting primary health care renewal; support and coordinate the analysis and sharing of information on primary health care renewal; and, provide national leadership of primary health care service transformation in collaboration with provincial/territorial counterparts, stakeholder groups and other mechanisms.
Expected Results: Immediate Outcomes: 1) Acceleration of PHC renewal 2) Increased emphasis on PHC renewal 3) Increased collaboration on PHC renewal Intermediate Outcomes: 4) Improved infrastructure and systems to deliver PHC Intermediate Outcomes: 5) Enhanced knowledge and capacity to deliver PHC 6) A more integrated approach to the delivery of PHC Long-term Outcome: 7) Fundamental change in support of sustainable PHC systems * This outcome is not expected to happen within the life of the PHCTF; expected time frame is five to ten years.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) Health Policy, Planning and Information
Total Grants
Total Contributions	248.9	75.6	0	0
Total Other Types of Transfer Payments
Total PA	248.9	75.6	0	0
Planned Audits and Evaluations The formative evaluation report has been completed and the PHCTF response and action plan to the report is expected to be approved by the end of fiscal year 05/06. The initiation of the summative evaluation of the PHCTF will also take place in fiscal year 05/06 with a completion in 06/07. Audits are currently being conducted on two initiative recipients funded by the PHCTF, these include the Bigstone Health Commission and the Northern and Aboriginal Population Health and Wellness Institute (NAPHWI). A management audit of the Ontario Per Capita file is also underway. All audits will be completed in fiscal year 05/06.

 

Details on Transfer Payments Programs

Name of Transfer Payment Program: Health Care Strategies and Policy Contribution Program
Start Date: September 24, 2002			End Date: March 31, 2007
Description: To support the federal government's interests in achieving an accessible, high quality, sustainable and accountable health system adaptable to the needs of Canadians.
Strategic Outcome(s): Strengthened knowledge base to address health and health care priorities Increased evidence & knowledge base for decision-making in health care Increased collaboration/coordination on identified health care system issues/priorities
Expected Results: Reports, consultations, research and evaluation; educational models/tools and resources for health providers, health system managers and decision makers; innovative models for funding and delivery; innovative collaborations and/or coalitions; case studies and best practices; policy research documents; environmental scans, system and technology assessments; increased evidence and knowledge base for decision-making in health care; Performance Measurement System; evaluation framework; annual audits & ongoing monitoring.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA) Health Policy, Planning and Information
Total Grants
Total Contributions	21.0	29.1	38.4	36.6
Total Other Types of Transfer Payments
Total PA	21.0	29.1	38.4	36.6
Planned Audits and Evaluations: Overall Health Care Strategies, Policy Grant and Contribution Programs formative evaluation due on March 31, 2007.

 

Details on Transfer Payments Programs

Name of Transfer Payment Program: Contributions Program to improve access to health services for Official Language Minority Communities
Start Date: April 1, 2003			End Date: June 30, 2008
Description: Contribution program to improve access to health services to official language minority communities. This initiative is part of the federal Action Plan for Official Languages.
Strategic outcomes: (a) improve access to health services for official language minority communities; (b) meet the needs and improve health services in official language minority communities, thereby enhancing the health of these communities; (c) improve the efficiency of the health system as a whole by improving health services for official language minority communities. These objectives are commensurate with Health Canada's mission to help people of Canada maintain and improve their health. More specifically, they relate to two of the departmental objectives namely ensuring high-quality health services that are efficient and accessible and reduce health inequalities in Canadian society.
Expected Results: Expected key program results have been developed with the Consultative Committees and are integrated into the Results-Based Management and Accountability Framework (RMAF) which have been developed for the Program. For both official language community there is two majors components: Component networking : the networking component is to mobilize the capacity of institutions, professionals and communities to foster the commitment to health services in both official languages for official language minority communities. Component training and retention of health professionnel : this component is to increase capacity for basic training, improve professional development and research, and promote the retention of health professionals in official language minority communities.
Networking Component A) French-speaking minority communities The expected results are to: -promote the establishment of strong, durable links among health sector stakeholders (health professionals, communities, policy makers, health care institutions, training institutions); -mitigate the geographic dispersal of Francophone and Anglophone minority communities and the isolation experienced by professionals; -promote communities ownership (in terms of the planning, development, strengthening or pursuit and promotion of improved access to health care in French); -maximize the use of existing resources and share best practices; -make health sector stakeholders more aware of the importance of language in health service delivery; -improve services to French-speaking minority communities by delivering high-quality health care and increasing their use; and - build capacity to provide health services in French through professional networking, and promote research capacity in French.
B) English-speaking minority communities The expected results are: -promote the establishment of strong, durable links among health sector stakeholders (health professionals, communities, policy makers, health facilities, training institutions); -mitigate the geographic dispersal of Anglophone minority communities and the isolation experienced by professionals; -promote communities ownership (in terms of the planning, development, strengthening or pursuit and promotion of improved access to health services in English); -maximize the use of existing resources and share best practices; - build capacity to provide health services in English through professional networking, and the participation of researchers in the minority language.
Training and Retention Of Health Professionnel A) Francophone minority communities The expected results are : -more Francophone professional health training through partnerships with the universities, colleges, etc.; -more incentives for recruitment and retention of health professionals able to serve Francophones, including greater motivation to remain in home regions after completing studies or professional training; -greater research capacity and better understanding of the needs of French-speaking minority communities; -more professionals to meet the needs of French-speaking minority communities; and greater satisfaction on the part of professionals and patients.
B) English-speaking minority communities The expected results are: -creation of mechanisms for promoting the professional training of health professionals to ensure that they can deliver health services to the Anglophone communities in the province; -improvement in the range and quality of services available to Anglophone minority communities in the Province of Quebec; -increase in the number of professionals to meet the needs of Anglophone minority communities; -a greater role for the Anglophone education sector in training and support for professionals who are working or intend to work in remote regions; and -greater satisfaction on the part of professionals and clients.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA)
Total Grants
Total Contributions	18.0	23.0	23.0	23.0
Total Other Types of Transfer Payments
Total PA	18.0	23.0	23.0	23.0
Planned Audits and Evaluations: The Program's Risk-based Audit Framework adopts an auditing approach, which assesses risk in proportion to the level of funds upon which contribution agreements are based. The Program will be audited by the Audit and Accountability Bureau Health Canada. The Program works in partnership among organizations created by official language communities themselves and Health Canada considers the risk associated with undesirable results to be low. The Department adopted monitoring practices and ongoing performance measures. The 2006 mid-term formative evaluation (on-going) will evaluate issues related to Program implementation and administration, including those that would apply to a partnership. The 2008 evaluation will evaluate the issues relating to Program relevance, attainment of results and cost-effectiveness ratio.

 

Details on Transfer Payments Programs

Name of Transfer Payment Program: Grant to the Canadian Blood Services (TB #826394)
Start Date : April 2000			End Date : Ongoing
Description : To support basic, applied and clinical research on blood safety and effectiveness issues through the auspices of Canadian blood services.
Strategic Outcomes : Access to Safe and Effective Health Products and Food and Information for Healthy Choices.
Expected Results : Continued improvements to basic applied and clinical research on blood safety and effectiveness.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA)
Total Grants	5.0	5.0	5.0	5.0
Total Contributions
Total Other Types of Transfer Payments
Total PA	5.0	5.0	5.0	5.0
Planned Audits and Evaluations: N/A

 

Details on Transfer Payments Programs

Name of Transfer Payment Program: Contributions in support of the Federal Tobacco Control Strategy (FTCS)
Start Date: 2001-2002			End Date: 2006-2007
Description: The purpose of the Federal Tobacco Control Strategy (FTCS) Contribution Program is to contribute to the achievement of FTCS objectives through assistance to provinces or other bodies. In doing this, the Program supports the implementation of the four components of the Federal Tobacco Control Strategy, namely: Protection (to reduce access to tobacco and to regulate the product); Prevention (to reduce the uptake of tobacco and to create barriers to smoking); Cessation (to increase the number of quitters and reduce barriers to quitting); and Harm Reduction (to reduce harm to smokers and those exposed to tobacco). Contributions are provided to support the provinces and territories as well as key national and regional non-governmental organizations and others in order to build ongoing capacity for delivering effective tobacco prevention and cessation programs. Contributions are also used to advance tobacco control initiatives to reduce harm to smokers and those exposed to tobacco. In addition, as part of the FTCS Mass Media program, contributions are also used to fund regionally-based mass media initiatives in support of the four components. Contributions are required as Health Canada's efforts need to be coordinated and integrated with the efforts of its partners to achieve a sustained reduction in tobacco use. In addition, many of Health Canada's partners are in a better position, because of their particular expertise, to deliver certain FTCS activities or can deliver them in a more cost-effective manner.
Strategic outcomes: Reduces the health and safety risks associated with tobacco consumption by: regulating tobacco; developing and implementing initiatives to reduce or prevent the harm associated with tobacco use. The goal of the Federal Tobacco Control Strategy is to: Reduce smoking prevalence rate to 20% decrease number of cigarettes sold annually by 30% increase compliance with sales to youth laws to 80% reduce second-hand smoke in public places explore ways to reduce tobacco toxicity
Expected Results: The goal of the Federal Tobacco Control Strategy is to: Reduce smoking prevalence rate to 20% decrease number of cigarettes sold annually by 30% increase compliance with sales to youth laws to 80% reduce second-hand smoke in public places explore ways to reduce tobacco toxicity
	Forecast Spending 2005-2006 *	Planned Spending 2006-2007**	Planned Spending 2007-2008***	Planned Spending 2008-2009***
Program Activity (PA)	27.1	31.4	0	0
Total Grants
Total Contributions	19.2	15.8	15.8	15.8
Total Other Types of Transfer Payments
Total PA	46.3	47.5	15.8	15.8
Planned Audits and Evaluations: The Federal Tobacco Control Strategy (FTCS) is currently being evaluated at its five-year mark. The evaluation is a full summative evaluation. It will examine the overall success of the strategy, cost-effectiveness, continued relevance as well as a review of management practices. The evaluation will be completed in the summer of 2006.

* based on P9 programme forecast

**one year extension using Minister's authority - not yet approved

*** no authorities - Treasury Board Submission yet to be submitted

Details on Transfer Payments Programs

Name of Transfer Payment Program: Alcohol and Drug Treatment and Rehabilitation (ADTR) Contribution Program.
Start Date: April 1, 1997			End Date: A-Base
Description: A cost-sharing program to provide payments to provinces and territories to support access to alcohol and drug treatment and rehabilitation programs.
Strategic outcomes: To assist in ensuring access for Canadians to effective alcohol and drug treatment and rehabilitation programs and services. Increased access to services by women and youth. Changes to provision of services for women and youth. Discussions began in 2004-2005 with the provinces and territories regarding the implementation of a performance measurement strategy.
Expected Results: Increased access to and utilization of alcohol and drug treatment and rehabilitation services by women and youth.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA)
Total Grants
Total Contributions	14.0	14.0	14.0	14.0
Total Other Types of Transfer Payments
Total PA	14.0	14.0	14.0	14.0
Planned Audits and Evaluations: The Drug Strategy and Controlled Substances Programme (DSCSP) anticipates completing its review of literature and varying data sources in building and supporting emerging evidence on the continued relevancy of the target population, women and youth by end of June 2006.

 

Details on Transfer Payments Programs

Name of Transfer Payment Program: Drug Strategy Community Initiatives Fund (DSCIF)
Start Date: April 2004			End Date: A-Base
Description: A contributions funding program under Canada's Drug Strategy to support community-based initiatives at the national, regional, provincial/territorial and local levels in two broad areas: health promotion and prevention, and harm reduction. It is delivered through Health Canada's national and regional offices and Northern Secretariat.
Strategic outcomes: The overall aim of the DSCIF is to address problematic substance use and to promote public awareness of alcohol and other drug issues
Expected Results: increased public awareness of existing and emerging drug issues in Canada; increased availability of effective national and community-based promotion and prevention initiatives to address substance use and abuse; increased access to, and utilization of, harm reduction initiatives to respond to problematic substance use; improved capacity of community organizations to address current and emerging needs of Canadians; and greater awareness and availability of effective models of intervention.
	Forecast Spending 2005-2006	Planned Spending 2006-2007	Planned Spending 2007-2008	Planned Spending 2008-2009
Program Activity (PA)
Total Grants
Total Contributions	10.8	9.9	10.8	10.5
Total Other Types of Transfer Payments
Total PA	10.8	9.9	10.8	10.5
Planned Audits and Evaluations: Audit and evaluation activities regarding the Drug Strategy Community Initiatives Fund are reflected in the overall audit and evaluation plans of Canada's Drug Strategy (CDS). As such, DSCIF is a key component of the Interim Year Two Risk-Based Evaluation that is currently underway, and the Interim Year Five Outcome-Based Evaluation to take place in 2007-2008.

 

Conditional Grants (Foundations) for Health Canada

Name of Recipient: Canada Health Infoway Inc. (Infoway)
Start Date: March 9, 2001	End Date: not applicable	Total Funding: 1.2 Billion
Description: Canada Health Infoway is a federally-funded independent not-for-profit organization with a mandate to foster and accelerate the development and adoption of electronic health information systems with compatible standards and communications technologies on a pan-Canadian basis. It is widely accepted that health information and communications technologies such as electronic health records (EHRs), telehealth and public health surveillance systems will significantly improve access to health care services, patient safety, quality of care and productivity. A recent study estimated that potential savings from a Canada-wide electronic health record similar to Infoway's model would be $6.1 billion annually. Infoway collaborates with the federal, provincial and territorial governments towards a common goal of modernizing Canada's health information systems. This collaborative approach reduces overall costs by coordinating efforts, avoiding duplication, taking advantage of economies of scale, replicating successful initiatives across the country, and sharing best practices. For example, Infoway's EHR Blueprint Architecture is being adopted across Canada by jurisdictions and vendors, saving time, effort, and dollars, and helping to ensure all systems will be interoperable; as well, some jurisdictions have saved both time and money by acquiring vendor solutions together, rather than individually. While Infoway provides advice and some funding to them, the provinces and territories are responsible for the actual system development, implementation and overall funding, including on-going operational costs. Electronic Health Record - Infoway's goal, endorsed by all jurisdictions, is to put in place the basic elements - i.e. patient and health professional registries; drug, laboratory and diagnotic imaging systems - of an interoperable EHR for 50% of Canadians by the end of 2009. Over 140 projects are completed or underway across Canada and it is expected that an active pace will continue to be maintained in 2006/07. The following provides examples of such projects: the Registries program comprises 10 completed and 14 active projects in 10 of 13 jurisdictions; approximately 30% of physicians have now been uniquely identified, a prerequisite for EHR use; with respect to Diagnostic Imaging, there are 4 completed and 9 active projects in 7 jurisdictions; the British Columbia Fraser Health Authority plans to have all of its twelve hospitals connected to its shared diagnostic imaging system by the end of 2005/06; in Southwestern Ontario, The Thames Valley Hospital Planning and Partnership is making significant headway as seven of its eight hospitals are now able to share diagnostic images; late in the summer of 2005, the Alberta government and Infoway announced a $189 million initiative to allow hospitals and clinics throughout Alberta to electronically capture and share patient X-rays and CT and MRI scans. Telehealth - Infoway is investing in projects to expand and sustain telehealth initiatives, particularly in rural and remote communities, including Aboriginal and official language minority communities. It is also working on linkages between telehealth and the EHR and increasing the integration of telemedicine activities into mainstream healthcare service delivery. Telehealth strategic plans have been put in place with most jurisdictions and telehealth solutions will be implemented in all jurisdictions by December 31, 2009. Health Surveillance Systems - Infoway conducted a comprehensive needs assessment and developed an implementation strategy. Based on this, they will invest in the implementation of a pan-Canadian health surveillance system focussed on infectious diseases, in particular on case, outbreak, immunization, and alerts management, building upon surveillance systems already in place in Canada. A national steering committee, made up of experts in both information technologies and public health representing all FPT jurisdictions, has completed the solution planning work and three streams of work are underway: solution procurement and integration, to be completed end of February 2006; public health surveillance standards review and development; and jurisdiction implementation planning sessions.
Strategic Outcome(s): Strengthened knowledge base to address health and health care priorities.
Summary of Annual Plans of Recipient: In 2005/06, Infoway updated three-year joint technology and investment plans with the jurisdictions, providing a consolidated long-term 'road map' that aligns national and provincial e-health strategies. This national three-year plan will be updated annually by Infoway and the Deputy Ministers, and will serve to more tightly align the joint investments made by Infoway with the provinces and territories. As of March 31, 2006, it is expected that Infoway will have approved approximately $650 million in project investments, with additional downstream commitments of approximately $420 million.
Planned Audit(s) and Evaluation(s): In 2005/06, independent third parties completed a financial audit, a compliance audit, and an evaluation to measure performance against outcomes set out in the Infoway Funding Agreement. In addition, Infoway prepared a Progress Report on surveillance systems. In 2006/07, independent third party financial and compliance audits will be undertaken. Independent performance evaluations are scheduled every five years. Infoway initiatives must generate value - measurable benefits - for the patients, providers and health care system. Therefore, Infoway's EHR solutions will be evaluated in the field to determine benefits, as well as utilization and satisfaction levels. The benefits evaluation framework is being enhanced and primary research will be stimulated in this area.
URL to Recipient site: Canada Health Infoway

 

Conditional Grants (Foundations) for Health Canada

Name of Foundation: Canadian Institute for Health Information (CIHI)
Start Date: Roadmap I March 31, 1999 Roadmap II April 1, 2002 Roadmap II+ March 31, 2002 Roadmap III April 1, 2005	End Date: Roadmap I March 31, 2003 Roadmap II March 31, 2007 Roadmap II+ March 31, 2007 Roadmap III, March 31, 2010	Total Funding: Roadmap I $95M Roadmap II $95M Roadmap II+ $70M Roadmap III $110M
Description: The Roadmap Initiative provides the financial support for the Canadian Institute for Health Information to: to serve as the national mechanism to coordinate the development and maintenance of a comprehensive and integrated health information system for Canada; and, to provide and coordinate the provision of accurate and timely information required for the establishment of sound health policy, the effective management of the Canadian health system and generating public awareness about factors affecting good health.
Strategic outcomes: CIHI plays a major role in supporting the reporting commitments of various First Ministers Meetings and the First Ministers Accords on Health Care Reform. The key areas identified for action under the original Health Information Roadmap were: Consulting with stakeholders to confirm priority health information needs; Developing health information standards to ensure the consistent collection, sharing and interpretation of health information; Filling in gaps in information on health services and related costs and outcomes; Filling in gaps in information on population health and factors that affect our health Creating a Canadian Population Health Initiative (CPHI) to provide new information and insights on health and the health system; and, Producing and disseminating regular, easy-to-understand public reports and conducting special studies on the health of Canadians and the health system.
Summary of Annual Plans: The 2005-06 Operational Plan and Budget was presented for approval to the Board of Directors at the June 2005 meeting, and then submitted to the Minister of Health. Some of the key projects include: Releasing the document Health Care in Canada 2005 and developing the 2006 edition Expanding the range of collaborative and analytical activities including the release of special reports on the Cost of Maternity Care (the 3rd part of the series Giving Birth in Canada), funding of health services in Canada, and the burden of neurological disorders in Canada Implement year 2 of the CPHI Action Plan 2004-2007 including the release of 2 sections of the 3rd part report series on Improving the health of Canadians 2005-2006. Further develop and implement the long-range analytical strategy/plan, including early-start projects approved by the Board in June 2004. Continue to develop, compile, and disseminate new and existing health indicators to address priority information needs, with a special focus on quality of care Complete development of CIHI's acute care inpatient grouping methodology (and related resource indicators), using ICD-10-CA and CCl activity and patient-specific cost data, and release new ICD-10-CA/CCl-based grouping methodologies for day-surgery (i.e., DPG) and ambulatory care (i.e., CACS) patients. Also, produce first-ever French versions of Day Procedure Groups (DPG) (New), Comprehensive Ambulatory Classification System (CACS) (New), and Continuing Care (RUGS-III) (New) Directories and supporting documentation. Continue to produce and disseminate policy-relevant analytical reports in the areas of health expenditures (National Health Expenditures Trends 2005, Preliminary Provincial/Territorial Government Health Expenditures), health human resources (e.g. workforce trends of physicians, registered nurses, registered psychiatric nurses, licensed practical nurses, provincial/territorial profile of the Evolving Role of Canada's Family Physicians (New), Geographic Distribution of Physicians in Canada (New), and health services (e.g. annual reports on mental health, continuing care, rehabilitation services, trauma, joint and organ replacements). Increase the scope, relevance and usefulness of our existing Health Human Resources products, including implementation (in collaboration with Statistics Canada and Health Canada) of a national survey on the nursing workforce, continued development of new data collection/reporting reporting systems for three more health professional groups (i.e., physiotherapists, occupational therapists, pharmacists) (New). Continue phased-in implementation of the new National Prescription Drug Utilization Information System (NPDUIS), based on claims-level data for publicly funded drug programs, and initiate expansion to include data from privately funded drug programs. Continue development of a Canadian Medication Incident Reporting and Prevention System (CMIRPS) designed to further enhance the safety of medication use in Canada. Continue to promote the adoption, and support implementation, of the National Rehabilitation Reporting System (NRS), the Continuing Care Reporting System (CCRS), the Home Care Reporting System (HCRS), and the Ontario Mental Health Reporting System (OMHRS). Continue to implement strategies and plans to further strengthen CIHI's presence at the provincial/territorial, regional and local levels, and identify opportunities to align existing CIHI products and services to address emerging regional needs (New).
Planned audit(s) and evaluation (s): CIHI will be conducted a complete third-party evaluation within one year of the completion of the project (i.e., 2008).
URL to Foundation site: The Canadian Institute for Health Information (CIHI)

 

Conditional Grants (Foundations) for Health Canada

Name of Recipient: Canadian Health Services Research Foundation
Start Date: 1996-97	End Date:	Total Funding: approx $151.5 M
Description: Total federal funding for the CHSRF is as follows (CHSRF's programs also receive funding from other sources): 1996-2001 - $66.5 M to set up the foundation and another $35 M to support its participation with the Canadian Institutes of Health Research 1999 - $25 M grant to support a ten-year program to develop capacity for research on nursing recruitment, retention, management, leadership and the issues emerging from health-system restructuring (Nursing Research Fund or NRF) 2003 - $25 M grant to enhance the skills of health system managers in the use of research to increase evidencebased decision making (Executive Training for Research Application or EXTRA) over a thirteen year period.
Strategic Outcome(s): The NRF will support research personnel, research dissemination, and research projects on nursing management, organization, and policy at a level of $2.5 million per year for 10 years. The aim is to create high quality new knowledge; increase knowledge exchange between researchers and decision makers; and increase the capacity for evidencebased decisions. EXTRA aims to equip health service professionals and their organizations with the skills to find, assess, interpret and use research to better manage the Canadian health care system. CHSRF will continue to enrol 24 senior fellows annually in the two-year EXTRA training program designed to achieve: knowledge of research evidence; capacity to draw on system thinking; development of collaborative professional relationships; and the ability to introduce and manage evidence-based change. CHSRF's work contributes to Health Canada's aim of strengthening the knowledge base to address health and health care priorities. CHSRF's programs further the development of health human resources, provide health managers with tools to improve primary and continuing care, and support research on nursing issues from a health system perspective.
Summary of Annual Plans of Recipient: CHSRF will continue its efforts on its four strategic objectives: To create high quality new research that is useful for health service managers and policy makers (especially in the foundation's priority theme areas). To increase the number and nature of applied health services and nursing researchers. To get needed research into the hands of health system managers and policymakers in the right format, at the right time, through the right channels. To help health system managers, policymakers and their organizations to routinely acquire, appraise, adapt and apply relevant research in their work. CHSRF will move to consolidate and add value to its research funding activity; this will include positioning more activities in relation to its four "flagship" programs: Research production and dissemination: i. Research Exchange and Impact for System Support (REISS) ii. Capacity for Applied and Developmental Research and Evaluation (CADRE) in Health Services and Nursing Research use and implementation: iii. Knowledge Brokering iv. Executive Training for Research Application (EXTRA) Emphasis will be placed on creative knowledge transfer and providing increased support to decision makers, as well as on organizational excellence. CHSRF's partnership work is expected to change due to the increasing number of national healthrelated knowledge agencies and the drive to identify opportunities and common objectives; and the provision of more direct assistance to grant and award applicants to help acquire matching co-sponsorship funding.
Planned Audit and Evaluation: Financial statements are audited annually. CHSRF commissioned an International Review Panel Report in 2002 and is currently preparing the background work and the process for the 2nd international review in 2007. As part of the preparations for this international review in 2007, CHSRF created a comprehensive logic model in 2004/05 for its overall impact on evidence-based decision-making in the health sector. This model will guide the overall evaluation and has already been used, in adapted form, by other organizations in Canada to guide their activities and evaluations in the area of evidence-based decision-making in health systems. A compliance audit of funded research projects was conducted in 1999 and another compliance audit will be conducted in 2006. The foundation also commissioned an internal controls review in April 2005 with the implementation of the recommendations occurring in 2005 and 2006. Finally, the foundation drafted an enterprise risk management framework in 2005 with the final version being completed in 2006.
URL to Recipient site: The Canadian Health Services Research Foundation

 

Horizontal Initiatives

Horizontal Initiative: Canada's Drug Strategy			Lead Department(s): Health Canada
Start Date: CDS started in 1987; CDS Renewed 2003 - 2004*		End Date: Ongoing	Total Funding Allocated: $752.2M*
Description: Canada's Drug Strategy (CDS) was first introduced in 1987 to address substance use and abuse issues in Canada through coordinated activities by various federal departments, governments and non - governmental organizations. In 1992, following some initial successes in the areas of prevention and treatment, Phase II was launched with an emphasis on Driving While Impaired. During Phase II of the CDS, changing government priorities resulted in less than half of the funding being applied to the Strategy making it difficult to fully address complex issues related to both supply and demand reduction. Under Canada's Drug Strategy Renewed (approved by Cabinet in May 2003), the CDS will continue to be a comprehensive inter - Departmental federal initiative designed to coordinate and enhance substance abuse programs, knowledge and partnerships in the areas of prevention, treatment, harm reduction and enforcement. For more information, please refer to Canada's Drug Strategy.
Shared Outcome(s): Improved Leadership - Setting directions and creating environments that support local action through community - based initiatives integrally linked to national objectives and targets Enhanced knowledge generation and management - Providing strengthened capacity to improve evidence - based policy and decision making by promoting leading - edge research, statistical monitoring of drug trends and evaluation of program effectiveness Enhanced partnerships and interventions - Discouraging substance abuse, targeting illegal conduct that threatens the safety and security of Canadians, and assisting those at risk from the effects of drugs by supporting partnerships and programs that focus on prevention, harm reduction, treatment and enforcement activities Improved modernization of relevant legislation and drug policies - Ensuring that legal and policy approaches underpinning CDS are coherent with and support the Strategy, by reviewing legislation and regulations for responsiveness to current requirements
Governance Structure(s): Health Canada (HC) Health Canada is the federal lead for Canada's Drug Strategy. The Minister of Health is responsible for coordination across federal departments. Health Canada also partners with provinces and territories to provide national leadership and coordination and manages programs that reduce and prevent harm associated with controlled substances and participates in various international fora in support of health-related supply and demand reduction activities. An Assistant Deputy Minister Interdepartmental Steering Committee exists and is chaired by Health Canada. Working groups focussing on Communications, Research and Surveillance, Evaluation and Risk Management, and Emerging Issues have been established to support decision-making by the ADM Steering Committee and Health Canada provides secretariat to support these structures. In addition, small coordination units will be implemented in core federal departments and Health Canada's regional offices. Public Health Agency of Canada (PHAC) The Public Health Agency of Canada, through its Centre for Infectious Disease Prevention and Control (CIDPC) and its Fetal Alcohol Syndrome Team, is responsible for conducting and dissemination of research and surveillance information on public health indicators and illness related to substance use/abuse and injection drug use, as well as on the linkages between substance abuse and fetal alcohol spectrum disorder. Department of Public Safety and Emergency Preparedness Canada (PSEPC) The Department of Public Safety and Emergency Preparedness Canada is responsible for: a) coordinating the Public Safety and Emergency Preparedness Portfolio's drug control policies and initiatives to ensure that they are consistent with and complimentary to the broader goals and objectives of CDS; and b) providing strategic advice to the Minister in fulfillment of the Minister's policy leadership role in policing and corrections. The Department also participates in various international fora in support of law enforcement-related supply and demand reduction activities. Royal Canadian Mounted Police (RCMP) The RCMP offers a balanced approach addressing both supply and demand issues. They investigate illegal drug activities and organized crime groups. They disrupt criminal activities and networks related to the supply of illicit drugs. They also deliver a number of drug awareness and prevention programs targeted at youth, Aboriginal communities, drug endangered children, parents and the Canadian workplace. Additionally, they coordinate specialized training of police officers in Drug Recognition Expertise to detect drug impaired driving. Correctional Services Canada (CSC) CSC provides substance abuse treatment programs to federal offenders with substance abuse problems and controls the supply of illicit drugs in correctional facilities through various security measures. Canada Border Services Agency (CBSA) The CBSA contributes to reducing the supply of illicit drugs through the interception of controlled substances and illegal drugs at Canadian ports/borders of entry. Department of Justice(DOJ) The Federal Prosecution Service of the Department of Justice prosecutes drug cases. The prosecution of drug cases comprises a significant part of the Prosecution's workload. The Programs Branch of the Department of Justice in collaboration with the Office of Demand Reduction of Health Canada, administers funding and monitors the implementation and evaluation of drug treatment courts in Canada. Drug treatment courts are implemented as alternatives to traditional prosecution through special courts that integrate both criminal justice and drug treatment responses. Department of Foreign Affairs Canada (FAC) The Department of Foreign Affairs Canada (FAC) represents Canada, in cooperation and coordination with other interested federal partners, on the international aspects of Canada's Drug Strategy. The Department manages contributions to the United Nations Office on Drugs and Crime (UNODC) and the Organization of American States' Inter-American Drug Abuse Control Commission (CICAD).
* CDS was initiated in 1987 and has undergone a number of reiterations in the past 17 years. CDS Renewed was approved in May of 2003. The financials presented reflect a start date of May 2003 and an end date of the 2004-2005 fiscal year. The funding allocation during this two year period is inclusive of both the enhanced funding received under CDS Renewed and a-base funding pertaining to activities undertaken in the area of demand and supply reduction.
Federal Partners Involved in each program	Names of Programs	Total Allocation	Planned Spending for 2006-2007	Expected Results for 2006-2007
1. Health Canada RCMP	Promotion / Prevention & Public and Professional Education / Training Programs / Activities	$4.87M $8.27M         $2.8M $15.94M	$5.85M $5.26M           $11.11M	Increased awareness of the nature, extent and consequences of substance use/abuse within the school, workplace and Aboriginal communities and among youth, professionals and the general public Improved skills/competencies in the delivery of programs
2. Health Canada Correctional Services Canada (CSC) Department of Justice	Treatment and Rehabilitation Programs / Activities	$173.68M $31.60M     $2.60M $207.88M	$87.58M $19.10M     $3.80M $110.48M	Enhanced access and motivation to participate in treatment for substance abuse Reduction in risk behaviours/decisions and overall assessed substance abuse treatment needs
3. Health Canada PHAC CSC	Research and Surveillance Programs / Activities	$20.38M $2.90M $1.50M       $4.10M $28.88M	$11.04M $ 1.0M $ 2.0M         $11.11M	Increased knowledge and understanding of emerging trends and related consequences in the area of substance abuse and what works in preventing and treating substance use/abuse More evidence-based responses to substance use/abuse
4. Health Canada Foreign Affairs Canada PSEPC	Grants & Contributions Program	$4.20M $5.00M $.31M     $9.51M	$15.75M $2.90M $.10M     $18.75M	Increased capacity/ability to identify, understand and address issues pertaining to the demand for and supply of illicit drugs and harmful substances
5. Health Canada PSEPC	Coordination and Collaboration Programs / Activities	$6.42M $1.25M $9.51M	$2.96M $.63M $3.59M	Increased collaboration/ involvement of stakeholders Improved coordination/direction of efforts among CDS partners/stakeholders Enhanced credibility/influence of CDS in setting directions/policies in the area of supply and demand reduction
6. Health Canada	Policy and Legislative Review and Development Programs / Activities	$2.6M	$1.55M	Improved policy and regulatory responses to the demand for and the supply of illicit drugs and harmful substances
7. Health Canada RCMP	Enforcement Programs / Activities	$27.22M $150.17M $163.80M $12.10M $126.44M $479.73M	$14.26M $79.07M $81.90M $ 5.90M $64.50M $235.63M	Improved understanding and knowledge of drugs, related trends, and production and diversion methods Enhanced ability to detect and respond to the supply of illicit drugs and harmful substances
Total		$752.21M	$396.15M
Contact: Colleen Ryan, Manager, CDS Evaluation, Risk Management and Reporting, (613) 957-2867, colleen_ryan@hc-sc.gc.ca
Approved by: Beth Pieterson			Date Approved: Beth Pieterson
Horizontal Initiative: Federal Tobacco Control Strategy			Lead Department(s): Health Canada
Start Date: 2001/02	End Date: 2005/06 & ongoing	Total Funding Allocated: $560M (See note about Health Canada total funding in section 11)
Description: The Federal Tobacco Control Strategy (FCTS) establishes a framework for a comprehensive, fully integrated, and multi-faceted approach to tobacco control. The FTCS is the federal contribution to the national tobacco control plan endorsed in 1999 by all Ministers of Health. It focuses on four mutually reinforcing components: protection, prevention, cessation and harm reduction, supplemented by effective use of public education campaigns to reach all Canadians.
Shared Outcome(s): The FTCS has five 10-year objectives (2001-2011): Reduce smoking prevalence to 20% from 25% (level in 1999). Reduce the number of cigarettes sold by 30%. Increase retailer compliance regarding youth access to tobacco from 69% to 80%. Reduce the number of people exposed to environmental tobacco smoke in enclosed public places. Explore how to mandate changes to tobacco products to reduce health hazards.
Governance Structure(s): Resources for the implementation of the FTCS were allocated to a number of departments and agencies. Health Canada (HC) is the lead department in the FTCS and is responsible for regulating the manufacture, sale, labelling and promotion of tobacco products as well as developing, implementing and promoting initiatives that reduce or prevent the negative health impacts associated with smoking. The partner departments and agencies are: The Department of Public Safety and Emergency Preparedness Canada (PSEPC) (formerly the Department of the Solicitor General) - administers contribution funding for monitoring activities in connection with determining levels of contraband tobacco activity. The Department also provides policy advice and support on smuggling issues. The Department of Justice - prosecutes smuggling offences, as well as offences concerning unlawful manufacture, distribution and possession of contraband tobacco products. The Royal Canadian Mounted Police (RCMP) - is responsible for the enforcement of laws in relation to the international movement of tobacco products (including the illicit manufacture, distribution or possession of contraband tobacco products). The Canada Revenue Agency (CRA) (formerly the Canada Customs and Revenue Agency (CCRA)) - is responsible for ensuring the assessment and collection of tobacco taxes and monitoring tobacco exports. The Canada Border Services Agency (CBSA) (previously part of the former Canada Customs and Revenue Agency) - is responsible for monitoring the impact of tax changes on the illegal international movement of tobacco and the national contraband market.
Federal Partners Involved in each program	Names of Programs	Total Allocation	Planned Spending for 2006-2007	Expected Results for 2006-2007
1. HC	FTCS	$482.5M (Note: this original allocation has been affected by several cuts since the FTCS began. The reductions went towards funding other departmental and government priorities, i.e. $47M to CEPA, $32.5M held back as part of the Government Advertising Plan, and $3M, starting in 05/06, reallocated as part the Expenditure Review exercise.)	$58.7M (TCP: $49M) (FNIHB: $9.7M)	Work with the University of Waterloo and the provincial governments of Prince Edward Island and British Columbia to evaluate a coordinated approach to cessation. Monitor the impact of tobacco control initiatives through the Canadian Tobacco Use Monitoring Survey. Pursue regulations that would mandate changes to cigarettes that would decrease the number of cigarette-lit fires and their associated harm and deaths. Ratification of the Framework Convention on Tobacco Control Work with 8 regional offices and partner with several National Aboriginal Organizations across Canada for program delivery and development Survey on current daily smokers (15+ years) in First Nations and Inuit communities.
2. PSEPC	FTCS	$3.2M	$45,000	Enhanced Partnership Arrangement with Akwesasne Mohawk Police
3. Justice	FTCS	$10.0M	$1,326,445	The number of contraband and cigarette related fines has been reduced from 1920 files in 2002 to 920 files as of March 2005 - a reduction of over 76%. The number of fines that were satisfied as of March 2005 was 571 as compared to March 2004 of 303, an increase of over 88%. Analyses of statistics have demonstrated that the most cost efficient methods of recovery are demand letters and phone calls which include negotiations. At year end 2005, demand letters generated over 920 payments totaling $641,9001 and negotiations resulted in 584 payments totaling $318,141*. Incarceration for non payment of fines has decreased from 47 in 2004 to 34 in 2005, a reduction of over 37%. Directives were given to Fine Recovery units to oppose all motions for payment extensions heard at court resulting in a decrease in counsel fees to client departments for said hearings.
4. RCMP	FTCS	$10.5M	$1,500,000	Regular reports on tobacco situation were provided to Finance and Health Canada. Tobacco analysts attended regular meetings to brief Finance. Improving border security through border alarm which are being monitored regularly.
5. CRA	FTCS	$53.8M (total allotment to the former CCRA)
6. CBSA	FTCS	(see row above)	$5.1M	Attended monthly meetings with Dept of Finance and partners to discuss and serve as a reference for questions on tobacco issues. Provided monthly analysis of the national contraband situation by compiling reports received from the Regions. Partnered with RCMP to annual risk assessment of the nature and extent of the tobacco contraband activity. Coordinated the development of tobacco intelligence in the regions. Actively participated in 50 Joint Force Operations with law enforcement partners across the Regions. Co-hosted the Joint US/Canada Tobacco Diversion Workshop 2004 with American and Canadian Agencies. Provided input into the World Customs Organization report on the global analysis - Customs and Tobacco 2004.
* Note that Québecs statistics are not included in these figures which would be substantially higher. This province was not yet integrated into the Department of Justice's Icase system when the March 2005 statistics were consolidated. As of June/05, Québec has been integrated in Icase.

 

Horizontal Initiative

Horizontal Initiative: Building Public Confidence in Lead Department(s): Pest Management Regulatory Pesticide Regulation and Improving Access to Agency (PMRA)--Health Canada (HC) Pest ManagementProducts			Lead Department(s): Pest Management Regulatory Agency (PMRA)--Health Canada (HC)
Start Date: 2002-2003		End Date: 2008-2009	Total Funding Allocated:
Description: The initiative is a part of the federal government's commitments as outlined in the Treasury Board submission Building Public Confidence in Pesticide Regulation and Improving Access to Pest Management Products. The Treasury Board submission and its associated Results-based Management and Accountability Framework (RMAF) describe the integrated approach by which initiatives will be measured, managed and reported throughout their life cycle. An important element of the commitments made through the Treasury Board submission is that stakeholders and public will be kept informed through a transparent management system. The participating departments will work together for shared outcomes; measure performance on delivery; and review progress achieved. This initiative incorporates efforts of six federal government partners to increase public and stakeholder confidence in the pesticide regulatory system, to protect health and environment, and to increase the competitiveness of the agri-food and forestry sectors. Research and monitoring in the area of pesticides is being coordinated with their regulation. Under this initiative, the presence and effects of pesticides in the environment, in marine and freshwater ecosystems, and in the forest environment are being monitored. The initiative enhances monitoring and enforcement of pesticide residue limits in foods, in feed, of pesticide residues in fertilizers, and pesticide guarantee verification for fertilizer-pesticide combinations. Reduced-risk pesticides and biological pesticides for forestry are being developed and their use facilitated. Commoditybased risk reduction strategies for the agriculture and agri-food sector are being developed and implemented. Programs improving access to agricultural minor-use pesticides and reduced-risk pesticides for agricultural use are being established. Research to support the introduction of minor-use pesticides that pose a reduced risk to the environment is being conducted. A reporting system to track adverse effects of pesticides has been developed, and information on these effects will be collected and recorded. Collectively, this work is being conducted to achieve public confidence in increased conservation and protection of human health and the environment while contributing to the competitiveness of Canada's agricultural sector. The information presented in this table has been organized along the following three main themes of this initiative: Research and Monitoring, carried out by Agriculture and Agri-food Canada (AAFC), the Canadian Food Inspection Agency (CFIA), the Department of Fisheries and Ocean (DFO), Environment Canada (EC), Health Canada's PMRA, and Natural Resources Canada (NRCan) Developing and Implementing of Commodity Specific Risk Reduction Strategies, carried out by AAFC and HC's PMRA Generation of Data to Support the Registration of Reduced Risk and Minor Use Pesticides for the Agricultural and Agri-food Sector and Reduced Risk Pesticides and Biopesticides for Forestry, carried out by AAFC, HC's PMRA and NRCan
Shared Outcomes: Immediate Outcomes: Increased knowledge by the PMRA about pesticides and alternatives Registration of reduced-risk and minor-use pesticides Access to safer pest management practices and products Compliance for safer food, feed, fertilizers and fertilizer-pesticide combinations Intermediate Outcomes: A regulatory system that better protects health and environment and contributes to the competitiveness of the agrifood and forestry sectors Use of safer pest management practices and products Increased transparency of pesticide regulation Final Outcome: Increased public and stakeholder confidence in pesticide regulation, protected health and environment as well as increased competitiveness of the agri-food and forestry sectors
Governance Structures: PMRA (HC)--Executive Director EC--Director General, Conservation Strategies Directorate and Director General, National Programs Directorate DFO--Director General, Fisheries, Environment and Biodiversity Science NRCan--Director General, Science Branch, Canadian Forest Service AAFC--Assistant Deputy Minister of the Farm Financial Programs Branch and Assistant Deputy Minister of Research Branch, Executive Director, Pest Management Centre CFIA--Vice President, Programs Deputy Minister Committee--Deputy Minister from Health and AAFC AAFC/PMRA Joint Management Committee: Assistant Deputy Minister of the Farm Financial Programs Branch, AAFC, Assistant Deputy Minister of Research Branch, AAFC, Executive Director, PMRA, Health Canada, Treasury Board Secretariat (ex-officio member)
Federal Partners Involved in each program	Names of Programs	Total Allocation	Planned Spending for 2006-2007	Expected Results for 2006-2007
AAFC, CFIA, DFO, EC, HC (PMRA), NRCan 1. AAFC	I. Research and Monitoring (a) Conducting research to support the introduction of minor-use pesticides that pose a reduced risk to the environment.	$8.0M	$2.0M	Following evaluation of research projects, continued funding for some as appropriate. Final reports and next steps for implementation of research results underway for projects completed in March, 2006. Initiation (in April, 2006)of approximately 20 new projects in Minor Use Research and Biopesticide Initiatives as a result of the November, 2005 Project Call. Results of 1 year of research work on these projects to be reported upon (April, 2007) Research planning, coordination continues with MOU Research Working Group
2. CFIA	(b) Enhanced monitoring and enforcement of pesticide residue limits in food and feed.		$0.25M	Identify food commodities consumed by targeted subgroup (children). Lab testing of an approximate 1500 samples per year. Follow-up inspections for non-compliant test sample results. Publish annual report of the findings of the National Chemical Residues Monitoring Program (NCRMP). Food recalls, as required, for risk mitigation and removal of hazardous foods from marketplace.
2. CFIA	(c) Enhanced monitoring and enforcement of pesticide residues in fertilizers and pesticide guarantee verification in fertilizer-pesticide combinations.	$2.15M	$0.25M	Develop monitoring and surveillance policies and processes to guide and advise operational staff on fertilizer-pesticide combinations and pesticide contaminated fertilizers. Increase interaction with the PMRA to obtain the most up-to-date pesticide safety and labelling information. Update the Compendium of Fertilizer-Use Pesticides, which contains information regarding registration, guarantees and proper labelling. Work to develop regulatory changes to facilitate updating of the Compendium more regularly, and, if successful, provide Compendium updates more regularly to the producers of mixtures and to the CFIA's inspection staff. Advise CFIA Operations on appropriate follow-up procedures and recommendations regarding the significance of sample analytical results. Sample fertilizer-pesticide combinations to verify guarantees. Sample fertilizers suspected to be contaminated with pesticides. Verify fertilizer-pesticide labels. Conduct investigation and compliance activities (anticipated based on sampling and inspection frequencies). Analyze samples submitted by inspectors.
3. DFO	(d) Monitor and research the presence and effects of pesticides in marine and freshwater ecosystems.	$7.9M	$1.0M	DFO will provide the PMRA with final reports on four regional National Fund projects: Impacts of forest spray programs on trout/salmon, Newfoundland-Labrador Effects of pesticides on fish reproduction, Quebec Impacts of pesticides on salmon habitat and on neurological development, Pacific Potential for biological effects from episodic release of pesticides into the aquatic environment, Gulf and Maritimes. DFO will provide the PMRA with a status report from DFO's Centre for Environmental Research on Pesticides (CERP). CERP will conduct studies to quantify impacts of exposure to pesticide residues in 2 model systems in Canada; one representative of prairie land use and another indicative of southern Ontario land use pattern. Impacts will be quantified in terms of reproductive success of the native fish populations as well as overall population numbers. After consultation with the PMRA, DFO will design and initiate new research projects related to the theme "Population Level Impacts of Pesticides on Fisheries Resources". Contribute to the Formative Evaluation of the Building Public Confidence in Pesticide Regulation and Improving Access to Pest Management Products Horizontal Initiative.
4. EC	(e) Monitor and research on presence and effects of pesticides in the environment.	$7.0M	$1.0M	EC will: start a new cycle of research and monitoring projects at Environment Canada support up to 6 new research and monitoring project themes to determine the environmental concentrations and impacts of in-use pesticides in the environment; produce a summary document on highlights of research and monitoring investigations covering the first cycle of work (2003-2006) at Environment Canada produce an annual report and make it available to the PMRA; provide science advice to meet regulatory data gaps and knowledge deficiency as well as to improve risk assessment methods EC Leads in specific research and monitoring themes have provided EC's Pesticide Program Coordinating Committee with a document highlighting each of their theme's results for the first three year cycle of work Themes include air and water surveillance; fish, amphibian and multitrophic aquatic effects; and, plant, mammal and bird terrestrial effects. Following three years of research we will obtain answers to questions regarding knowledge generation with highlights of findings, contribution to the initial Pesticide Science Fund (PSF) objectives (e.g., national in scope and linked to regulatory decision-making priority, advanced knowledge of pesticide fate and effects, etc.), contribution to future departmental priorities, links within EC and to other interdepartmental research/monitoring activities, leverage of complementary work and building of partnerships, scientific (or other) publications procuded and finally the theme's top five priorities for PSF (incl. research, monitoring, methods development, risk assessment and modelling). These documents were used by the Committee to prioritize research and monitoring activities for a second cycle of work beginning fiscal year 2006-07. Environmental priorities will be set according to the fundamentals of detecting change, understanding why it is changing, better understanding of what we can do about it, and using this information to inform decision makers and Canadians. Collected knowledge will be used in the context of EC's Competitiveness and Environmental Sustainability Framework (CESF) and applied to pesticides. This will support decisions related to national competitiveness, to the protection of the health and safety of Canadians as well as to the conservation of ecosystem functions. In order to better integrate and coordinate EC research with regulation, EC will continue to work with the PMRA in the implementation of the EC/PMRA MOU. The MOU has four components, Science Policy, Knowledge Generation, Issue Management and Compliance Promotion and Enforcement include many initiatives and activities not listed herein. EC will continue working on providing leadership in the development and implementation of a federal, co-ordinated pesticides science strategy for research and monitoring. As well EC will continue to contribute to PMRA's pesticide assessments where appropriate and will continue to provide science/policy advice on key Government of Canada policies as they relate to pesticide management and use in Canada.
5. HC (PMRA)	(f) Linking pesticide regulation and research.	$4.2M	$0.8M	Identify PMRA's research and monitoring priorities annually and communicate to 5NR partners through regular meetings and other avenues as needed. Facilitate discussion among the 5NR on identifying actions to address specific priorities, including collaborative research. Discuss with the 5NR how the results of their research and monitoring are used in regulatory decisions to build better linkages between research and regulation. Facilitate the two-way communication and coordination between regulation and research between governments within Canada (through PMRA's FPT Committee) and internationally as well as with the private and academic sectors, through presentations linking research and regulation at regional, national and international meetings.(e.g., through SETAC, CSA, IUPAC). To strengthen the framework in linking pesticide research and monitoring, develop a MOU amongst the 5NR on linking research to regulation. Improve risk assessment procedures particularly in the area of environmental fate prediction (e.g., water modelling and exposure assessment). Continue to improve and expand the use of probabilistic risk assessments.
5. HC (PMRA)	(g) Conducting research to support the introduction of minor-use pesticides that pose a reduced risk to the environment.	$3.5M	$0.9M	Advance the risk assessment methodologies through: Further refinement and application of environmental protection goals; Publication of draft guidance on environmental risk assessment methods; Research to support the harmonization of risk assessment methodology with international partners (e.g., occupational exposure assessment, groundwater modelling, pesticide degradation kinetics). Facilitate access to reduced risk products, specifically low risk products, through developing, and publishing for external comment, guidance on registration of low risk products. Continue to develop a database on environmental toxicology and fate to guide decisions, internally and externally, on comparative risk and reduced risk products. Finalize and publish a Best Management Practices guide to reduce spray drift by applicators. Publish for public comment a document identifying various options to better communicate buffer zones on labels to applicators.
6. NRCan	(h) Research and monitor pesticides in the forest environment.	$3.5M	$0.4M	Third and final year of research work for four projects will be completed and results reported in final reports and publications. Provide results to clients/stakeholders and PMRA. The research projects are: Environmental fate and ecological effects of a systemic insecticide for control of exotic wood boring insect pests, completion of second year field research program (GLP study comparing fate of imidacloprid following soil and stem injections); Development of a biological treatment for control of root rot pathogen and impact on microbial biodiversity; Advanced methods for monitoring impacts of pest control products on key microbial communities of forest soils, publish guidelines that demonstrate the use of cutting edge molecular methods to study environmental fate of microbes; Monitoring status of spruce budworm population to improve forest protection programs, integration of information on mortality agents in infestation forecasting and spray decision making for spruce budworm. Refine research priorities and plan for request for new proposals, January 2007.
AAFC HC (PMRA) 1. AAFC	II. Developing and implementing commodity specific risk reduction strategies (a) Commodity based risk reduction strategies.	$19.3	$2.5	Process to engage stakeholders in crop prioritization based on risk and needs assessments developed. Next wave of about 10 crop profiles to be finalized and published. Develop up to 5 risk reduction strategies and support implementation of priority projects as established with Technical Working Group/stakeholders. Fund research and implementation projects from November 2005 call for proposals. Follow-up from workshop on barriers to grower adoption of IPM practices Analysis of data from pilot pesticide use survey. Continued implementation of AAFC/PMRA joint communication plan.
2. HC (PMRA)	(a) Commodity based risk reduction strategies (RR).	$25.7M	$4.0M (2.0 for commodity strategies / 2.0 for RR product review)	Planned staffing actions in 2006-2007, indeterminate positions. Ongoing consultations with stakeholders, Work share with other government departments and 5NRs. Work on pesticide risk indicator: consult, build and validate database. Refine, together with AAFC, prioritization criteria for determining priority crops for the program. Workshare with AAFC on crop profiles. Risk reduction strategies have been developed for pulse crops and canola. A long term fireblight management strategy has been developed for apples. Steering committee and working groups have been meeting to develop solutions to the identified priorities and implement steps to resolve these issues. Substantial progress has been made in developing strategies and forming steering committees to lead the strategies for a number of other crops, particularly, greenhouse vegetables, grape, peach, potato, strawberry and apple. Pursue risk reduction program for honey, Richardson ground squirrel and develop a work plan for forestry uses and needs. Consolidate and integrate all information collected with this program into the registration stream of the PMRA. Continue review of reduced-risk pesticides submitted for registration.
AAFC HC (PMRA) NRCan 1. AAFC	III. Generation of data to support the registration of reduced-risk and minor-use pesticides for the agricultural and agri-food sector and reduced-risk pesticides and biopesticides for forestry (a) Improving access to agricultural minor-use pesticides, and reduced-risk pesticides for agricultural use.	$33.7M $12.0M Abase	$6.5M $2.0M Abase	Thirty-six pest-crop combinations will be identified at annual national stakeholder meeting hosted by AAFC. Manufacturer (registrant) written support will be obtained by July 2006 for each pest-crop pair, then sent to the PMRA for review by October with the majority by August (PSCR 3.1). Subsequently, data requirements (DACO) for each pest-crop pair will be issued by the PMRA to AAFC according to PMRA-established timeline (97 days from receipt) AAFC will convert DACOs to study plans by January 2007 and assign trials that complete the study plans, to contractors and collaborating AAFC personnel across Canada. Good laboratory practice trials require quality assurance oversight that is provided by contractors and AAFC Headquarters staff. Data generation from field trials in 2006 and laboratory analysis of residues proceeds to final report stage in the spring-summer of 2007 and are submitted to the PMRA. The PMRA provides a decision on use 247 days later. Total process takes about 36 months.
2. HC (PMRA)	(a) Improving access to agricultural minor-use pesticides, and reduced-risk pesticides for agricultural use.	$20.8M	$4.0M	Product evaluation work--review presubmission proposals from AAFC and provincial coordinators and issue data requirements. Register new minor crop uses, including minor use and reduced-risk products and uses. Harmonization work and regulatory projects-- Joint Reviews in collaboration with the U.S. EPA, AAFC and U.S. Department of Agriculture IR-4 Program, further work on crop groupings and on Maximum Residue Levels (MRL) promulgation. Increase communication and provide feedback to AAFC, to improve the quality and use of scientific rationales.
3. NRCan	(b) Develop and facilitate the use of reduced-risk pesticides and biological pesticides for forestry.	$4.1	$0.3	Review final reports of nine projects funded for three years and plan strategy and priorities for future funding. NRCan will continue work to integrate and coordinate activities with the other 5NR partners and stakeholders. The NRCan-CFS Minor Use Advisor hired under this fund will continue to work in collaboration with AAFC to facilitate registration of reduced risk/minor use pest control products against pest on outdoor woody ornamentals and forests. Coordinate and report on six projects for minor use pesticides in Canada. Support for the 2006 National Forest Pest Management Forum. Support for forest projects on reduce risk pest control products.
Results to be Achieved by Non-federal Partners: n/a
Contact Information: Executive Director, PMRA
Approved by:			Date Approved:

 

Horizontal Initiatives for Health Canada, First Nations Inuit Health Branch, Early Childhood Development

Horizontal Initiative: Federal Early Childhood Development (ECD) Strategy for First Nations and Other Aboriginal Children			Lead Department(s): Health Canada, First Nations Inuit Health Branch
Start Date: October 2002			End Date: 2006-2007 and ongoing
Total Funding Allocated: As a result of an ECD Strategy announced in October 2002, $320 million over five years will be dedicated to enhancing various federal ECD programs.
Description: The ECD Strategy for First Nations and Other Aboriginal Children was announced on October 31, 2002. The strategy provides $320 million over five years to: improve and expand existing ECD programs and services for Aboriginal children; expand ECD capacity and networks; introduce new research initiatives to improve understanding of how Aboriginal children are doing; and work towards the development of a "single window" approach to ensure better integration and coordination of federal Aboriginal ECD programming.
Shared Outcome(s): The federal ECD Strategy complements the September 2000 First Ministers F/P/T ECD Agreement. It seeks to address the gap in life chances between Aboriginal and non-Aboriginal children by improving the developmental opportunities that Aboriginal children and their families are exposed to at an early age (0-6 years). These outcomes are shared by the following federal departments: Health Canada - First Nations Inuit Health Branch, Public Health Agency of Canada, Human Resources Development Canada, Social Development Canada, and Indian and Northern Affairs Canada.
Governance Structure(s): Interdepartmental ECD ADM Steering Committee; Interdepartmental ECD Working Group.
Federal Partners Involved in each program	Names of Programs	Total Allocation over 5 years ($ in Thousands)	Planned Spending for 2005-2006	Expected Results for 2005-2006
1. Health Canada Electronic Link: Aboriginal Head Start On Reserve	(a) Aboriginal Head Start on Reserve (AHSOR)	$107,595 from 2002 MC (total for 2002-03 thru to 2006-07)	$21,519 (and ongoing) - committed in 2002	Program expansion and enhancement
Electronic Link: http://www.hc-sc.gc.ca/ fnihb/cp/fas_fae/ index.ht	(b) Fetal Alcohol Spectrum Disorder - First Nations and Inuit Component (FASD-FNIC)	$70,000 (total for 2002-03 thru to 2006-07)	$15,000 (and ongoing) - committed in 2002	Program expansion and enhancement
	(c) Capacity building	$7,575 (total for 2002-03 thru to 2006-07)	$1,515 (and ongoing) - committed in 2002	Program expansion and enhancement
Public Health Agency of Canada Electronic Link: Aboriginal Head Start in Urban and Northern Communities	(a) Aboriginal Head Start Urban and Northern (AHSUN)	$62,880 (total for 2002-03 thru to 2006-07)	$12,576 (and ongoing) - committed in 2002
2. Human Resources Development Canada	(a) First Nations and Inuit Child Care Initiative (FNICCI)	$45,700 (total for 2002-03 thru to 2006-07)	$9,140 (and ongoing) - committed in 2002	Program expansion and enhancement
	(b) Research and knowledge	$21,200 (total for 2002-03 thru to 2006-07)	$4,240 (and ongoing) - committed in 2002	Program expansion and enhancement
3. Indian Affairs and Northern Development	(a) Capacity Building and Indian Children Survey	($5,050 - total for 2002-03 thru to 2006-07)	$1,010 (and ongoing) - committed in 2002	Increased capacity
4. Social Development Canada	(a) Non-applicable
Total		$320,000	$65,000
Results to be achieved by Non-Federal Partners (if applicable):
Contact: Nicki Sims-Jones, Manager, ECD Strategy Unit, First Nations and Inuit Health Branch, Health Canada Postal Locator 1919B Tunney's Pasture, Ottawa Telephone: (613) 948-2589 Fax: (613) 946-4625
Approved by: Carolyn Harrison, Director, Children and Youth Directorate, First Nations and Inuit Health Branch, Health Canada, Postal Locator 1919B, Tunney's Pasture, Ottawa Telephone: (613) 948-5445 Fax: (613) 946-4625			Date Approved: 01/10/05